Generated by All in One SEO v5.0.0.1, this is an llms.txt file, used by LLMs to index the site.

# Global Virus Network

solving viral challenges facing humanity

## Sitemaps

- [XML Sitemap](https://gvn.org/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [Global Virus Network with the Support of the University of South Florida Brings Florida High School Students to the Front Lines of Pandemic Preparedness ](https://gvn.org/globalguardians2026/) - Photo credit: USF Health Global Virus Network with the Support of the University of South Florida Brings Florida High School Students to the Front Lines of Pandemic Preparedness TAMPA, Fla. (July 30, 2026) -Thirty outstanding high school students from 18 communities across Florida arrived in Tampa last week for the Global Virus Network (GVN) Global Guardians for Pandemic Preparedness Program, curious about
- [GVN Ebola Q&A](https://gvn.org/ebola-qa/) - Frequently Asked Questions: 2026 Ebola (Bundibugyo Strain) Outbreak Wednesday, June 24, 2026 12:39 EDT PM Frequently Asked Questions: 2026 Ebola (Bundibugyo Strain) Outbreak What is the current trajectory of the outbreak? The outbreak appears to be ongoing with no clear evidence yet of sustained decline. Improved diagnostic capacity is influencing the apparent case counts in
- [GVN to Host Global Virus Network to Host International Media Briefing on Ebola Outbreak in the Democratic Republic of the Congo](https://gvn.org/global-virus-network-to-host-international-media-briefing-on-ebola-outbreak-in-the-democratic-republic-of-the-congo/) - 2026 GVN Ebola Q&A Full Video Recording Zoom AI Companion Summary Zoom Transcript Global Virus Network to Host International Media Briefing on Ebola Outbreak in the Democratic Republic of the Congo On Wednesday, June 10, 2026 at 8:00-9:00 a.m. EDT / 12:00 PM - 1:00 PM GMT, frontline experts from the DRC, WHO, Africa CDC,
- [Urgent Media Briefing - Ebola in DRC](https://gvn.org/global-media-briefing-for-journalists-ebola/) - MEDIA ALERT Urgent Global Virus Network Media Briefing: Ebola in the DRC - Frontline and Global Experts Provide Updates & Answer Questions on the Outbreak, Risks, and Response For accredited media and journalists only. Advance registration required by 10:00 a.m. GMT/UTC Wednesday, June 10, 2026 Date: Wednesday, June 10, 2026 Time: 8:00-9:00 a.m. EDT
- [GVN Expert Discusses Urgent Need for Greater Global Support to Contain Ebola in Africa](https://gvn.org/gvn-expert-discusses-urgent-need-for-greater-global-support-to-contain-ebola-in-africa/) - GVN Expert Discusses Urgent Need for Greater Global Support to Contain Ebola in Africa In a recent interview with Sky News, Prof. Salim Abdool Karim, GVN Center of Excellence Director of CAPRISA in South Africa, World Health Organization (WHO) Special Advisor on Pandemics, and Chair of the Africa CDC Emergency Consultative Group, discussed the growing
- [Global Virus Network Experts Urge Rapid Regional Action as Bundibugyo Ebola Outbreak Raises Cross-Border Concern](https://gvn.org/global-virus-network-experts-urge-rapid-regional-action-as-bundibugyo-ebola-outbreak-raises-cross-border-concern/) - TAMPA, FL, USA (May 19, 2026) - The Global Virus Network (GVN) calls for greater global financial, logistical and research support for the local response to the rare Bundibugjo Ebola virus outbreak in Africa. The spread of this virus, largely undetected, in the Ituri Province of the Democratic Republic of the Congo (DRC) was declared
- [Hantavirus Cluster Linked to Cruise Ship Highlights Ongoing Zoonotic Risk and the Need for Vigilance](https://gvn.org/hantavirus-cluster-linked-to-cruise-ship-highlights-ongoing-zoonotic-risk-and-the-need-for-vigilance/) - Hantavirus Cluster Linked to Cruise Ship Highlights Ongoing Zoonotic Risk and the Need for Vigilance Experts emphasize caution while underscoring the importance of environmental controls, early detection, and clear communication in travel settings TAMPA, FL, USA (May 5, 2026) - The Global Virus Network (GVN), representing eminent human and animal virologists from more than 90
- [Global Virus Network Statement on H5N1 Vaccine Developments](https://gvn.org/global-virus-network-statement-on-h5n1-vaccine-developments/) - Global Virus Network Statement on H5N1 Vaccine Developments New vaccine momentum reflects growing urgency of avian influenza (H5N1) threat and reinforces need for coordinated global preparedness, building on prior analysis published in The Lancet Regional Health-Americas TAMPA, FL, USA (April 27, 2026) - The Global Virus Network (GVN), representing eminent human and animal virologists from more than 90 Centers of Excellence and Affiliates in
- [Global Virus Network on Measles Resurgence](https://gvn.org/global-virus-network-on-measles-resurgence/) - Global Virus Network on Measles Resurgence Rising cases in the U.S. and globally highlight gaps in vaccination coverage and growing vulnerabilities in public health systems TAMPA, FL, USA (April 21, 2026) - The Global Virus Network (GVN), representing eminent human and animal virologists from more than 90 Centers of Excellence and Affiliates in over 40 countries dedicated to
- [Global Virus Network Annual Meeting Advances a Science-Driven Agenda for Pandemic Preparedness](https://gvn.org/global-virus-network-annual-meeting-advances-a-science-driven-agenda-for-pandemic-preparedness/) - Global Virus Network Meeting Advances a Science-Driven Agenda for Pandemic Preparedness World-leading virologists highlight advances in antiviral therapeutics, artificial intelligence, immunology, and global surveillance shaping how future pandemics may be detected and controlled. TAMPA, FL (April 2, 2026): Artificial intelligence capable of predicting viral evolution months before dangerous variants emerge, next-generation antivirals designed to overcome limitations of current COVID-19
- [Global Virus Network Monitors SARS-CoV-2 Variant BA.3.2 (“Cicada”), Emphasizes No Cause for Alarm](https://gvn.org/global-virus-network-monitors-sars-cov-2-variant-ba-3-2-cicada/) - Global Virus Network Monitors SARS-CoV-2 Variant BA.3.2 ("Cicada"), Emphasizes No Cause for Alarm Early findings show immune escape consistent with Omicron evolution, with no evidence of increased severity or widespread transmission TAMPA, FL, USA (April 3, 2026) - The Global Virus Network (GVN), representing eminent human and animal virologists from more than 90 Centers
- [Global Virus Network Launches Expanded “Global Guardians for Pandemic Preparedness” Program for Florida High School Students](https://gvn.org/global-virus-network-launches-expanded-global-guardians-for-pandemic-preparedness-program-for-florida-high-school-students/) - Global Virus Network Launches Expanded "Global Guardians for Pandemic Preparedness" Program for Florida High School Students Applications now open for immersive five-day summer program at the University of South Florida; deadline April 30 TAMPA, FL (April 1, 2026) - The Global Virus Network (GVN), representing eminent human and animal virologists from more than 90 Centers of Excellence and Affiliates
- [How the next CDC director can win back America’s trust](https://gvn.org/how-the-next-cdc-director-can-win-back-americas-trust/) - Featured in STAT How the next CDC director can win back America's trust A new STAT opinion piece featuring perspectives from GVN leadership Tampa, FL, USA- March 31, 2026 - GVN is pleased to share a new STAT opinion piece by Dr. Charles J. Lockwood (member of the GVN board of directors; executive vice president of USF Health
- [Global Virus Network Awards Education & Training Grants to Advance Next-Generation Virology Research and Pandemic Preparedness](https://gvn.org/global-virus-network-awards-education-training-grants-to-advance-next-generation-virology-research-and-pandemic-preparedness/) - Global Virus Network Awards Education & Training Grants to Advance Next-Generation Virology Research and Pandemic Preparedness Tampa, FL, USA- March 24, 2026 - The Global Virus Network (GVN), a coalition of leading virologists connecting more than 90 Centers of Excellence and Affiliates in over 40 countries dedicated to advancing research, collaboration, and pandemic preparedness, today
- [Global Virus Network Launches First-Ever “Global Guardians” Youth Camp to Prepare the Next Generation of Virus Hunters](https://gvn.org/global-virus-network-launches-first-ever-global-guardians-youth-camp-to-prepare-the-next-generation-of-virus-hunters/) - Global Virus Network Launches First Ever Global Guardians Youth Camp to Prepare the Next Generation of Virus Hunters Three-day program in partnership with USF engages Tampa high school students in virology, pandemic response, and public health careers Tampa, FL, August 20, 2025 - The Global Virus Network (GVN), in partnership with the University of South
- [Global Virus Network opens International Headquarters at University of South Florida](https://gvn.org/global-virus-network-opens-international-headquarters-at-university-of-south-florida/) - GVN and USF leadership cut the ribbon to officially open GVN's International Headquarters at the USF Institute for Translational Virology and Innovation (ITVI). Global Virus Network opens International Headquarters at University of South Florida Tampa, FL (March 9, 2026) - The Global Virus Network (GVN) marked the opening of its International Headquarters on March 5
- [Global Virus Network Statement on Nipah Virus Outbreak](https://gvn.org/gvn-statement-on-nipah-virus-outbreak/) - Global Virus Network Statement on Nipah Virus Outbreak Tampa, FL, USA, January 30, 2026: The Global Virus Network (GVN), representing eminent human and animal virologists from more than 90 Centers of Excellence and Affiliates in over 40 countries dedicated to advancing research, collaboration, and pandemic preparedness, is monitoring reports of a Nipah virus outbreak in
- [Training the Next Generation of Translational Virologists: Reflections from the 2025 Global Virus Network Short Course](https://gvn.org/training-the-next-generation-of-translational-virologists-reflections-from-the-2025-global-virus-network-short-course/) - Training the Next Generation of Translational Virologists: Reflections from the 2025 Global Virus Network Short Course Tampa, FL, USA - January 27, 2026 - The Global Virus Network's (GVN) 2025 Short Course in Translational Virology brought together a remarkable international cohort in December 2025 for eight days of scientific immersion, mentorship, and hands-on learning at
- [Global Virus Network Warns Measles Resurgence](https://gvn.org/global-virus-network-warns-measles-resurgence/) - Global Virus Network Warns Measles Resurgence GVN Urges Measles-Mumps-Rubella (MMR) Vaccination for Unvaccinated Children and Adults to Prevent Avoidable Illness and Death Tampa, FL, USA, January 20, 2026: The Global Virus Network (GVN), representing eminent human and animal virologists from more than 90 Centers of Excellence and Affiliates in over 40 countries dedicated to advancing
- [Global Virus Network Experts: New Flu Strain Underscores Urgent Need for Vigilance, Vaccination, and Investment in Virus Science](https://gvn.org/global-virus-network-experts-new-flu-strain-underscores-urgent-need-for-vigilance-vaccination-and-investment-in-virus-science/) - Tampa, FL, USA, November 20, 2025: The Global Virus Network (GVN), a coalition of leading human and animal virologists in more than 40 countries dedicated to advancing pandemic preparedness through research, education and training, and global health solutions, today issued a statement on the emergence of a new influenza A (H3N2) variant known as H3N2
- [Global Virus Network Announces Appointment of New Board Members](https://gvn.org/global-virus-network-announces-appointment-of-new-board-members/) - Global leaders in science, medicine, and journalism join GVN's Board to strengthen pandemic preparedness and global health Tampa, FL, USA - December 10, 2025 - The Global Virus Network (GVN), a worldwide coalition of leading human and animal virologists from 90+ Centers of Excellence and Affiliates in more than 40 countries dedicated to advancing research
- [Global Virus Network Statement on the Marburg Virus Outbreak in Ethiopia](https://gvn.org/global-virus-network-statement-on-the-marburg-virus-outbreak-in-ethiopia/) - Tampa, FL, USA, November 26, 2025: The Global Virus Network (GVN), a coalition of leading human and animal virologists in more than 40 countries dedicated to advancing pandemic preparedness through research, education and training, and global health solutions, today issued a statement on the newly confirmed outbreak of Marburg virus disease (MVD) in southern Ethiopia.
- [Global Virus Network Awards Pandemic Preparedness Grants to Advance Global Surveillance and Early Detection of Viral Threats](https://gvn.org/global-virus-network-awards-pandemic-preparedness-grants-to-advance-global-surveillance-and-early-detection-of-viral-threats/) - Tampa, FL, USA - November 20, 2025 - The Global Virus Network (GVN) is pleased to announce that, for the first time, it is awarding pandemic preparedness research grants, totaling $160,000, to GVN scientists across four continents. These awards support innovative, investigator-led projects designed to enhance viral surveillance, early detection, and scientific preparedness, particularly in
- [Global Virus Network Welcomes New Centers of Excellence Across the Americas](https://gvn.org/global-virus-network-welcomes-new-centers-of-excellence-across-the-americas/) - University of South Florida's Institute for Translational Virology & Innovation, Brazil's Department of Microbiology, Immunology and Parasitology at the Federal University of São Paulo, and Canada's Pathogen Research Centre at Western University bring advanced expertise in HIV, arboviruses, and pandemic preparedness TAMPA, FL, USA, October 30, 2025 - The Global Virus Network (GVN), a coalition
- [Global Virus Network Launches Multi-Country Mpox Diagnostic Evaluation to Close Global Preparedness Gaps](https://gvn.org/global-virus-network-launches-multi-country-mpox-diagnostic-evaluation-to-close-global-preparedness-gaps/) - Tampa, FL, USA - September 25, 2025 - With global attention shifting away from mpox after recent declines in case counts, the Global Virus Network (GVN) is warning against complacency and urges accelerating efforts to strengthen outbreak readiness. Through its Mpox Action Committee and Centers of Excellence, GVN has initiated one of the first coordinated,
- [GLOBAL VIRUS NETWORK ANNOUNCES 2025 RISING STAR MENTORSHIP PROGRAM AWARDEES](https://gvn.org/global-virus-network-announces-2025-rising-star-mentorship-program-awardees/) - Five early-career virologists selected for prestigious two-year mentorship and research program Tampa, FL, August 27, 2025 - The Global Virus Network (GVN), a worldwide coalition of animal and human virologists spanning 80+ Centers of Excellence and Affiliates across more than 40 countries dedicated to advancing pandemic preparedness, announced today the five distinguished recipients of its
- [Global Virus Network Reaffirms Support for mRNA Vaccines and Collaborative Vaccine Research ](https://gvn.org/global-virus-network-reaffirms-support-for-mrna-vaccines-and-collaborative-vaccine-research/) - Scientists Throughout the World Must Commit to Advancing the Development of mRNA Vaccine Technology and Reassure the Public of its Safety Tampa, FL, USA, August 11, 2025 - The Global Virus Network (GVN), a coalition of leading human and animal virologists from 80+ Centers of Excellence and Affiliates in more than 40 countries dedicated to
- [A Statement from the Global Virus Network (GVN) on the Rapidly Escalating Measles Crisis in the U.S. and Worldwide](https://gvn.org/a-statement-from-the-global-virus-network-gvn-on-the-rapidly-escalating-measles-crisis-in-the-u-s-and-worldwide/) - GVN Urges Immediate Action to Reverse Declining Immunization Rates Amid Largest U.S. Measles Surge in Decades Tampa, FL, USA, July 16, 2025 - The Global Virus Network (GVN), a coalition of leading human and animal virologists from 80+ Centers of Excellence and Affiliates in more than 40 countries, is sounding the alarm over a sharp resurgence of
- [Global Virus Network Expands Global Capacity with New Centers of Excellence in Brazil and Florida](https://gvn.org/global-virus-network-expands-global-capacity-with-new-centers-of-excellence-in-brazil-and-florida/) - Brazil's Universidade Federal de Minas Gerais and the University of Florida Emerging Pathogens Institute Named Newest Centers of Excellence Tampa, FL, USA, June 25, 2025: The Global Virus Network (GVN), an international coalition of eminent human and animal virologists from 80+ Centers of Excellence and Affiliates in 40+ countries, announced today the addition of two distinguished
- [Global Virus Network Issues Scientific Guidance on New COVID-19 Variant NB.1.8.1 and Vaccine Protection](https://gvn.org/global-virus-network-issues-scientific-guidance-on-new-covid-19-variant-nb-1-8-1-and-vaccine-protection/) - Scientific collaboration, accurate public communication, and continued investment in prevention tools are critical in navigating the evolving COVID-19 landscape Tampa, FL, USA, June 5, 2025: The Global Virus Network (GVN) is closely monitoring the emergence of a newly identified SARS-CoV-2 variant, NB.1.8.1, a sublineage of the Omicron family. This variant was first identified in January 2025 and has
- [Global Virus Network Statement in Support of the WHO Pandemic Preparedness Accord Edit](https://gvn.org/global-virus-network-statement-in-support-of-the-who-pandemic-preparedness-accord-edit/) - Tampa, FL, USA, May 21, 2025: The Global Virus Network (GVN) strongly supports the World Health Organization's (WHO) newly adopted Pandemic Preparedness Accord. This agreement represents a vital and timely step toward establishing a more coordinated, transparent, and equitable global framework for pandemic prevention, preparedness, and response. GVN, an international coalition of leading virologists and
- [Global Virus Network Meeting Unites Caribbean and Latin America to Tackle Emerging Viral Threats](https://gvn.org/global-virus-network-meeting-unites-caribbean-and-latin-america-to-tackle-emerging-viral-threats/) - Dr. Christine Carrington of UWI St. Augustine Honored with Inaugural GVN Regional Leadership Award for Advancing Genomic Surveillance and Pandemic Preparedness KINGSTON, JAMAICA - May 8, 2025 - The Global Virus Network (GVN), in partnership with The University of the West Indies (UWI) Mona Campus and the State University of New York (SUNY) at the
- [Strengthening Global Pandemic Preparedness: The Urgent Need for Investment, Collaboration, and Action](https://gvn.org/strengthening-global-pandemic-preparedness-the-urgent-need-for-investment-collaboration-and-action/) - A Statement by the Global Virus Network Tampa, FL, USA, April 30, 2025: The Global Virus Network (GVN) is highly concerned that the world is unprepared for the next pandemic and has not incorporated the lessons learned from COVID-19. The GVN, comprised of 80+ Virology Centers of Excellence and Affiliates in 40+ countries, whose mission
- [Global Virus Network Issues Urgent Call to Action to Mitigate the Rising Threat of H5N1 Avian Influenza](https://gvn.org/global-virus-network-issues-urgent-call-to-action-to-mitigate-the-rising-threat-of-h5n1-avian-influenza/) - Top global virologists publish a comprehensive analysis and advocate for a multi-government initiative in the Lancet Regional Health-Americas Tampa, FL, USA, April 28, 2025: Today, the Global Virus Network (GVN), representing eminent human and animal virologists from 80+ Centers of Excellence and Affiliates in 40+ countries, published a comprehensive analysis and call-to-action in The Lancet
- [ Associated Press: Measles is popping up in the US. Here’s how to avoid one of the world’s most contagious viruses](https://gvn.org/measles-is-popping-up-in-the-us-heres-how-to-avoid-one-of-the-worlds-most-contagious-viruses/) - Measles is not often seen in the United States, but Americans are growing more concerned about the preventable virus as cases continue to rise in rural West Texas. Last week, an unvaccinated child died in the outbreak, which involves nearly 200 cases. The U.S. Centers for Disease Control and Prevention said the last confirmed measles death in the
- [A Statement from the Global Virus Network (GVN) on the Rise of Measles Cases in the U.S. and Global Implications](https://gvn.org/a-statement-from-the-global-virus-network-gvn-on-the-rise-of-measles-cases-in-the-u-s-and-global-implications/) - A Statement from the Global Virus Network (GVN) on the Rise of Measles Cases in the U.S. and Global Implications The GVN urgently recommends the measles-mumps-rubella (MMR) vaccine for unvaccinated children and adults to prevent avoidable and unnecessary health crises Tampa, FL, USA, March 24, 2025: The Global Virus Network (GVN), representing eminent human and
- [Global Experts Convene in Tampa to Explore the Cutting-Edge Science of Microbiomes and Biodiversity for Global Health Solutions](https://gvn.org/global-experts-convene-in-tampa-to-explore-the-cutting-edge-science-of-microbiomes-and-biodiversity-for-global-health-solutions/) - WELCOME TO THE Global Experts Convene in Tampa to Explore the Cutting-Edge Science of Microbiomes and Biodiversity for Global Health Solutions Tampa, Florida - March 4, 2025 - A groundbreaking gathering of international experts at the 2nd International Conference on Microbiomes, Biodiversity, and Their Impact on Global and One Health highlights the transformative potential of
- [Global Virus Network Celebrates the 2024 Lasker-Bloomberg Public Service Award for Quarraisha Abdool Karim and Salim S. Abdool Karim](https://gvn.org/gvn-celebrates-lasker-award-for-drs-abdool-karim/) - The Global Virus Network (GVN) proudly congratulates Quarraisha Abdool Karim and Salim S. Abdool Karim on their receipt of the prestigious 2024 Lasker~Bloomberg Public Service Award. As leading members of the GVN, including as hosts of the GVN Annual Scientific Meeting last month in Durban, South Africa, Drs. Abdool Karim have demonstrated unwavering commitments to
- [A Statement from the Global Virus Network (GVN) on the Passing of Dr. Diane Griffin](https://gvn.org/a-statement-from-the-global-virus-network-gvn-on-the-passing-of-dr-diane-griffin/) - Johns Hopkins Bloomberg School of Public Health's Dr. Diane Griffin was an inaugural member of the GVN and recipient of the 2017 GVN Robert C. Gallo Award for Scientific Excellence and Leadership Tampa, FL, USA, November 5, 2024: The Global Virus Network (GVN) mourns the passing of the 2017 GVN Robert C. Gallo Award for
- [Global Virus Network Bolsters Multinational Mpox Response Through Critical Meeting of Key Global Partners](https://gvn.org/gvn-bolsters-mpox-response/) - Laboratory Leadership Service (LLS) fellow Nicolle Baird piloting a real-time polymerase chain reaction (PCR) assay in Ghana to better understand the mpox outbreak occurring in the West Africa region in November 2022. Credit: U.S. CDC Last week's meeting marked a prelude to GVN's international meeting in Durban, South Africa, September 16-18, 2024 Tampa, FL (August
- [Global Outbreaks of Monkeypox](https://gvn.org/global-outbreaks-of-monkeypox-2/) - May 25, 2022 INTRODUCTION WHO and other health organizations are alarmed at the recent global outbreak of monkeypox. As of May 21, 2022, more than 80 cases of monkeypox have been confirmed in at least 12 countries outside of Africa (1). The first case of the disease in the UK was reported on May 7,
- [GVN Convenes First-of-its-kind Conference to Evaluate the Public Health Magnitude of Long Covid](https://gvn.org/global-virus-network-gvn-convenes-first-of-its-kind-conference-to-evaluate-the-public-health-magnitude-of-long-covid-and-define-a-global-research-roadmap-to-address-the-crisis/) - GVN Convenes First-of-its-kind Conference to Evaluate the Public Health Magnitude of Long Covid and Define a Global Research Roadmap to Address the Crisis World Leaders in Science, Healthcare, Academia, Business and Government Discuss Issues and Ramifications of Long Covid Baltimore, MD, USA (July 22, 2022) – The Global Virus Network (GVN), a coalition of world leading
- [GVN Adds Four New Centers](https://gvn.org/gvn-adds-four-new-centers/) - Global Virus Network (GVN) Adds Duke University School of Medicine, Czech Republic's National Institute of Virology and Bacteriology, University of Pennsylvania Perelman School of Medicine, and Yale University as Newest Centers of Excellence Tampa, FL, USA, February 4, 2025: The Global Virus Network (GVN), comprised of eminent human and animal virologists from 80+ Centers of
- [USF Selected as the International Headquarters of the Global Virus Network](https://gvn.org/usf-selected-as-the-international-headquarters-of-the-global-virus-network/) - Dr. Robert Gallo, world-renowned scientist and co-discoverer of HIV, joins USF medical school faculty TAMPA, Fla. (June 5, 2024) -- The University of South Florida will serve as host for the international headquarters of the Global Virus Network, a distinguished organization comprised of virologists spanning in excess of 80 Centers of Excellence and Affiliates in
- [Marburg Virus Disease: Another Filovirus Zoonosis](https://gvn.org/marburg-virus-disease-another-filovirus-zoonosis/) - Updated: December 20, 2024 The Marburg Virus Disease (MVD) outbreak in Rwanda has officially been declared over as of December 20, 2024. The outbreak, first declared on September 27, 2024, included ten infected individuals and claimed six lives at the time of its announcement. By November 8, 2024, Rwanda reported a total of 66 confirmed
- [Global Virus Network’s Annual Meeting Fortifies Bonds on the African Continent to Catalyze Innovative Research, Strengthen Pandemic Preparedness, and Combat Scientific Misinformation](https://gvn.org/gvn-fortifying-bonds-on-the-african-continent/) - Duke-NUS Medical School's Dr. Linfa Wang Awarded GVN's 2024 Robert C. Gallo Award for Scientific Excellence and Leadership Durban, South Africa (,September 18, 2024) - The Global Virus Network concluded its annual meeting of closed scientific sessions held 16-18 September 2024 with a press conference. Co-hosted by the Centre for the AIDS Programme of Research
- [The Global Virus Network (GVN) Escalates MPOX Emergency Response Across Africa and Beyond](https://gvn.org/the-global-virus-network-gvn-escalates-mpox-emergency-response-across-africa-and-beyond/) - Credit: Institute of Tropical Medicine, Belgium The GVN MPOX Action Committee is poised to mobilize resources and catalyze efforts in the urgent global call to action As the World Health Organization (WHO) declares MPOX a public health emergency of international concern, the Global Virus Network (GVN), headquartered at the University of South Florida (USF), USA, Credit: Institute of Tropical Medicine, Belgium The GVN MPOX Action Committee is poised to mobilize resources and catalyze efforts in the urgent global call to action As the World Health Organization (WHO) declares MPOX a public health emergency of international concern, the Global Virus Network (GVN), headquartered at the University of South Florida (USF), USA,
- [GVN Experts Convene to Discuss H5N1 Flu -- 3rd ad hoc panel](https://gvn.org/gvn-experts-convene-to-discuss-influenza-3rd-panel/) - On July 30th, the Global Virus Network hosted a 3rd ad hoc panel of experts to discuss the highly pathogenic avian influenza virus. This panel brought together experts to discuss and analyze potential implications for human health and global health security, strategizing responses to this viral threat. The 1st ad hoc panel occurred on May
- [GVN Experts Convene to Discuss H5N1 Flu -- 2nd ad hoc panel](https://gvn.org/gvn-experts-convene-to-discuss-influenza-2nd-panel/) - On June 27th, the Global Virus Network hosted a 2nd ad hoc panel of experts to discuss the highly pathogenic avian influenza virus. This panel brought together experts to discuss and analyze potential implications for human health and global health security, strategizing responses to this viral threat. The 1st ad hoc panel occurred on May
- [Global Virus Network Experts Convene to Discuss H5N1 Flu](https://gvn.org/gvn-experts-convene-to-discuss-h5n1-flu/) - On May 13 at 10 a.m. EDT, the Global Virus Network will host an ad hoc panel of experts to discuss the highly pathogenic avian influenza virus (H5N1) circulating worldwide, now considered a "pandemic among animals" (panzootic). This panel brings together experts to discuss and analyze potential implications for human health and global health security,
- [Battling Pandemic Viruses Like Avian Influenza](https://gvn.org/battling-pandemic-viruses-like-avian-influenza/) - Authors: Maggie L. Bartlett, PhD, and Sten Vermund, MD, PhD The increasing number of avian influenza spillovers to non-bird species demands innovation to prevent a future influenza pandemic. As deadly as the coronavirus pandemic has been, the catastrophic potential of influenza viruses is much worse. The 1918-1919 influenza pandemic infected a third of the world's
- [Further Thoughts on Viral Persistence](https://gvn.org/further-thoughts-on-viral-persistence/) - August 2, 2022 INTRODUCTION Our previous Perspectives focused on the question of whether persistent cryptic expression of virus might be contributory to long COVID. To further consider this question, it may be useful to look at examples of persistence by other viruses. DNA VIRUSES The clearest and most easily understood examples of persistence are found
- [Is Infection of Astrocytes a Causative Factor in COVID Brain Fog? ](https://gvn.org/is-infection-of-astrocytes-a-causative-factor-in-covid-brain-fog/) - September 12, 2022 INTRODUCTION One of the prominent symptoms of COVID-19, especially long COVID, is called "brain fog", which includes deficits in attention and concentration, memory, and executive function. This raises the question of the cause. One possibility is that it is only an indirect effect from dysregulated immune activity and/or inflammation. A second possibility is that it is due to direct infection of cell populations within the
- [Vaccine and Post-Infection Immunity](https://gvn.org/vaccine-and-post-infection-immunity/) - Immunity against SARS-CoV-2 is acquired in two ways, infection and vaccination. How do they differ? Which is "better"? In comparisons, consideration must be given to rates of infection, transmission, hospitalization, death, and long COVID as well as innate, humoral and cell-mediated immune responses. The only correlate of protection that is currently considered robust is the
- [Dengue virus: Urgency in our warming world](https://gvn.org/dengue-virus-urgency-in-our-warming-world/) - Why is this important? In the summer of 2023, Mexico and countries in Central America and the Caribbean were in the news because of extensive outbreaks of the mosquito-borne dengue virus (DENV) (1). These outbreaks were at least partially weather-related: Warmer temperatures exacerbated by El Niño and global warming are linked to heavier-than-normal precipitation
- [‘Triple-demic’ of respiratory illnesses launches vaccination season. Have you gotten yours?](https://gvn.org/triple-demic-of-respiratory-illnesses-launches-vaccination-season/) - The letter below, written by GVN's president, Dr. Sten Vermund, was originally published in The Baltimore Sun. We are amid the "triple-demic" of respiratory illnesses season that includes a significant increase in U.S. COVID-19 hospitalizations alongside annual seasonal surges in respiratory viruses like influenza ("the flu") and respiratory syncytial virus (RSV). For the flu and
- [GVN Announces Participant of Postdoctoral Fellowship Program](https://gvn.org/gvn-announces-participant-of-postdoctoral-fellowship-program/) - Awardee to receive training and mentorship to help propel his rising career in virology Baltimore, MD, December 12, 2023: The Global Virus Network (GVN) a coalition comprised of human and animal virologists from 71 Centers of Excellence and 9 Affiliates in 40 countries, announced the recipient of the GVN - Abbott Pandemic Defense Postdoctoral Fellowship.
- [U.S. Senate Committee on Appropriations Full Committee Hearing “U.S. Government Response: Fighting Ebola and Protecting America” Wednesday, November 12, 2014 Testimony submitted by: Global Virus Network (GVN)](https://gvn.org/u-s-senate-committee-on-appropriations-fighting-ebola-and-protecting-america/) - Robert C. Gallo, MD, GVN Co-Founder and Scientific Director, and Director of GVN Center of Excellence at the Institute of Human Virology (IHV), University of Maryland School of Medicine; Stanley Plotkin, MD, GVN Senior Advisor, University of Pennsylvania; Diane Griffin, MD PhD, GVN Center of Excellence Director at the Johns Hopkins Bloomberg School of Public
- [Universal Access to New Vaccines in 2023: A Necessity for Public Health](https://gvn.org/universal-access-to-new-vaccines-in-2023-a-necessity-for-public-health/) - A Joint Statement by the World Health Network and Global Virus Network Respiratory virus season in 2023-2024 is a significant challenge in the fight against COVID-19. We know that even mild cases of COVID-19 may affect people's daily lives for several days or weeks, and we all have seen-even among previously healthy individuals-that the repercussions
- [Internationally Renowned Public Health Expert Sten Vermund Appointed GVN President](https://gvn.org/gvn-appoints-new-president-sten-vermund/) - Brings Decades Of Infectious Disease Epidemiology & Prevention Experience Enhancing GVN's Abilities To End Viral Threats & Advance Pandemic Preparedness Baltimore, MD, November 2, 2023: The Global Virus Network (GVN) today announced the appointment of Sten Vermund, MD, PhD, as President of the GVN. Dr. Vermund is the Anna M.R. Lauder Professor of Public Health,
- [Annual Meeting Catalyzes Information-Sharing on Cutting-Edge Discoveries to Contribute to Necessary Changes in Pandemic Preparedness](https://gvn.org/annual-meeting-catalyzes-information-sharing/) - Tulane's Dr. Robert Garry Awarded GVN's 2023 Robert C. Gallo Award for Scientific Excellence and Leadership Monte Carlo, Monaco, October 24, 2023: Capping the three day meeting of the Global Virus Network (GVN)-hosted in partnership with the Centre Scientifique de Monaco (CSM, a GVN Affiliate) and the Princely Government of Monaco-were intimate discussions between H.S.H.
- [Global Virus Network’s Top Virologists Partner with Monaco to Advance Pandemic Preparedness Across EU Countries](https://gvn.org/gvn-top-virologists-partner-with-monaco-102023/) - The first day of the joint meeting also included discussion on harnessing the powers of artificial intelligence (AI) to transform pandemic preparedness Monte Carlo, Monaco, October 20, 2023: The first of three days of the annual meeting of the Global Virus Network (GVN), hosted in partnership with the Centre Scientifique de Monaco (CSM, a GVN
- [Top Virologists to Meet in Monaco to Tackle Ongoing Pandemic Challenges and Emerging Viral Threats](https://gvn.org/top-virologists-to-meet-in-monaco/) - World-Renowned Experts of the Global Virus Network will Discuss Ending Viral Threats Through Global Collaborative Science, Innovation, and Implementation The Global Virus Network (GVN), in partnership with the Centre Scientifique de Monaco (CSM, a GVN Affiliate), the Fondation Prince Albert II de Monaco, and the Princely Government of Monaco, will host the GVN 2023 international
- [Response to A Recent Outbreak of Nipah Virus in India in the context of COVID-19 pandemic](https://gvn.org/response-to-a-recent-outbreak-of-nipah-virus-in-india-in-the-context-of-covid-19-pandemic/) - February 24, 2022 Context India experienced a devastating second wave of COVID-19 between February and early May of 2021. Since then, cases have declined gradually. Interestingly, the southern Indian state of Kerala accounted for more than half of the country's new COVID-19 infections this summer, but Kerala has one of India's lowest COVID-19 fatality rates
- [Improving Ventilation and Filtration for Public Health](https://gvn.org/improving-ventilation-and-filtration-for-public-health/) - The Global Virus Network recommends public health agencies update and standardize their guidance regarding indoor air quality so that people can more easily follow that guidance. * * * Recently, the U.S. Centers for Disease Control and Prevention (CDC) updated its guidance regarding ventilation in buildings, calling for five air changes per hour (1). That
- [Mpox (Monkeypox): We Must Not Let Our Guard Down](https://gvn.org/mpox-monkeypox-we-must-not-let-our-guard-down/) - The Global Virus Network (GVN) recommends people and public health agencies continue taking precautions against the spread of Mpox, which is still spreading and evolving. * * * This month, the World Health Organization declared an end to the Mpox emergency and urged a transition to a "robust, proactive and sustainable" response to Mpox. Although
- [On the Pandemic Potential for Influenza Currently Circulating Among Birds and Mammals](https://gvn.org/on-the-pandemic-potential-for-influenza-currently-circulating-among-birds-and-mammals/) - The Global Virus Network (GVN) recommends that people in close contact with birds and mammals (wild or farmed) use personal protective equipment and get vaccinated against seasonal influenza. * * * It is nearly impossible to predict if the currently spreading avian influenza will become even better adapted to mammals and spill over to people.
- [Responding to Long COVID Responsibly](https://gvn.org/responding-to-long-covid-responsibly/) - To effectively address the unique challenges presented by Long COVID, the Global Virus Network recommends a unified and integrated approach involving the public, policymakers, and those involved in the research enterprise and in healthcare systems to create and implement policy changes, support continuing research, foster awareness, and advocate for-and initiate-multi-specialty care. *
- [Lassa fever vaccine development: Where are we?](https://gvn.org/lassa-fever-vaccine-development-where-are-we/) - Joseph Anejo-Okopi, PhD1,2. 1Department of Microbiology, Faculty of Science, Federal University of Health Sciences Otukpo, Nigeria. 2AIDS Prevention Initiative in Nigeria, Jos University Teaching Hospital, Jos, Nigeria Email Address: josephokopi@yahoo.com, joseph.okopi@fuhso.edu.ng, December 5, 2022 Introduction Lassa virus (LASV) causes acute viral hemorrhagic fever (VHF) called Lassa fever (LF) that is endemic to West Africa (Nigeria,
- [Antivirals in the Time of Coronavirus](https://gvn.org/antivirals-in-the-time-of-coronavirus/) - An Evaluation of Remdesivir and Hydroxychloroquine Many years ago, efforts to contain HIV resulted in the first widespread successful use of antiviral drugs, including deoxynucleotide analogs such as AZT, able to terminate reverse transcription of viral RNA. The current coronavirus pandemic has spurred extensive efforts to identify effective and safe anti-SARS-CoV-2 drugs. Recent reports have
- [Testing for SARS-COV-2](https://gvn.org/testing-for-sars-cov-2/) - Testing, Testing, Testing... The uncertainties about SARS-CoV-2 include critical questions such as what the death rate is for infected people, and what the infection rate is for the general public. This makes testing for infection of critical importance. There are numerous ways to establish the presence of infection. One is recovery of live virus, which
- [So Will and When Will We Have a Vaccine?](https://gvn.org/so-will-and-when-will-we-have-a-vaccine/) - Just to cut to the chase, we just do not know; but we may hope for one year and a half to two years, maybe less. And that will be great, but we have to distinguish between getting early evidence of efficacy and getting a vaccine ready for mass vaccination. But let’s consider background material
- [Why Do Genes and Mutations Matter in SARS-CoV-2?](https://gvn.org/why-do-genes-and-mutations-matter-in-sars-cov-2/) - Why should we concern ourselves with genetics and mutations in SARS-CoV-2? There are many reasons why these are of interest, including the rate at which mutations are occurring. One reason is that mutations can result in immune evasion. Changes can occur in recognition sites (epitopes) for antibodies and for cytotoxic T cells, and these could,
- [New Insights into the SARS-CoV-2 Vaccine](https://gvn.org/new-insights-into-the-sars-cov-2-vaccine/) - There has been some very interesting news in the last several days that relate to vaccine development. The first of these is a report of results on the Phase 1 trials of the Moderna mRNA vaccine. Most importantly, the vaccine appeared to be safe; no major adverse events were reported. Vaccines developed binding antibodies to
- [What’s Going to Happen When Summer Gets Here?](https://gvn.org/whats-going-to-happen-when-summer-gets-here/) - How seasonality and climate affect SARS-CoV-2 There has been much speculation over the effects of climate on the spread of SARS-CoV-2. This is obviously a difficult question, as there are many variables to tease apart, including: population density, socioeconomic status, geography, and cultural norms. Viral -transmission seems to occur more easily indoors than outdoors. Another
- [So Where Did the Virus Come From, Anyway?](https://gvn.org/so-where-did-the-virus-come-from-anyway/) - The question of where viruses involved in spillover zoonoses originate is always important and fascinating. Identifying their origin is critical in understanding how zoonotic epidemics originate, and in preparing preventive strategies for future epidemic. Fascinating, because identification, like solving a difficult whodunit, involves a series of forensics including those from epidemiology, molecular genetics, phylogenetics, and
- [On the Surface, Using a Good Disinfection Strategy Matters](https://gvn.org/on-the-surface-using-a-good-disinfection-strategy-matters/) - One approach to COVID-19 that has been gaining traction, is the idea of decontaminating surfaces to inactivate viruses that have been deposited upon them, either by aerosols, droplets, or contaminated touch. Infection from surfaces is a major concern for public entities and private businesses such as schools, public transportation, airlines, hotels, hospitals and doctors’ offices,
- [Further Insights into SARS-CoV-2 Genetic Variability: D614G](https://gvn.org/further-insights-into-sars-cov-2-genetic-variability-d614g/) - Can a single amino acid mutation in the spike protein affect the infectivity and immunogenicity of SARS-CoV-2? Recently, a great deal of attention has become focused on a specific SARS-CoV2 mutant in which amino acid residue 614 of the spike protein is changed from aspartic acid to the less bulky and more neutral glycine. This
- [Antibody Dependent Enhancement and SARS-CoV-2](https://gvn.org/antibody-dependent-enhancement-and-sars-cov-2/) - When Developing a SARS-CoV-2 Vaccine, Researchers Need to Consider that Antibodies May Enhance Infection Rather than Provide Protection There is encouraging news from recent clinical trials of SARS-CoV-2 vaccines, including several candidate vaccines that induce neutralizing antibodies with no apparent adverse effects. Their protective efficacy at preventing infections is not yet known, but will be
- [SARS-CoV-2 Salivary Tests](https://gvn.org/sars-cov-2-salivary-tests/) - The benefits of saliva sampling for frequent and massive COVID-19 testing Saliva tests for detection of SARS-CoV-2 RNA and antigens are becoming widely available lately. What are the advantages and disadvantages of sampling saliva over the nasal swabs? Saliva sampling simply involves spitting into a collection container. Recently, the U.S. Food and Drug Administration (FDA)
- [The Role of Cytokine Storm in the Severity of COVID-19](https://gvn.org/the-role-of-cytokine-storm-in-the-severity-of-covid-19/) - There are two ways in which pathogens make us sick. One is by the direct effects of the pathogen itself. The other is by collateral damage from our hyperactive immune responses to the pathogen by the release of interferons (IFNs), interleukins (ILs), tumor-necrosis factors (TNF-α), chemokines, and several other mediators. This latter mechanism has appeared
- [Hydroxychloroquine-What’s the Deal?](https://gvn.org/hydroxychloroquine-whats-the-deal/) - The absence of efficient therapeutics for COVID-19 has brought much attention to evaluation of repurposing drugs. Hydroxychloroquine (HC) is an antimalarial drug that affects endosomal function and blocks autophagosome-lysosome fusion (1). Since coronaviruses use the endolysosomal pathway to enter the cell before uncoating, HC has been shown to inhibit SARS-CoV-2 replication in cellular models. The
- [Will Neutralizing and Therapeutic Antibodies Play a Role in the Treatment of COVID-19?](https://gvn.org/will-neutralizing-and-therapeutic-antibodies-play-a-role-in-the-treatment-of-covid-19/) - Interest has increasingly been focused on the potential of virus-neutralizing monoclonal antibodies (mAbs) to treat COVID-19 by passive immunization. These antibodies generally target the viral spike protein to prevent infection by blocking ACE2 receptor binding to its receptor binding domain (RBD). There are several issues, however, that need to be addressed to determine when and
- [COVID-19 Vs. Influenza: Influenza Vaccination Amid COVID-19 Pandemic](https://gvn.org/covid-19-vs-influenza-influenza-vaccination-amid-covid-19-pandemic/) - Severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2), a highly contagious virus, emerged in 2019 from Wuhan, China (1). It rapidly spread around the world causing a novel acute respiratory disease, coronavirus disease 2019 (COVID-19). The World Health Organization (WHO) declared COVID-19 a pandemic on March 11, 2020. Consequently, the current COVID-19 pandemic impacts global health and
- [Current Status of COVID-19 Vaccine Development](https://gvn.org/current-status-of-covid-19-vaccine-development/) - As the COVID-19 pandemic expands, interests in the progress of vaccine development are intensifying. Despite an unprecedented rate of progress, it is still uncertain when a safe, effective vaccine will be available for wide distribution to the public. Successful vaccine development goes through a series of stages, from animal studies for the evaluation of its
- [Transmission Dynamics of SARS-CoV-2: Superspreaders and Superspreading Events](https://gvn.org/transmission-dynamics-of-sars-cov-2-superspreaders-and-superspreading-events/) - The concept of Superspreaders and Superspreading events has recently attracted a lot of attention. In fact it is important to understand that most of SARS-CoV-2 infected persons are in fact not contagious! Thus, transmission is really dependent on a handful of individuals we call Superspreaders who nurture Superspreading events. Let’s distinguish between Superspreaders and Superspreading
- [Effect of Suppressed Innate Immunity on Covid-19 Severity](https://gvn.org/effect-of-suppressed-innate-immunity-on-covid-19-severity/) - One of the important determinants of severe Covid-19 appears to be an inappropriate response by the innate immune system. Specifically, this involves, on the one hand, insufficient or delayed expression and signaling by type 1 interferons (IFNs), which induce innate cell-mediated immunity. The interferon (IFN) response constitutes the major first line of defense against viruses.
- [Herd Immunity - Can We Get There?](https://gvn.org/herd-immunity-can-we-get-there/) - The concept of herd immunity is frequently brought up as an alternative to lockdown and intervention-based strategies for curbing the COVID-19 pandemic, this sensitive issue being much influenced by policy makers. In this context it is important to first define herd immunity. This is obtained when enough of the population has immunity to an infectious
- [How Long Is A SARS-CoV-2 Infected Person Contagious?](https://gvn.org/how-long-is-a-sars-cov-2-infected-person-contagious/) - As the COVID-19 pandemic rages on, the global community has become accustomed to comprehensive, interventional strategies such as wearing a mask, social distancing, hand hygiene, and surface cleaning and disinfection. It is well known that transmission of SARS-CoV-2 occurs through direct, indirect, or close contact with infected people through infectious secretions, such as saliva and
- [Rapid and Frequent Testing for COVID-19](https://gvn.org/rapid-and-frequent-testing-for-covid-19/) - The cases of new SARS-CoV-2 infections are currently increasing at an alarming rate, suggesting that winter might bring a large healthcare crisis. Diagnostics have become a critical tool in curbing COVID-19. It is important that accurate results be obtained rapidly and that collection of samples be as fast, simple, and convenient as possible. What tests
- [Progress in the Treatments of COVID-19](https://gvn.org/progress-in-the-treatments-of-covid-19/) - Since the beginning of the COVID-19 pandemic, extensive research has focused on therapeutics. A combinational approach of traditional drug development and drug repurposing is necessary to make progress in treating and preventing COVID-19 in a timely manner. While developing new drugs is critical, repurposing existing molecules has been a major strategy. In the early stages
- [Interferon Antagonism of SARS-CoV-2](https://gvn.org/interferon-antagonism-of-sars-cov-2/) - It has become clear that the type 1 interferon responses to SARS-CoV-2 have a great deal to do with the outcome of infection. Patients with benign courses of infection yield high levels of expression of interferon-α (IFNα), while critical cases of COVID-19 show low levels of its expression. Paradoxically, in severe disease, expression of INF
- [What does it mean to be a COVID-19 Long-Hauler?](https://gvn.org/what-does-it-mean-to-be-a-covid-19-long-hauler/) - What does it mean to be a COVID-19 Long-Hauler? Some of the serious aspects of COVID-19 are long-term symptoms that persist for a significant period after SARS-CoV-2 infection and acute symptoms have apparently resolved. People experiencing these conditions have been called “long-haulers” and are a consequential proportion of those infected with SARS-CoV-2. Particularly, many patients
- [Emergence and Global Spread of SARS-CoV-2 Variants](https://gvn.org/emergence-and-global-spread-of-sars-cov-2-variants/) - Emergence and Global Spread of SARS-CoV-2 Variants With the extended COVID-19 pandemic, SARS-CoV-2 is evolving, and multiple COVID-19 variants are circulating globally. Since December, 2020, a great deal of attention has been focused on emergence of SARS-CoV-2 variants from the UK (VOC 202012/01; B1.1.7. lineage) and from South Africa (20C/501Y.V2; B.1.351 lineage). In the UK,
- [Update on SARS-CoV-2 Variants](https://gvn.org/update-on-sars-cov-2-variants-020521/) - Update on SARS-CoV-2 Variants Efficient Vaccine Distribution is Critical to Mitigate the Continuing Evolution of SARS-CoV-2 February 5, 2021 We’ve recently reported on SARS-CoV-2 variants, and described some of the reasons for concern. These include increased transmissibility, the possibility of false negative tests for viral RNA, resistance to immune protection from vaccine or prior infection,
- [COVID-19 and Autoimmunity](https://gvn.org/covid-19-and-autoimmunity/) - COVID-19 and Autoimmunity Are Severe Cases of COVID-19 Related to an Autoimmune Disease? February 15, 2021 COVID-19, the disease caused by SARS-CoV-2, involves at least two distinct phases. The first phase is attributed to typical progress of respiratory disease by causing fever, cough, loss of taste/smell, and other symptoms typical of respiratory infections. The second
- [Pregnancy and COVID-19 Vaccines](https://gvn.org/pregnancy-and-covid-19-vaccines/) - Pregnancy and COVID-19 Vaccines March 5, 2021 While the COVID-19 vaccination program is extending globally, we have many questions regarding the vaccines' safety, durability, and efficacy against variants. One of the important safety questions is the effects of COVID-19 vaccines on pregnant women as clinical trials for COVID-19 vaccines were conducted without their participation. Are
- [Should the Global Community Be Concerned About the South African Variant?](https://gvn.org/should-the-global-community-be-concerned-about-the-south-african-variant/) - Should the Global Community Be Concerned About the South African Variant? February 23, 2021 Currently, the downward trend of SARS-CoV-2 infections per day in the U.S. is continuing, and the case numbers of COVID-19 are less than half of what it was at the peak of the pandemic (Worldometers).The mortality rate of COVID-19 is also
- [Correlates of Protection](https://gvn.org/correlates-of-protection/) - Role of Correlates of Protection, or Immune Measurements, in Predicting Protective Immunity of COVID-19 Vaccines March 29, 2021 Broadly speaking, correlates of protection are measurements of immune parameters that allow prediction of the degree of protection against infection or disease induced by a pathogen. A prime point of interest in consideration of protection against SARS-CoV-2
- [COVID-19 Vaccine for Long-Haulers: A Surprising Benefit?](https://gvn.org/covid-19-vaccine-for-long-haulers-a-surprising-benefit/) - COVID-19 Vaccine for Long-Haulers: A Surprising Benefit? April 9, 2021 We are in the COVID-19 pandemic over one year now and still learning something new about SARS-CoV-2 and COVID-19. One of the serious and mysterious aspects of COVID-19 is long-term symptoms that persist for a significant period after SARS-CoV-2 infection as previously discussed. Many patients
- [Understanding Multisystem Inflammatory Syndrome in Children with COVID-19](https://gvn.org/understanding-multisystem-inflammatory-syndrome-in-children-with-covid-19/) - Understanding Multisystem Inflammatory Syndrome in Children with COVID-19 April 16, 2021 Multisystem inflammatory syndrome in children (MIS-C) is a rare but is severe hyperinflammatory condition in children and adolescents. It is also known as pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. This typically occurs 2–6 weeks after acute SARS-CoV-2 infection. Symptoms include persistent fever,
- [SARS-CoV-2 Transmission To, From, and Among Children: What's New?](https://gvn.org/sars-cov-2-transmission-to-from-and-among-children-what-is-new/) - SARS-CoV-2 Transmission To, From, and Among Children: What's New? April 30, 2021 The dynamics of infection of children has been of great interest, particularly as it pertains to the issue of whether or not to open schools and to vaccinate children. The discussions have at times been contentious. There are multiple aspects to the issue.
- [Vaccine Priorities: Children or Underserved Populations?](https://gvn.org/vaccine-priorities-children-or-underserved-populations/) - Vaccine Priorities: Children or Underserved Populations? May 24, 2021 In the setting of still somewhat limited vaccine supplies and deliveries, a current question is what the most effective priority is among those who are still not vaccinated. What will have the most effective dampening effect on the pandemic? There are several considerations. To what extent
- [Old vaccines for new pandemics (Ep 66) - Big Biology Podcast featuring Dr. Gallo and Dr. Chumakov - GVN](https://gvn.org/old-vaccines-for-new-pandemics-ep-66-big-biology-podcast-featuring-dr-gallo-gvn/) - Find the podcast episode here. What has COVID-19 taught us about preparing for future epidemics? Can we trigger innate immune responses – our first lines of defense - to mitigate novel infections? Can we use live-attenuated vaccines (LAV) meant for other infections to protect us while we develop specific vaccines for new pathogens? On this
- [Impact of the Delta Variant on Transmission, Vaccine, and Treatment Efficacy](https://gvn.org/impact-of-the-delta-variant-on-transmission-vaccine-and-treatment-efficacy/) - Impact of the Delta Variant on Transmission, Vaccine, and Treatment Efficacy June 21, 2021 One of the consequences of unchecked SARS-CoV-2 infections is the generation of mutations that have the potential to increase infectivity and transmissibility, confer a degree of resistance to vaccines, neutralizing antibodies, and monoclonal antibody therapy, and in some cases generate false
- [Does COVID-19 Curb or Promote the Progression of Cancer?](https://gvn.org/does-covid-19-curb-or-promote-the-progression-of-cancer/) - Does COVID-19 Curb or Promote the Progression of Cancer? July 2, 2021 One of the many questions about the long-term implications of COVID-19 is whether there might be some positive or negative consequences on cancer. The inflammatory milieu elicited by infection with SARS-CoV-2 might elicit pro-cancer effects as well as COVID-related immune-deficiency or increase DNA
- [SARS-CoV-2 Lambda Variant: The New Kid on the Block](https://gvn.org/sars-cov-2-lambda-variant-the-new-kid-on-the-block/) - SARS-CoV-2 Lambda Variant: The New Kid on the Block July 19, 2021 The COVID-19 pandemic has been marked by the ongoing emergence of new genetic variants. Although SARS-CoV-2 is an RNA virus, its genome is relative stable, thanks to a proofreading polymerase. However, in a situation with extensive viral transmission globally, the evolution of SARS-CoV-2
- [Vaccines and Variants](https://gvn.org/vaccines-and-variants/) - Vaccines and Variants August 16, 2021 Extensive vaccination had resulted in reduced COVID-19 cases and mortality in certain places, such as the United States and Israel, thus giving a cautious optimism that the worst of the pandemic was over. However, this turned out not to be the case, due to unpredicted factors. One was the
- [Covid-19 Vaccines or Natural Immunity - Do Both Protect?](https://gvn.org/covid-19-vaccines-or-natural-immunity-do-both-protect/) - Covid-19 Vaccines or Natural Immunity - Do Both Protect? September 10, 2021 In the current circumstances of disturbingly high rates of infection by the Delta variant and the concerns over obtaining effective vaccine coverage, the degree of protection provided to SARS-CoV-2 infected convalescent people is of clear relevance for natural immunity. Pei et al. estimate
- [SARS-CoV-2, Children, and Multi-Inflammatory Syndrome](https://gvn.org/sars-cov-2-children-and-multi-inflammatory-syndrome/) - October 1, 2021 With the advent of the school year and children returning to in-person classes, there comes a concern over consequences with respect to the spread of the highly contagious Delta variant. It has been accepted that children are not as susceptible to viral infection and severe illness as adults. However, the current prevalence
- [New Antivirals: Could They Be Game Changers?](https://gvn.org/new-antivirals-could-they-be-game-changers/) - November 1, 2021 There have been recent reports of potentially effective oral antiviral drugs, including RNA replicase and viral protease inhibitors. If these prove safe and effective, this may overhaul the care of patients with COVID-19 by preventing severe COVID-19 in infected patients and, possibly in the future, prevent infection after contamination. It is likely
- [Long COVID: The Impact of Post-Acute Sequelae of COVID-19 (PASC)](https://gvn.org/long-covid-the-impact-of-post-acute-sequelae-of-covid-19-pasc/) - November 12, 2021 There is mounting evidence of the importance and seriousness of the long-term effects of COVID-19. Post-acute sequelae of SARS-CoV-2 (PASC, or “long COVID”) is characterized by persistent symptoms and/or delayed or long-term complications beyond 4 weeks from the onset of symptoms (1). Approximately 80% of individuals with a confirmed COVID-19 diagnosis continue to
- [Omicron: Transmissibility, Immune Evasion, and Pathogenicity](https://gvn.org/omicron-transmissibility-immune-evasion-and-pathogenicity/) - January 13, 2022 We are currently in a wave of SARS-CoV-2 infections dominated by the recently discovered omicron variant. What new threats does it pose? It is clearly able to overcome immune barriers to infection. Also, this variant is far more transmissible than others, making it an hyper transmissible variant. However, there may be a
- [Cell-Mediated and Innate Immunity Against SARS-COV-2: What is Known](https://gvn.org/cell-mediated-and-innate-immunity-against-sars-cov-2-what-is-known/) - January 26, 2022 Titers of neutralizing antibodies (nAbs) against SARS-CoV-2 have proven a reasonable predictor of protection against infection and disease. However, T cell responses (CD8+ and CD4+), innate immune mechanisms, and Fc-mediated cellular cytotoxicity can also provide protective immunity against the virus. T CELLS The role of T cell activities in correlates of protection
- [COVID-19 and the Gut Microbiome](https://gvn.org/covid-19-and-the-gut-microbiome/) - February 11, 2022 EFFECTS OF MICROBIOMES The importance of the immunomodulatory effects of gut microbial populations has now been well recognized. In addition to their normal beneficial effects, alterations in the gut microbiota composition can lead to profound immune dysregulation and systemic inflammation. Because severe COVID-19 and long term COVID are driven by inappropriate immune
- [Is Bradykinin Involved in COVID-19 Pathogenesis?](https://gvn.org/is-bradykinin-involved-in-covid-19-pathogenesis/) - March 18, 2022 INFLAMMATION One of the hallmarks of Covid-19 disease is inflammation, mediated in part by overproduction of inflammatory cytokines. However, the mechanisms of such inflammatory process have not been clearly understood. In the past year the potential role of bradykinin, a small peptide and a members of family kinins, in the pathogenesis of
- [Impact of Interferon on Disease Severity of COVID-19](https://gvn.org/impact-of-interferon-on-disease-severity-of-covid-19/) - March 28, 2022 INTRODUCTION Types 1 and 3 interferon (IFN) expression and activity have been shown to play a significant role in determining the disease severity of SARS-CoV-2 infection. It is becoming clear that the timing of IFN expression is critical in the efficacy of the early response to viral infection on reducing disease severity.
- [Specialized Pro-Resolving Mediators (SPMS) as Potential COVID-19 Therapeutic](https://gvn.org/specialized-pro-resolving-mediators-spms-as-potential-covid-19-therapeutic/) - April 21, 2022 INTRODUCTION Our last Perspective described how the timing of the type 1 interferon (IFN) response is a critical early point in determining whether infection with SARS-CoV2 will lead to severe disease or not. IFN activity later in infection, when disease has already developed, is apparently ineffective, and is instead detrimental. Indeed, an
- [Impact of the Omicron Variants on the Ongoing Pandemic](https://gvn.org/impact-of-the-omicron-variants-on-the-ongoing-pandemic/) - May 10, 2022 INTRODUCTION The emergence of the Omicron variant in November 2021 has led to a rapid surge of COVID-19 cases worldwide. Since then, Omicron has kept evolving into several different sublineages. Furthermore, recombinant Omicron variants have been detected in patients by coinfection with the two such sublineages, as well as with the delta
- [Could Viral Persistence Explain Long COVID? ](https://gvn.org/could-viral-persistence-explain-long-covid/) - Author: Dr. ReitzJune 30, 2022 INTRODUCTION One serious aspect of Covid is what has been called ‘long Covid”, in which various symptoms can persist for as long as a year or more. These can include fatigue, brain fog, loss of taste and/or smell, and cardiovascular problems. There are two schools of thought on the cause, although
- [Covid Alteration of the Gut Microbiome: A Factor in Long Covid?](https://gvn.org/covid-alteration-of-the-gut-microbiome-a-factor-in-long-covid/) - October 6, 2022 In a previous Perspective we considered the relationship between Covid pathology and the gut microbiome. Since then, new studies have shed additional light on the topic. We will consider these new findings, including whether dysregulation of the microbiome might be related to long Covid. INTRODUCTION As we pointed out previously, there is
- [Why Are Omicron Variants Less Lethal?](https://gvn.org/why-are-omicron-variants-less-lethal/) - Omicron-derived SARS-CoV2 variants (exemplified most recently by XBB1.5(1)) are highly adept at evading immunity against vaccines and infection with previous variants and many parts of the world are currently experiencing high infection rates, yet deaths and hospitalizations have not proportionally increased. Why is this? Could previous waves have already killed those most vulnerable? Has increased
- [Long Covid and the Vascular Endothelium](https://gvn.org/long-covid-and-the-vascular-endothelium/) - Infection with SARS-CoV2 infection often involves the vascular endothelium, resulting in a variety of deleterious effects. Among these is endothelial dysfunction, distinct from endothelial injury, in which the vascular endothelium loses elasticity and the ability to vasodilate and vasoconstrict. It constitutes a type of non-obstructive coronary artery disease and is generally associated with impaired production
- [COVID-19 and the Gut Microbiome](https://gvn.org/covid-19-and-the-gut-microbiome/) - February 11, 2022 Effects of Microbiomes The importance of the immunomodulatory effects of gut microbial populations has now been well recognized. In addition to their normal beneficial effects, alterations in the gut microbiota composition can lead to profound immune dysregulation and systemic inflammation. Because severe COVID-19 and long term COVID are driven by inappropriate immune
- [Global Virus Network (GVN) Announces 2022 Elected Members Of Rising Star Mentorship Program ](https://gvn.org/global-virus-network-gvn-announces-2022-elected-members-of-rising-star-mentorship-program/) - The eleven awardees will receive training and mentorship to help support and propel their rising careers in virology BALTIMORE, MD, December 6, 2022: The Global Virus Network (GVN), a coalition comprised of human and animal virologists from 68 Centers of Excellence and 11 Affiliates in 39 countries, today announced eleven members of the 2022 GVN
- [GVN Statement on SARS-CoV-2 Variant BF7](https://gvn.org/gvn-statement-on-sars-cov-2-variant-bf7/) - SARS-CoV-2 variants continue to appear worldwide. There is some concern about the variant BF7, shorthand for BA.5.2.1.7, which reportedly is spreading in China. BA.5.2.1.7 is part of the Omicron lineage of SARS-CoV-2 and had been indicated as a potential variant of concern. Recent data from the US CDC and other agencies in other countries, however, show
- [Flu Vaccines: What Does the Future Hold?](https://gvn.org/flu-vaccines-what-does-the-future-hold/) - Omicron spinoffs, respiratory syncytial virus (RSV), and influenza (flu) viruses have formed a sort of unholy trinity of respiratory infections. Covid vaccines were initially highly effective against infection, hospitalization, and death, but with the multiplication of new variants, only strong protection against hospitalization and death remains. In a previous Perspective (https://gvn.org/respiratory-syncytial-virus-newly-resurgent/), we noted that the
- [Surge of SARS-CoV-2 Variants in China and USA Further Emphasizes Need for Surveillance, Preparedness, and International Collaborations](https://gvn.org/surge-of-sars-cov-2-variants-in-china-and-usa-further-emphasizes-need-for-surveillance-preparedness-and-international-collaborations/) - BALTIMORE, MD, January 9, 2023: Christian Bréchot, MD, PhD, President of the Global Virus Network (GVN), Associate Vice President for International Partnerships and Innovation at the University of South Florida and Professor of the Division of Infectious Disease, Department of Internal Medicine at USF Health Morsani College of Medicine, the GVN Southeast U.S. Regional Headquarters
- [Global Virus Network (GVN) Leaders Publish STAT Op-Ed with a U.S. Government Call to Action and Road Map for the Future of COVID-19](https://gvn.org/global-virus-network-gvn-leaders-publish-stat-op-ed-with-a-u-s-government-call-to-action-and-road-map-for-the-future-of-covid-19/) - BALTIMORE, MD, January 31, 2023: STAT today published "How the Biden Administration's COVID preparedness policies could narrow America's political divide" co-authored by leadership of the Global Virus Network (GVN), representing 68 Centers of Excellence and 11 Affiliates in 37 countries, and comprising foremost experts in every class of virus causing disease in humans and some
- [Global Virus Network (GVN) Adds Brazil’s Laboratory for Clinical Research in Neuroinfections at Fiocruz](https://gvn.org/global-virus-network-gvn-adds-brazils-laboratory-for-clinical-research-in-neuroinfections-at-fiocruz/) - Baltimore, Maryland, USA, March 1, 2023: The Global Virus Network (GVN), representing 71 Centers of Excellence and 9 Affiliates in 40 countries comprising foremost experts in every class of virus causing disease in humans, and the Oswaldo Cruz Foundation (Fiocruz) in Rio de Janeiro, Brazil announced the addition of the Laboratory for Clinical Research in
- [Researchers Discover Bacterial Protein that Causes Genomic Instability and Contributes to Reduced Fertility, Birth Defects](https://gvn.org/bacterial-protein-causes-genomic-instability/) - Study Underscores Significant Implications for Cancer and Obstetrics Medicine, as well as Diagnostics, and Preventative Therapy A team of researchers from the University of Maryland School of Maryland's (UMSOM) Institute of Human Virology (IHV), a Center of Excellence of the Global Virus Network (GVN), published new findings that emphasize the crucial role of the urinary and genital tract
- [Why Worry About Avian Flu?](https://gvn.org/why-worry-about-avian-flu/) - The Covid pandemic is the latest concern regarding potential zoonotic spillover of a dangerous virus. What will actually be the next virus? In the game of spillover roulette, some have put their bets on yet another coronavirus. Lately, however, the smart money seems to be betting on avian flu, or more specifically, H5N1 avian flu.
- [Eradicating Polio Will Require Changing the Current Public Health Strategy](https://gvn.org/eradicatingpolio03062023/) - Leadership of the Global Virus Network Say Policy Decisions Should Reflect the Science Baltimore, MD, March 6, 2023- The recent public health emergency declarations in New York and London due to polio infections and detection of the virus in these cities' wastewater strongly indicate that polio is no longer close to being eradicated.Now, four members
- [GVN Announces Two New Executive Appointments](https://gvn.org/gvn-announces-two-new-executive-appointments/) - Strategic Focus On Corporate Partnerships, Content Creation and Thought Leadership Baltimore, MD, USA (May 18, 2023) - The Global Virus Network (GVN) recently appointed Andrea Ridenour as Senior Vice President of Corporate Partnerships & Development and Robert Frederick as Chief Content Officer. "Two of the GVN's most important strategic priorities are enhancing financial development by
- [Global Virus Network (GVN) Adds Turkish Virology Consortium](https://gvn.org/global-virus-network-adds-turkish-virology-consortium/) - Baltimore, Maryland, USA, August 7, 2023: The Global Virus Network (GVN), representing more than 70 Centers of Excellence in over 40 countries comprising foremost experts in every class of virus causing disease in humans, announced the addition of the Turkish Virology Consortium (TVC) as its newest Center of Excellence. "We are pleased to add Turkey's leading
- [Multiple Sclerosis: How is it Associated with Epstein-Barr Virus?](https://gvn.org/multiple-sclerosis-how-is-it-associated-with-epstein-barr-virus/) - In the past, Multiple Sclerosis (MS) has been associated with many virus infections. But causation has been hard to establish for any specific virus. The association to Epstein-Barr Virus (EBV) comes from a recent study involving a large military cohort (> 10 million adults) in which there were 955 cases of MS. The risk of
- [Exploring the Mystery of Acute Pediatric Non-A-E Hepatitis](https://gvn.org/exploring-the-mystery-of-acute-pediatric-non-a-e-hepatitis/) - Recent outbreaks of non-A, -B, -C, -D, or -E hepatitis among young children have presented epidemiologists with a mystery. The hepatitis cases tended to be severe, leading in many cases to liver transplantation. But, in searching for an infectious origin, one group of researchers detected in many of these hepatitis cases a prominent cause of
- [Ebola in Uganda](https://gvn.org/ebola-in-uganda/) - A moderate sized Ebola outbreak (142 confirmed cases) in Uganda has recently been in the news. Fifty-five people died; the others recovered. It has now largely been controlled, but there are some issues associated with the outbreak that are worth considering. These relate to conventional control by contact tracing and isolation (which was how it
- [GVN and Monaco COVID-19 Diagnostic Conference: Executive Summary](https://gvn.org/gvn-and-monaco-covid-19-diagnostic-conference-executive-summary/) - A December 2-3, 2021 Conference Towards the Deployment of a Global and Collaborative Diagnostic Arsenal to Detect and Fight Against Pandemics Amid global spread of the Omicron variant, under the High Patronage of H.S.H. Prince Albert II of Monaco, the Global Virus Network(GVN), the Centre Scientifique de Monaco, the Fondation Prince Albert II de Monaco,
- [Global Virus Network (GVN) Announces Seven Distinguished International Appointments to Board of Directors](https://gvn.org/global-virus-network-gvn-announces-seven-distinguished-international-appointments-to-board-of-directors-2/) - World Leaders In Academia, Business, Government, Healthcare, Philanthropy & Science Commit Their Expertise To Advancing The Development & Expansion Of The GVN Baltimore, MD, USA (May 3, 2022) – The Global Virus Network (GVN), a coalition of the world’s leading medical virology research centers working together to prevent illness and death from viral disease, today announced
- [Respiratory Syncytial Virus: Newly Resurgent](https://gvn.org/respiratory-syncytial-virus-newly-resurgent/) - December 5, 2022 Introduction We seem to be in a sort of Golden Age of respiratory viruses, including flu, SARS-CoV2 and respiratory syncytial virus (RSV). RSV is an enveloped negative strand RNA virus with a genome of approximately 15,000 nucleotides encoding 11 proteins. There are two serotypes, A and B, which can be discriminated by
- [Global Virus Network (GVN) Adds Thailand’s Mahidol University as Newest Member to Combat Viral Threats](https://gvn.org/global-virus-network-gvn-adds-thailands-mahidol-university-as-newest-member-to-combat-viral-threats/) - Baltimore, Maryland, USA, October 26, 2022: The Global Virus Network (GVN), representing 68 Centers of Excellence and 11 Affiliates in 39 countries comprising foremost experts in every class of virus causing disease in humans, and the Mahidol University in Thailand announced the addition of the Mahidol Virus Network as GVN's newest Center of Excellence. "We
- [Global Virus Network (GVN) Convenes First-Of-Its-Kind Conference To Evaluate The Public Health Magnitude Of Long-COVID And Define A Global Research Roadmap To Address The Crisis](https://gvn.org/global-virus-network-gvn-convenes-first-of-its-kind-conference-to-evaluate-the-public-health-magnitude-of-long-covid-and-define-a-global-research-roadmap-to-address-the-crisis-2/) - World Leaders in Science, Healthcare, Academia, Business and Government Discuss Issues and Ramifications of Long Covid Baltimore, MD, USA (July 22, 2022) - The Global Virus Network (GVN), a coalition of world leading medical virology research centers, yesterday concluded a two-day gathering on the 'Science of Long COVID.' The first-of-its-kind conference reviewed the wealth of cohort
- [Aided by GVN and IHV, Kerala, India Celebrates Major Milestones to Advance Virus Research](https://gvn.org/aided-by-gvn-and-ihv-kerala-india-celebrates-major-milestones-to-advance-virus-research/) - Aided by GVN and IHV, Kerala, India Celebrates Major Milestones to Advance Virus Research October 6, 2022 During a conference attended by thousands, Dr. Gallo’s Malayalam Language Edition of “Virus Hunting” Was Released Thousands of students listened to Dr. Robert Gallo’s virtual lecture, “General Reflections on Pandemics and the Importance of the Global Virus Network
- [Global Virus Network Meeting Strengthens Ties Among Top Virus Researchers](https://gvn.org/gvn-beijing-2015/) - Global Virus Network Meeting Strengthens Ties Among Top Virus Researchers GVN’s programs facilitate international collaborations to address growing viral threats Beijing, China, May 19, 2015: The Global Virus Network (GVN), a coalition of the world’s leading medical virology research centers working together to prevent illness and death from viral disease, held its 7th meeting in
- [GVN Publishes Article, "Challenging Chikungunya," in Antiviral Research on the spread, treatment and vaccine development of Chikungunya](https://gvn.org/the-global-virus-network-challenging-chikungunya/) - "Challenging Chikungunya" is one of a series of articles posted by Antiviral Research and based on a symposium, “Chikungunya discovers the New World,” co-sponsored by GVN and the American Society of Tropical Medicine and Hygiene (ASTMH).
- [Scott Weaver with First Robert C. Gallo Award](https://gvn.org/award-scott-weaver/) - Global Virus Network (GVN) Presents Mosquito-Borne Virus Expert for Scientific Excellence The Award was presented during a meeting organized by Emory University and co-sponsored by the GVN on the Zika virus May 2, 2016, Atlanta, GA: The Global Virus Network (GVN), representing 35 Centers of Excellence and 5 Affiliates in 26 countries, and comprising foremost experts
- [Global Virus Network (GVN) Center of Excellence TSRI Investigation Reveals First-Ever Image of Elusive Viral Protein](https://gvn.org/global-virus-network-gvn-center-of-excellence-tsri-investigation-reveals-first-ever-image-of-elusive-viral-protein/) - Global Virus Network (GVN) Center of Excellence TSRI Investigation Reveals First-Ever Image of Elusive Viral Protein New Direction for Lifesaving Vaccine LA JOLLA, CA – June 2, 2017 – Before Ebola virus ever struck West Africa, locals were already on the lookout for a deadly pathogen: Lassa virus. With thousands dying from Lassa every year—and
- [Global Virus Network Adds The University of Zambia's Africa Center of Excellence for Infectious Diseases of Humans and Animals as a New Affiliate Member](https://gvn.org/global-virus-network-adds-the-university-of-zambias-africa-center-of-excellence-for-infectious-diseases-of-humans-and-animals-as-a-new-affiliate-member/) - The new Affiliate’s membership is sponsored by two GVN Centers of Excellence, Hokkaido University and University College Dublin Baltimore, Maryland, USA, and Lusaka, Zambia, January 24, 2018: The Global Virus Network (GVN) and the AfricaCenter of Excellence for Infectious Diseases of Humans and Animals (ACEIDHA) at the University of Zambia in Lusaka, Zambia announced today
- [Global Virus Network Issues Open Letter to WHO On Potent Human Carcinogen - Human T Cell Leukemia Virus-1](https://gvn.org/global-virus-network-issues-open-letter-to-who-on-potent-human-carcinogen-human-t-cell-leukemia-virus-1/) - The Lancet publishes letter from top scientists and advocates from around the world to eradicate HTLV-1, a debilitating and deadly virus Baltimore, MD, USA, May 10, 2018: The Global Virus Network (GVN), an international coalition of the world’s foremost medical virologists, comprising 41 Centers of Excellence and 7 Affiliates in 26 countries, dedicated to identifying
- [Global Virus Network Adds Uganda Virus Research Institute as Newest Center of Excellence](https://gvn.org/global-virus-network-adds-uganda-virus-research-institute-as-newest-center-of-excellence/) - Baltimore, Maryland, USA, and Entebbe, Uganda, May 29, 2018: The Global Virus Network (GVN) and the Uganda Virus Research Institute (UVRI) announced today the induction of the Institute as GVN’s newest Center of Excellence. The GVN represents 41 Centers of Excellence and 7 affiliates in 26 countries and comprises foremost experts in every class of
- [Global Virus Network Hosts Fifth Short Course](https://gvn.org/global-virus-network-hosts-fifth-short-course-trains-next-generation-of-virus-researchers-from-around-the-globe/) - Trains Next Generation of Virus Researchers from Around the Globe Baltimore, Maryland, USA, August 16, 2018: The Global Virus Network (GVN) last week held its Fifth Annual Short Course on Medical Virology on August 5-11 for 16 early-career human and animal virologists from Austria, Canada, China, Jamaica, Japan, Kenya, Nigeria, Saudi Arabia, Trinidad, United States, and
- [ENHANCED MODEL FOR MONITORING ZONES OF INCREASED RISK OF COVID-19 SPREAD](https://gvn.org/enhanced-model-for-monitoring-zones-of-increased-risk-of-covid-19-spread/) - Research By GVN Scientists Establishes Link Between Temperature, Latitude, Spread & Seasonality Baltimore, MD, March 10, 2020: Scientists affiliated with the Global Virus Network (GVN), the worldwide coalition of preeminent virologists engaged in the preparedness, defense and first research response to emerging, existing and unidentified viruses that pose a clear and present threat to public
- [TWO CENTERS OF EXCELLENCE OF THE GLOBAL VIRUS NETWORK INDEPENDENTLY VERIFY AN ANTIMICROBIAL TECHNOLOGY THAT ERADICATES SARS-CoV-2 ON SURFACES FOR MORE THAN SIX WEEKS](https://gvn.org/two-centers-of-excellence-of-the-global-virus-network-independently-verify-an-antimicrobialtechnology-that-kills-sars-cov-2-on-surfaces-for-more-than-six-weeks/) - Global Virus Network Also Advances The Study Of The Oral Polio Vaccine As A Preventive Measure Against SARS-CoV-2 Baltimore, Maryland, USA, June 4, 2020: The Global Virus Network (GVN), a coalition comprised of the world’s preeminent human and animal virologists from 53 Centers of Excellence and 10 Affiliates in 32 countries, announced that two of
- [From molecular biology to human retroviruses: in memory of GVN Italy Center Director Umberto Bertazzoni (1937-2020)](https://gvn.org/in-memory-of-gvn-italy-center-director-umberto-bertazzoni/) - Born in Trissino (VI) in 1937, Umberto Bertazzoni graduated from the University of Pavia in Pharmacy (1960) and in Biological Sciences (1964). He was a researcher at the Joint Research Center of Ispra from 1964 to 1974, researcher at the Institute of Genetics of the CNR of Pavia from 1974 to 1994 and Head of
- [GVN in the News - Dr. Christian Bréchot Interview with LCI, France, July 13, 2021](https://gvn.org/gvn-in-the-news-dr-christian-brechot-interview-with-lci-france-july-13-2021/)
- [Langya Virus](https://gvn.org/langya-virus/) - Langya Virus August 15, 2022 A sentinel surveillance study in China has detected the zoonotic Langya henipavirus (Paramyxoviridae) in 35 patients. RNA of the virus was found in 27% of shrews in the wild, revealing a potential animal reservoir. Zoonotic transmission is the first step potentially leading to “jumps” across species. Currently, there is no evidence of
- [New Antivirals: Could They Be Game Changers?](https://gvn.org/new-antivirals-could-they-be-game-changers/) - New Antivirals: Could They Be Game Changers? November 1, 2021 There have been recent reports of potentially effective oral antiviral drugs, including RNA replicase and viral protease inhibitors. If these prove safe and effective, this may overhaul the care of patients with COVID-19 by preventing severe COVID-19 in infected patients and, possibly in the future,
- [Avian Influenza Viruses](https://gvn.org/avian-influenza-viruses/) - Avian Influenza Viruses November 26, 2021 The global death toll from COVID-19 reached 5 million on November 1, 2021, but the actual figures are likely much higher (1). In recent history, the 1918 H1N1 flu pandemic caused by an Influenza A (H1N1) virus was the most severe known pandemic, killing more than 50 million people worldwide (2). The sequence analysis
- [Global Spread of Omicron, New Variant of Concern](https://gvn.org/global-spread-of-omicron-new-variant-of-concern/) - Global Spread of Omicron, New Variant of Concern November 29, 2021 The first known confirmed Omicron (B.1.1.529) infection was from a specimen collected on November 9, 2021. The variant quickly became a new variant of concern because of its rapid spread in South Africa and globally, as well as the large number of mutations found
- [GVN and Monaco COVID-19 Diagnostic Conference: Promises and Challenges](https://gvn.org/gvn-and-monaco-covid-19-diagnostic-conference-promises-and-challenges/) - GVN and Monaco COVID-19 Diagnostic Conference: Promises and Challenges Thursday, December 02, 2021 - Friday, December 03, 2021 Towards the deployment of a global and collaborative diagnostic arsenal to detect and fight against pandemics November 30, 2021: The current COVID-19 pandemic, and in particular the proliferation of variants such as Omicron, again emphasize the importance of
- [Deltacron: a new variant or a laboratory contamination?  ](https://gvn.org/deltacron-a-new-variant-or-a-laboratory-contamination/) - Deltacron: a new variant or a laboratory contamination? Scientists have recently reported the emergence of new SARS-CoV-2 variant, "Deltacron", resulting from the recombination of Omicron and Delta variants in infected patients. According to a GVN scientist, Deltacron is not a new variant, but the result of laboratory contamination. His sequence analysis suggests that the Omicron
- [Omicron: Transmissibility, Immune Evasion, and Pathogenicity](https://gvn.org/omicron-transmissibility-immune-evasion-and-pathogenicity/) - Omicron: Transmissibility, Immune Evasion, and Pathogenicity January 13, 2022 We are currently in a wave of SARS-CoV-2 infections dominated by the recently discovered omicron variant. What new threats does it pose? It is clearly able to overcome immune barriers to infection. Also, this variant is far more transmissible than others, making it an hyper transmissible
- [Global Virus Network (GVN) Adds the Institute of Biomedical Systems and Biotechnologies at Peter the Great St. Petersburg Polytechnic University as Newest Member to Combat Viral Threats](https://gvn.org/global-virus-network-gvn-adds-the-institute-of-biomedical-systems-and-biotechnologies-at-peter-the-great-st-petersburg-polytechnic-university-as-newest-member-to-combat-viral-threats/) - Baltimore, Maryland, USA, January 20, 2022: The Global Virus Network (GVN), representing 66 Centers of Excellence and 10 Affiliates in 35 countries comprising foremost experts in every class of virus causing disease in humans, and the Institute of Biomedical Systems and Biotechnologies at Peter the Great St. Petersburg Polytechnic University (SPbPU) announced the addition of
- [Cell-Mediated and Innate Immunity Against SARS-CoV-2: What is Known](https://gvn.org/cell-mediated-and-innate-immunity-against-sars-cov-2-what-is-known/) - Cell-Mediated and Innate Immunity Against SARS-CoV-2: What is Known January 26, 2022 Titers of neutralizing antibodies (nAbs) against SARS-CoV-2 have proven a reasonable predictor of protection against infection and disease. However, T cell responses (CD8+ and CD4+), innate immune mechanisms, and Fc-mediated cellular cytotoxicity can also provide protective immunity against the virus. T cells The
- [Ongoing Outbreaks of Lassa Virus in Nigeria](https://gvn.org/ongoing-outbreaks-of-lassa-virus-in-nigeria/) - Ongoing Outbreaks of Lassa Virus in Nigeria March 8, 2022 Context The first known confirmed Omicron (B.1.1.529) infection was from a specimen collected on November 9, 2021 in Botswana (1). The variant rapidly began to spread to South Africa and other Southern African countries. Nigeria also experienced daily surge of COVID-19 cases in December, and
- [Is Bradykinin Involved in Covid-19 Pathogenesis?](https://gvn.org/is-bradykinin-involved-in-covid-19-pathogenesis/) - Is Bradykinin Involved in Covid-19 Pathogenesis? March 18, 2022 Inflammation One of the hallmarks of Covid-19 disease is inflammation, mediated in part by overproduction of inflammatory cytokines. However, the mechanisms of such inflammatory process have not been clearly understood. In the past year the potential role of bradykinin, a small peptide and a members of
- [Strategies to Eradicate Transmission of Poliovirus and Paralytic Poliomyelitis](https://gvn.org/strategies-to-eradicate-transmission-of-poliovirus-and-paralytic-poliomyelitis/) - Strategies to Eradicate Transmission of Poliovirus and Paralytic Poliomyelitis March 23, 2022 Introduction Polio (poliomyelitis) is a highly infectious disease that mostly affects children under 5 years of age. The causative agent, poliovirus, replicates in the gut but in some cases can invade the central nervous system and cause permanent paralysis (approximately one in 200
- [Impact of Interferon on Disease Severity of Covid-19](https://gvn.org/impact-of-interferon-on-disease-severity-of-covid-19/) - Impact of Interferon on Disease Severity of Covid-19 March 28, 2022 Introduction Types 1 and 3 interferon (IFN) expression and activity have been shown to play a significant role in determining the disease severity of SARS-CoV-2 infection. It is becoming clear that the timing of IFN expression is critical in the efficacy of the early
- [GLOBAL VIRUS NETWORK AND ABBOTT LAUNCH  PANDEMIC DEFENSE POSTDOCTORAL FELLOWSHIP PROGRAM](https://gvn.org/global-virus-network-and-abbott-launch-pandemic-defense-postdoctoral-fellowship-program/) - The partnership is training the next generation of virologists to combat future pandemic threats, with a focus on pathogen discovery in developing nations Baltimore, Maryland, USA, April 6, 2022 - The Global Virus Network (“GVN”), the world’s leading coalition of virologists combatting current and emerging pandemic viral threats, and Abbott, the global healthcare company, announce
- [Specialized Pro-Resolving Mediators (SPMs) as Potential Covid-19 Therapeutic](https://gvn.org/specialized-pro-resolving-mediators-spms-as-potential-covid-19-therapeutic/) - April 21, 2022 Introduction Our last Perspective described how the timing of the type 1 interferon (IFN) response is a critical early point in determining whether infection with SARS-CoV2 will lead to severe disease or not. IFN activity later in infection, when disease has already developed, is apparently ineffective, and is instead detrimental. Indeed, an
- [Global Expansion of Acute Hepatitis Outbreaks in Healthy Children](https://gvn.org/global-expansion-of-acute-hepatitis-outbreaks-in-healthy-children/) - Global Expansion of Acute Hepatitis Outbreaks in Healthy Children May 5, 2022 Introduction A recent rise in acute hepatitis among children is expanding globally. The UK first reported an unexpected, significant increase in cases of severe acute hepatitis of unknown origin in previously healthy children. According to the WHO (1), as of 21 April 2022,
- [Impact of the Omicron variants on the Ongoing Pandemic](https://gvn.org/impact-of-the-omicron-variants-on-the-ongoing-pandemic/) - Impact of the Omicron variants on the Ongoing Pandemic May 10, 2022 Introduction The emergence of the Omicron variant in November 2021 has led to a rapid surge of COVID-19 cases worldwide. Since then, Omicron has kept evolving into several different sublineages. Furthermore, recombinant Omicron variants have been detected in patients by coinfection with the
- [Could Viral Persistence Explain Long Covid?](https://gvn.org/could-viral-persistence-explain-long-covid/) - Could Viral Persistence Explain Long Covid? Author: Dr. Reitz June 30, 2022 Introduction One serious aspect of Covid is what has been called ‘long Covid”, in which various symptoms can persist for as long as a year or more. These can include fatigue, brain fog, loss of taste and/or smell, and cardiovascular problems. There are
- [Global Outbreaks of Monkeypox](https://gvn.org/global-outbreaks-of-monkeypox/) - May 25, 2022 Introduction WHO and other health organizations are alarmed at the recent global outbreak of monkeypox. As of May 21, 2022, more than 80 cases of monkeypox have been confirmed in at least 12 countries outside of Africa (1). The first case of the disease in the UK was reported on May 7,
- [GVN Statement on SARS-CoV-2 Variant BA.2.75](https://gvn.org/gvn-statement-on-sars-cov-2-variant-ba-2-75/) - There is some concern about the new SARS-CoV-2 variant BA.2.75. Very preliminary data on this variant suggests high growth advantage when compared to earlier variants. The N460K mutation in the Spike protein has been suggested as distinctive, conferring growth advantage to pseudotype virions. Epidemiologists around the world are aware of this variant, and the GVN
- [World Hepatitis Day 2022](https://gvn.org/world-hepatitis-day-2022/) - Hundreds of millions of people worldwide are affected by viral hepatitis. Chronic hepatitis B and C are estimated to affect half a billion of people. Many more are affected by acute hepatitis, especially in developing countries, resulting in significant symptoms, including death. Recently, clusters of cases of non A-E viral hepatis have raised concerns, and
- [Japanese Encephalitis Virus: Ongoing Public Health Threat](https://gvn.org/japanese-encephalitis-virus-ongoing-public-health-threat/) - April 7, 2022 Introduction Japanese encephalitis virus (JEV) is the leading cause of vaccine-preventable encephalitis. JEV is a flavivirus (genus Flavivirus, family Flaviviridae) and shares a close genetic and antigenic relationship with West Nile virus, St. Louis encephalitis virus, and Murray Valley encephalitis virus (1). Most people infected with JE do not have symptoms or
- [Resurgent Outbreaks of Measles](https://gvn.org/resurgent-outbreaks-of-measles/) - Resurgent Outbreaks of Measles May 18, 2022 Introduction Two years of the COVID-19 pandemic has brought another health crisis to children. The number of measles cases reported worldwide (more than 17,300 cases) has increased by 79 percent in the first two months of 2022 compared to the same time last year (1). Countries with the
- [Global Virus Network (GVN) Launches Task Force to Combat Monkeypox Global Outbreak](https://gvn.org/global-virus-network-gvn-launches-task-force-to-combat-monkeypox-global-outbreak/) - Unusual outbreaks of monkeypox via human-to-human have been reported in the US, Australia, the UK, Spain, Portugal, and other European countries; While the transmission of monkeypox from animals to humans is well known, the increasing number of community transmission cases simultaneously occurring worldwide may represent an urgent pandemic threat. Baltimore, Maryland, USA, May 20, 2022: A higher
- [GVN Statement on Monkeypox Outbreaks](https://gvn.org/gvn-statement-on-monkeypox-outbreaks/) - May 20, 2022 Unusual outbreaks of monkeypox have recently been reported in the US, the UK, Spain, Portugal, and other European countries. The chain of transmission is currently unknown, but it is clear that it involves human to human transmission. Although the virus has been known in the past to rarely cause such human-to-human transmission,
- [‘LIVE’ POLIO VACCINE FIRES UP IMMUNE SYSTEM PROVIDING PROTECTION FROM SARS-CoV-2 INFECTION](https://gvn.org/live-polio-vaccine-fires-up-immune-system-providing-protection-from-sars-cov-2-infection/) - Global Virus Network (GVN) studies suggest that the oral polio vaccine can protect people in developing nations that do not yet have access to COVID vaccines Baltimore, Maryland, USA, March 31, 2022: Two new studies from the Global Virus Network (GVN) in partnership with the Petroleum Industry Health Organization of Iran provide evidence that getting
- [Global Virus Network Adds the Aegis Consortium as Newest Center of Excellence](https://gvn.org/global-virus-network-adds-the-aegis-consortium-as-newest-center-of-excellence/) - Baltimore, Maryland, USA, March 23, 2022: The Global Virus Network (GVN), representing 69 Centers of Excellence and 11 Affiliates in 37 countries comprising foremost experts in every class of virus causing disease in humans and some animals, and the Aegis Consortium at the University of Arizona Health Sciences announced today the induction of Aegis as
- [GVN Adds the Centre Scientifique de Monaco as Newest Member to Combat Viral Threats](https://gvn.org/gvn-adds-the-centre-scientifique-de-monaco-as-newest-member-to-combat-viral-threats/) - Baltimore, Maryland, USA, March 22, 2022: The Global Virus Network (GVN), representing 69 Centers of Excellence and 11 Affiliates in 37 countries comprising foremost experts in every class of virus causing disease in humans, and the Centre Scientifique de Monaco (CSM) announced CSM as GVN’s newest Affiliate. “Just last year, we co-hosted a significant international
- [GVN Scandinavia-Baltic-Ukraine Region 2015 Meeting](https://gvn.org/gvn-scandinavia-baltic-ukraine-region-2015-meeting/) - Global Virus Network conference of virologists for the Scandinavia-Baltic-Ukraine region 8th-10th of June, 2015 Djurönäset, Sweden GVN convenes regional conference in Stockholm, Sweden. 10 countries joining in. --Meeting Agenda-- Monday, June 8th 12.45 – 14.00 Lunch Session 1 14.00-16.00 (Chair Anders Vahlne) 14.00 – 14.15 Welcome words. Andres Merits (Estonia), Anders Vahlne (Sweden) 14.15
- [Global Virus Network and the Japanese Society for Virology (JSV) Host Meeting of Top Virologists From Around the World](https://gvn.org/global-virus-network-and-the-japanese-society-for-virology-jsv-host-meeting-of-top-virologists-from-around-the-world/) - Virus Researchers Descend Upon Sapporo to Address Rising Global Viral Threats Sapporo, Japan, October 18, 2016: The Global Virus Network (GVN), a coalition of the world’s leading medical virology research centers working together to prevent illness and death from viral disease, will hold its 8thmeeting in Sapporo, Japan October 23—25, 2016 in partnership with the
- [Global Virus Network Hosts Fourth Short Course  to Train Next Generation of Virus Researchers  from Around the Globe](https://gvn.org/4th-short-course/) - The GVN’s elite Short Course aims to alleviate worldwide decline in rising, highly trained medical virologists Baltimore, Maryland, USA, August 14, 2017: The Global Virus Network (GVN) launched its Fourth Annual Short Course on Medical Virology held August 13-19, 2017 for 15 early career medical virologists from Australia, Brazil, India, Jamaica, Japan, Lithuania, Malaysia, Nigeria,
- [Global Virus Network Adds Premier Rega Institute for  Medical Research as Newest Center of Excellence](https://gvn.org/rega-institute-new-center/) - Baltimore, Maryland, USA, and Leuven, Belgium, August 17, 2017: The Global Virus Network (GVN) and the Laboratories of Virology & Chemotherapy at the Rega Institute for Medical Research, University of Leuven, Belgium announced today the induction of the institute as GVN’s newest Center of Excellence. The GVN represents 40 Centers of Excellence and six affiliates
- [University of Nebraska Medical Center, West African Centre for Cell Biology of Infectious Pathogens and Colombia-Wisconsin One-Health Consortium Join Renowned Global Virus Network to Combat Viral Diseases](https://gvn.org/university-of-nebraska-medical-center-west-african-centre-for-cell-biology-of-infectious-pathogens-and-colombia-wisconsin-one-health-consortium-join-renowned-global-virus-network-to-combat-viral-dise/) - Baltimore, Maryland, USA, November 13, 2018: The Global Virus Network (GVN), representing 45 Centers of Excellence and 7 Affiliates in 29 countries comprising foremost experts in every class of virus causing disease in humans, announced today the addition of the University of Nebraska Medical Center (UNMC), West African Centre for Cell Biology of Infectious Pathogens
- [Global Virus Network (GVN) Statement on the Unknown, Viral Pneumonia Outbreak in Wuhan, China](https://gvn.org/gvn-statement-on-the-unknown-viral-pneumonia-outbreak-in-wuhan-china/) - Global Virus Network (GVN) Statement on the Unknown, Viral Pneumonia Outbreak in Wuhan, China Baltimore, Maryland, USA, January, 7, 2020: In light of the recent pandemics emerging from China including the 2003 outbreak of severe acute respiratory syndrome (SARS), a viral respiratory illness caused by a coronavirus, and the 2013 outbreak of H7N9, an influenza virus that
- [Global Virus Network (GVN) Statement on New Strain of Coronavirus Infection in Wuhan, China](https://gvn.org/gvn-statement-on-the-new-strain-of-coronavirus-infection-in-wuhan-china/) - Global Virus Network (GVN) Statement on New Strain of Coronavirus Infection in Wuhan, China Baltimore, Maryland, USA, January, 10, 2020: In light of the recent pandemics emerging from China including the 2003 outbreak of severe acute respiratory syndrome (SARS), a viral respiratory illness caused by a coronavirus, and the 2013 outbreak of H7N9, an influenza
- [Global Virus Network (GVN) Statement on New Strain of Coronavirus Infection in Wuhan, China](https://gvn.org/gvn-statement-on-the-new-strain-of-coronavirus-infection-in-wuhan-china-012120/) - Global Virus Network (GVN) Statement on New Strain of Coronavirus Infection in Wuhan, China Baltimore, Maryland, USA, January, 21, 2020: In light of the recent pandemics emerging from China including the 2003 outbreak of severe acute respiratory syndrome (SARS), a viral respiratory illness caused by a coronavirus, and the 2013 outbreak of H7N9, an influenza
- [GLOBAL VIRUS NETWORK COMMENDS THE PHARMACEUTICAL INDUSTRY FOR UNPRECEDENTED COVID-19 VACCINE ADVANCES](https://gvn.org/global-virus-network-commends-the-pharmaceutical-industry-for-unprecedented-covid-19-vaccine-advances/) - Recommends Large-scale Vaccination To Thwart The Pandemic Baltimore, Maryland, USA, December 16, 2020: The Global Virus Network (GVN), a coalition comprised of the world's preeminent human and animal virologists from 59 Centers of Excellence and 10 Affiliates in 33 countries, working collaboratively in the preparedness, defense and first research response to emerging, exiting and unidentified
- [A Media Briefing Addressing the Exploding International COVID-19 Crisis: Global Virus Network - Ideas For a Global Vaccination Strategy](https://gvn.org/a-media-briefing-addressing-the-exploding-international-covid-19-crisis-global-virus-network-ideas-for-a-global-vaccination-strategy/) - June 30, 2021 Drs. Robert Gallo, Christian Bréchot, Sharon Lewin, and Amadou Sall Global Vaccination Vaccination is one of the most effective control measures for human infectious diseases. COVID-19 vaccines, particularly mRNA vaccines, have been very effective, including against the current SARS-CoV-2 variants. Thus, successful vaccination has resulted in mitigating SARS-CoV-2 infection in countries, such
- [Global Virus Network (GVN) Adds Senegal’s IRESSEF As Newest Member to Mitigate Viral Threats](https://gvn.org/global-virus-network-gvn-adds-senegals-iressef-as-newest-member-to-mitigate-viral-threats/) - Baltimore, Maryland, USA, July 15, 2021: The Global Virus Network (GVN), representing 63 Centers of Excellence and 11 Affiliates in 35 countries comprising foremost experts in every class of virus causing disease in humans, and the Institut de Recherche en Santé, de Surveillance Epidémiologique et de Formation , or the IRESSEF, announced the addition of
- [Unusual Surge of Respiratory Syncytial Virus in Children](https://gvn.org/unusual-surge-of-respiratory-syncytial-virus-in-children/) - Unusual Surge of Respiratory Syncytial Virus in Children September 24, 2021 Pediatricians have reported early emergence of respiratory syncytial virus (RSV) in the beginning of summer and consequently, a surge of RSV in children. This has been a global trend amid the ongoing pandemic. RSV is the leading viral agent of severe acute respiratory infections
- [WILL THERE BE A TWINDEMIC?](https://gvn.org/will-there-be-a-twindemic/) - By Dr. Peter Palese, Ph.D. “Twindemic” is a term that has not yet been in the headlines but is likely to become part of our lexicon as the summer progresses. Twindemic refers to the possibility that we will see continuing cases of COVID-19 together with severe influenza forcing the country to deal with two serious
- [Recent Resurgence of Ebola Virus](https://gvn.org/recent-resurgence-of-ebola-virus/) - Recent Resurgence of Ebola Virus October 25, 2021 The COVID-19 pandemic negatively impacted the epidemiological control of several infectious diseases worldwide. Specifically, Ebola virus disease has been sporadically resurging in Guinea and the Democratic Republic of the Congo (DRC) in 2021. A total of 16 confirmed and 7 probable cases were reported, of whom 12
- [GVN and Monaco COVID-19 Diagnostic Conference: Promises and Challenges](https://gvn.org/gvn-and-monaco-covid-19-diagnostic-conference-press-release-110921/) - GVN and Monaco COVID-19 Diagnostic Conference: Promises and Challenges Thursday, December 02, 2021 - Friday, December 03, 2021 Towards the deployment of a global and collaborative diagnostic arsenal to detect and fight against pandemics The current COVID-19 pandemic has again emphasized the importance of accurate, rapid, and massively deployed diagnostics to effectively contain viral transmission.
- [GVN Announces Inaugural Participants of Postdoctoral Fellowship Program](https://gvn.org/gvn-announces-inaugural-participants-of-postdoctoral-fellowship-program/) - The three awardees will receive training and mentorship to help support and propel their rising careers in virology BALTIMORE, MD, March 8, 2022: The Global Virus Network (GVN), a coalition comprised of human and animal virologists from 68 Centers of Excellence and 10 Affiliates in 36 countries, today announced the three inaugural members of the GVN Postdoctoral
- [A Statement from the Global Virus Network on the 2022 Russian Invasion of Ukraine](https://gvn.org/a-statement-from-the-global-virus-network-on-the-2022-russian-invasion-of-ukraine/) - BALTIMORE, MD, March 2, 2022: The Global Virus Network (GVN) is an apolitical global organization comprised of the world’s leading scientists, including those from Russia and Ukraine, who specialize in education and research for the purpose of protecting mankind from viral proliferation and viruses that cause pandemics. The scientists of the Global Virus Network collaborate to alleviate
- [Global Virus Network (GVN) Adds the Centre for the AIDS Programme of Research in South Africa (CAPRISA) as Newest Member to Combat Viral Threats](https://gvn.org/global-virus-network-gvn-adds-the-centre-for-the-aids-programme-of-research-in-south-africa-caprisa-as-newest-member-to-combat-viral-threats/) - Baltimore, Maryland, USA, February 8, 2021: The Global Virus Network (GVN), representing 68 Centers of Excellence and 10 Affiliates in 36 countries comprising foremost experts in every class of virus causing disease in humans, and the Centre for the AIDS Programme of Research in South Africa (CAPRISA) in Durban announced the addition of CAPRISA as GVN’s
- [Global Virus Network (GVN) Adds the Scientific Platform Pasteur-University of São Paulo as Newest Member to Mitigate Viral Threats](https://gvn.org/global-virus-network-gvn-adds-the-scientific-platform-pasteur-university-of-sao-paulo-as-newest-member-to-mitigate-viral-threats/) - Baltimore, Maryland, USA, January 26, 2022: The Global Virus Network (GVN), representing 67 Centers of Excellence and 10 Affiliates in 36 countries comprising foremost experts in every class of virus causing disease in humans, and the Scientific Platform Pasteur-University of São Paulo (SPPU) announced the addition of the SPPU as GVN’s newest Center of Excellence. “We are
- [Global Virus Network Announces Inaugural Cohort of Rising Star Mentorship Program](https://gvn.org/global-virus-network-announces-inaugural-cohort-of-rising-star-mentorship-program/) - The five awardees will receive training and mentorship to help support and propel their rising careers in virology BALTIMORE, MD, August 18, 2021: The Global Virus Network (GVN), a coalition comprised of human and animal virologists from 63 Centers of Excellence and 11 Affiliates in 35 countries, today announced the five inaugural members of the GVN
- [Global Virus Network Recommends Moving Forward With Boosters for COVID-19 Response](https://gvn.org/global-virus-network-recommends-moving-forward-with-boosters-for-covid-19-response/) - Fragile populations should receive a booster third dose of the COVID-19 mRNA vaccine to help protect against emerging variants BALTIMORE, MD, August 10, 2021: Members of the Global Virus Network (GVN), a coalition comprised of human and animal virologists from 63 Centers of Excellence and 11 Affiliates in 35 countries, and colleagues, today shared that GVN
- [Global Virus Network’s Position on the Administration of Booster Doses of the COVID-19 Vaccine](https://gvn.org/global-virus-networks-position-on-the-administration-of-booster-doses-of-the-covid-19-vaccine/) - Scientists from the Global Virus Network (GVN) centers have discussed the World Health Organization’s request for a moratorium on the administration of a booster, or a third dose of the COVID-19 mRNA vaccine for Pfizer or Moderna recipients, while many around the world have not yet received their initial immunizations. Considering the emerging variants of
- [Global Virus Network (GVN) Adds Gilead Sciences to GVN Healthcare & Pharma Centers of Excellence Coalition](https://gvn.org/global-virus-network-gvn-adds-gilead-sciences-to-gvn-healthcare-pharma-centers-of-excellence-coalition/) - The Partnership Focuses on Stimulating Collaborations and Training the Next Generation of Virus Researchers to Prepare for and Mitigate Future Global Threats Baltimore, Maryland, USA, June 30, 2021: The Global Virus Network (“GVN”), the world’s leading coalition of virologists combatting current and emerging pandemic viral threats and viral causes of disease through international collaborative research
- [Celdara Medical and Global Virus Network Announce Collaboration to Advance Infectious Disease and Viral Infection Research and Development](https://gvn.org/celdara-medical-and-global-virus-network-announce-collaboration-to-advance-infectious-disease-and-viral-infection-research-and-development/) - The partnership will initially focus on SARS-CoV-2 and future pandemic threats. BALTIMORE, MD and CAMBRIDGE, Mass. and LEBANON, N.H. and NEW YORK, June 2, 2021 — Celdara Medical, LLC (Celdara), an experienced biopharma developer focused on launching promising products to the patients who need them the most, today announced a new strategic collaboration with the
- [Global Virus Network Analysis Suggests Measles, Polio and Tuberculosis Vaccines May Boost Immunity to Coronavirus](https://gvn.org/global-virus-network-analysis-suggests-measles-polio-and-tuberculosis-vaccines-may-boost-immunity-to-coronavirus/) - Innate Immunity Created by Live Attenuated Vaccines Like Measles and Polio May Provide Some Protection Against Future Pandemics – Idea Needs To Be Tested, Scientists Say BALTIMORE, MD, May 18, 2021: Members of the Global Virus Network (GVN), a coalition comprised of human and animal virologists from 63 Centers of Excellence and 11 Affiliates in
- [Global Virus Network (GVN) Announces Eight Distinguished International Appointments to Board of Directors](https://gvn.org/global-virus-network-gvn-announces-eight-distinguished-international-appointments-to-board-of-directors/) - World Leaders in Business, Science, Law, Industry, Philanthropy & Government Are Committed to Supporting the GVN Baltimore, MD, USA (April 6, 2021) – The Global Virus Network (GVN), a coalition of the world’s leading medical virology research centers working together to prevent illness and death from viral disease, today announced the election of eight distinguished
- [A Statement From the Leadership of the Global Virus Network on the Passing of Dr. John Martin](https://gvn.org/a-statement-from-the-leadership-of-the-global-virus-network-on-the-passing-of-dr-john-martin/) - An Outstanding Clinical Scientist, A Dedicated Humanitarian, An Astute Businessman, An Effective Global Leader, and A True Friend Baltimore, MD, April 1, 2021: The Global Virus Network, the world’s leading coalition of virologists combatting current and emerging pandemic viral threats and viral causes of disease through international collaborative research response, mourns the passing of its good friend
- [Global Virus Network (GVN) Catalyzes World Health Organization (WHO) to Officially Recognize HTLV-1 as Threatening Pathogen to Humans](https://gvn.org/global-virus-network-gvn-catalyzes-world-health-organization-who-to-officially-recognize-htlv-1-as-threatening-pathogen-to-humans/) - March 29, 2021 During GVN’s 9th International Meeting in Melbourne, Australia on September 25-27, 2017 in partnership with the Peter Doherty Institute and the Institut Pasteur, researchers held impressive sessions on one of the most potent human carcinogens, human T cell leukemia virus-1 (HTLV-1). The sessions were organized by Dr. Sharon Lewin, Director of The
- [GLOBAL VIRUS NETWORK (GVN) ADDS SANOFI PASTEUR TO GVN HEALTHCARE & PHARMA CENTERS OF EXCELLENCE COALITION](https://gvn.org/global-virus-network-gvn-adds-sanofi-pasteur-to-gvn-healthcare-pharma-centers-of-excellence-coalition/) - The Partnership Focuses on Training The Next Generation of Virus Researchers to Safeguard Mankind from Current and Future Threats Baltimore, Maryland, USA, March 23, 2021: The Global Virus Network (“GVN”), the world’s leading coalition of virologists combatting current and emerging pandemic viral threats and viral causes of disease through international collaborative research response, by training
- [Global Virus Network (GVN) Adds Renowned Institut Pasteur Korea (IPK) to Combat Viral Diseases](https://gvn.org/global-virus-network-gvn-adds-renowned-institut-pasteur-korea-ipk-to-combat-viral-diseases/) - Baltimore, Maryland, USA, March 22, 2021: The Global Virus Network (GVN), representing 62 Centers of Excellence and 11 Affiliates in 34 countries comprising foremost experts in every class of virus causing disease in humans, and the Institut Pasteur Korea (IPK) announced today the addition of the IPK as GVN’s newest Center of Excellence. “We are
- [Philanthropist Donates US$1 Million to Global Virus Network: Anonymous Gift Will Support Educational & Training Initiatives](https://gvn.org/philanthropist-donates-us1-million-to-global-virus-network-anonymous-gift-will-support-educational-training-initiatives/) - Largest Gift In The Organization’s History Coincides With The Tenth Anniversary of the Founding of the Global Virus Network Baltimore, Maryland, USA, March 2, 2021: The Global Virus Network (GVN), a coalition of the world’s leading medical virology research centers working to prevent illness and death from viral disease, today announced the donation of US$1
- [Global Virus Network Names USF Health the GVN Southeast U.S. Regional Headquarters](https://gvn.org/global-virus-network-names-usf-health-the-gvn-southeast-u-s-regional-headquarters/) - Baltimore, Maryland, USA (Feb. 23, 2021) -- The Global Virus Network (GVN), a coalition comprising the world’s foremost experts in every class of virus causing disease in humans and some animals, today announced that USF Health, at the University of South Florida (USF) in Tampa, Fla., will serve as GVN’s Southeast United States Regional Headquarters. USF
- [GLOBAL VIRUS NETWORK (GVN) ADDS FOUR PREEMINENT ACADEMIC INSTITUTIONS TO STRENGTHEN GLOBAL COLLABORATION IN VIRAL RESEARCH AND RESPONSE TO PANDEMICS](https://gvn.org/global-virus-network-gvn-adds-four-preeminent-academic-institutions-to-strengthen-global-collaboration-in-viral-research-and-response-to-pandemics/) - The Four New GVN Members Form Three New Centers of Excellence and One Affiliate from Asia, the Caribbean, Europe and North America Baltimore, Maryland, USA, January 28, 2021: The Global Virus Network (GVN), comprising foremost experts around the world in every class of virus causing disease in humans and some animals, today announced the addition of three
- [A Statement from the Global Virus Network (GVN) on the Need for Innovative Strategies to Mitigate SARS-CoV-2 Variants and Expand Vaccination Strategies](https://gvn.org/a-statement-from-the-global-virus-network-gvn-on-the-need-for-innovative-strategies-to-mitigate-sars-cov-2-variants-and-expand-vaccination-strategies/) - Baltimore, Maryland, USA, January 15, 2021: As hospitalization and mortality from COVID-19 continue to surge around the world, it will be imperative to quickly distribute the vaccines that are proven to at least show short-term protection and overall safety. Combining vaccine distribution to protective measures (mask, physical distancing and hand washing) and novel approaches to treatment,
- [TOP SCIENTISTS CALL ON GLOBAL HEALTH AGENCIES TO FUND INNATE IMMUNITY RESEARCH AS ADDITIONAL MEASURE TO FIGHT PANDEMIC VIRUSES](https://gvn.org/top-scientists-call-on-global-health-agencies-to-fund-innate-immunity-research-as-additional-measure-to-fight-pandemic-viruses/) - Global Experts Host Symposium and Agree that Innate Immunity May Be Effective, Globally Available Tool to Supplement Delay in Vaccine Availability and Distribution Baltimore, Maryland, USA, January 08, 2021: The Global Virus Network (GVN) and Washington University School of Medicine in St. Louis co-hosted a December 11, 2020 international symposium on innate immunity and COVID-19.
- [ROBERT GALLO OF THE UM SCHOOL OF MEDICINE INSTITUTE OF HUMAN VIROLOGY AND GLOBAL VIRUS NETWORK AWARDED TOP LIFE SCIENCES AND MEDICINE PRIZE FROM CHINA](https://gvn.org/robert-gallo-of-the-um-school-of-medicine-institute-of-human-virology-and-global-virus-network-awarded-top-life-sciences-and-medicine-prize-from-china/) - Baltimore, Maryland, USA, December 21, 2020: Robert C. Gallo, MD, The Homer & Martha Gudelsky Distinguished Professor in Medicine, co-founder and director of the Institute Human Virology at the University of Maryland School of Medicine and co-founder and international scientific advisor of the Global Virus Network, was awarded the “VCANBIO Award for Biosciences and Medicine,”
- [GVN STATEMENT ON RECENT COVID-19 VACCINE DATA SUCCESS](https://gvn.org/gvn-statement-on-recent-covid-19-vaccine-data-success/) - Baltimore, Maryland, USA, November 17, 2020: The Global Virus Network (GVN), , which comprises global preeminent human and animal virologists from 57 Centers of Excellence and 11 Affiliates in 33 countries, said today that the 94.5% efficacy rate of the Moderna vaccine, according to early data announced yesterday, is a significant step towards developing an effective
- [Global Virus Network (GVN) and the University of South Florida Launch Online Course “Microbiomes and Their Impact on Viral Infections”](https://gvn.org/global-virus-network-gvn-and-the-university-of-south-florida-launch-online-course-microbiomes-and-their-impact-on-viral-infections/) - GVN Offers Four Scholarships to Self-Paced Online Training Course Baltimore, Maryland, USA, November 17, 2020: The Global Virus Network (GVN), together with the University of South Florida (USF) Institute on Microbiomes, recently launched the self-paced online course “Microbiomes and Their Impact on Viral Infections.” Taught by world-renowned instructors, this course will provide students, academics, and
- [GVN Statement on Pfizer and BioNTech Data from COVID-19 Vaccine Study](https://gvn.org/gvn-statement-on-pfizer-and-biontech-data-from-covid-19-vaccine-study/) - Baltimore, Maryland, USA, July 23, 2020: The Global Virus Network (GVN), a coalition comprised of the world’s preeminent human and animal virologists from 57 Centers of Excellence and 10 Affiliates in 33 countries, said today that the results of the Phase 3 study by Pfizer and BioNTech on their mRNA-based vaccine candidate, BNT162b2, represents a
- [GVN 2020 Special Annual Meeting Executive Summary](https://gvn.org/gvn-2020-special-annual-meeting-executive-summary/) - A New Era in the Fight Against COVID-19 Pandemic: Forging a “Viral Pandemic Readiness Alliance” A September 22-23, 2020 Special Meeting of Top Global Experts Launches “Global Virus Network’s Vision for Future Pandemic Preparedness” We are in the midst of a pandemic that has completely upended the world with major economic, social and psychological impacts.
- [GVN’s Top Virus Experts Meet Together To Identify Most Promising Advances To Battle COVID-19 & Strategies To Prepare For Future Pandemics](https://gvn.org/gvns-top-virus-experts-meet-together-to-identify-most-promising-advances-to-battle-covid-19-strategies-to-prepare-for-future-pandemics/) - Rapid Diagnostic Testing, Repurposing Drug Therapies and Vaccines Targeting Innate Immunity, Are Integral Factors in Mitigating COVID-19 Baltimore, Maryland, USA, September 30, 2020: The Global Virus Network (GVN), a coalition of the world’s leading medical and basic virology research centers working to prevent illness and death from viral disease, convened a press conference with attendees
- [Global Virus Network International Press Conference September 24, 2020](https://gvn.org/global-virus-network-international-press-conference-september-24-2020/) - https://youtu.be/ZXOaUBnIlG0 GVN 2020 Meeting Press Release GVN 2020 Special Annual Meeting Executive Summary
- [Global Virus Network (GVN) Presents Doherty Institute Director, University of Melbourne Professor Sharon Lewin with the Robert C. Gallo Award for Scientific Excellence and Leadership in Medical Virology](https://gvn.org/global-virus-network-gvn-presents-doherty-institute-director-university-of-melbourne-professor-sharon-lewin-with-the-robert-c-gallo-award-for-scientific-excellence-and-leadership-in-medical-virolo/) - Baltimore, Maryland, USA, September 22, 2020: The Global Virus Network (GVN), comprising foremost experts around the world in every class of virus-causing disease in humans and some animals, today presented Doherty Institute Director, University of Melbourne Professor Sharon Lewin with the Robert C. Gallo Award for Scientific Excellence and Leadership in Medical Virology Presented today
- [Global Virus Network Announces 2020 Special Annual Meeting](https://gvn.org/global-virus-network-announces-2020-special-annual-meeting/) - World-Renowned Scientists Come Together to Address COVID-19, Ramifications for Future Epidemics and Pandemics at September 22-23 Virtual Meeting Editors’ note: Media are invited to participate in a virtual press conference on Thursday, September 24 at 9 am ET, which will highlight key outcomes/findings of the meeting. GVN founders and session chairs will present the findings,
- [Abbott partners with the Global Virus Network on a new coalition to prepare for future pandemics](https://gvn.org/abbott-partners-with-the-global-virus-network-on-a-new-coalition-to-prepare-for-future-pandemics/) - In late 2019, a group of infectious disease experts had an idea— to create a coalition among leaders in the public and private sectors that could help prepare for how the global health community responds to emerging pandemics and collaborate to end major viral pandemics. As the initial program formed between Abbott and Global Virus
- [Prominent Australian and Russian Research Institutions Join Global Virus Network to Combat Viral Diseases](https://gvn.org/prominent-australian-and-russian-research-institutions-join-global-virus-network-to-combat-viral-diseases/) - Center for Emerging Viruses, Inflammation and Therapeutics of the Menzies Health Institute Queensland (MHIQ) at Griffith University, Australia and the Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences Join GVN at Critical Time for Information Sharing Baltimore, Maryland, USA, September 8, 2020: The Global
- [Global Virus Network’s Institute of Human Virology and Italian Researchers identify a SARS-CoV-2 Viral Strain with Deletion in a Protein, Possibly Reducing Fatalities](https://gvn.org/global-virus-networks-institute-of-human-virology-and-italian-researchers-identify-a-sars-cov-2-viral-strain-with-deletion-in-a-protein-possibly-reducing-fatalities/) - A deletion in a protein, NSP1, which is important for reducing innate immune response may signal emergence of a less pathogenic viral strain Baltimore, Maryland, USA, August 24, 2020: The Institute of Human Virology (IHV) at the University of Maryland School of Medicine, a Global Virus Network (GVN) Center of Excellence, in collaboration with scientists
- [RENOWNED DOHERTY INSTITUTE IN AUSTRALIA INDEPENDENTLY VERIFIES EARLIER FINDINGS THAT AN ANTIMICROBIAL TECHNOLOGY ERADICATES SARS-COV-2 ON SURFACES FOR MORE THAN SIX WEEKS](https://gvn.org/renowned-doherty-institute-in-australia-independently-verifies-earlier-findings-that-an-antimicrobial-technology-eradicates-sars-cov-2-on-surfaces-for-more-than-six-weeks/) - The Findings Corroborate Research Previously Released by the Rega Medical Research Institute of KU Leuven, Belgium Baltimore, Maryland, USA, August 13, 2020: The Global Virus Network (GVN), a coalition comprised of the world’s preeminent human and animal virologists from 55 Centers of Excellence and 10 Affiliates in 33 countries, announced that the Peter Doherty Institute
- [A Statement From the Leadership of the Global Virus Network on the Passing of Renowned Chinese Virologist Yi Zeng](https://gvn.org/a-statement-from-the-leadership-of-the-global-virus-network-on-the-passing-of-renowned-chinese-virologist-yi-zeng/) - A top cancer researcher and leader in public service is mourned Baltimore, Maryland, USA, July 23, 2020: The Global Virus Network (GVN), a coalition comprised of the world’s preeminent human and animal virologists from 55 Centers of Excellence and 10 Affiliates in 32 countries, collectively mourns the passing of Professor Yi Zeng, MD, Academician of
- [Cleveland Clinic and The University of Southern Denmark Join Global Virus Network to Combat Viral Diseases](https://gvn.org/cleveland-clinic-and-the-university-of-southern-denmark-join-global-virus-network-to-combat-viral-diseases/) - GVN’s latest additions further bolster its 55 Centers for Excellence, expanding knowledge of viruses and treatment Baltimore, Maryland, USA, Tuesday, July 7, 2020: The Global Virus Network (GVN), comprising foremost experts around the world in every class of virus causing disease in humans and some animals, today announced the addition of Cleveland Clinic and the
- [The Global Virus Network’s Position Regarding the Risk of COVID-19 Transmission by Asymptomatic Infected Subjects](https://gvn.org/the-global-virus-networks-position-regarding-the-risk-of-covid19-transmission-by-asymptomatic-infected-subjects/) - BALTIMORE, MD, June 12, 2020: According to the Global Virus Network (GVN), a coalition comprised of the world’s preeminent human and animal virologists from 53 Centers of Excellence and 10 Affiliates in 32 countries, whether or not asymptomatic COVID-19 infected subjects can transmit the virus has tremendous impact on the global public health strategy against
- [Global Virus Network Suggests Oral Polio Vaccine May Provide Temporary Protection Against COVID-19](https://gvn.org/global-virus-network-suggests-oral-polio-vaccine-may-provide-temporary-protection-against-covid-19/) - World-renowned scientists publish strong argument for the live attenuated vaccine in Journal Science BALTIMORE, MD, June 11, 2020: The Global Virus Network (GVN), a coalition comprised of the world’s preeminent human and animal virologists from 53 Centers of Excellence and 10 Affiliates in 32 countries, published a viewpoint in Science today that the stimulation of
- [Dr. Robert Gallo Exclusive Broadcast Interview with Walter Isaacson of Amanpour & Co.](https://gvn.org/dr-robert-gallo-exclusive-broadcast-interview-with-walter-isaacson-of-amanpour-co/) - Can an Oral Polio Vaccine Help Stop COVID-19? Please see this just released Associated Press article, “Could old vaccines for other germs protect against COVID-19?” with Dr. Robert Gallo (Institute of Human Virology at the University of Maryland School of Medicine) and Dr. Konstantin Chumakov (U.S. Food and Drug Administration), both of the Global Virus
- [Global Virus Network’s Institute of Human Virology and Italian Scientists Identify Unique Mutations in SARS-CoV-2 Found in Europe and North America](https://gvn.org/global-virus-networks-institute-of-human-virology-and-italian-scientists-identify-unique-mutations-in-sars-cov-2-found-in-europe-and-north-america/) - BALTIMORE, MD, April 9, 2020: The Institute of Human Virology (IHV) at the University of Maryland School of Medicine, a Global Virus Network (GVN) Center of Excellence, and scientists from Trieste, Italy announced today the characterization of a novel mutation in the RNA polymerase of certain viral strains of SARS-CoV-2 carried by patients located in
- [Editorial from Dr. Christian Brechot and Dr. Robert Gallo](https://gvn.org/editorial-from-dr-christian-brechot-and-dr-robert-gallo/) - The SARS-CoV-2 epidemic is spreading and has become a pandemic with a major impact on national health systems and economics, as well as population behaviors. Delineating the future of the pandemic expansion and the geographical areas which will be hit has important consequences as to the capacity to be prepared and take adequate measures to
- [Global Virus Network (GVN) Coordinates Efforts Between Top International Experts Researching COVID-19](https://gvn.org/global-virus-network-gvn-coordinates-efforts-between-top-international-experts-researching-covid-19/) - The GVN Is Connecting Academia, Governments, Public Health Organizations and Industry to Advance the Response for COVID-19 and Prepare for the Next Outbreak Baltimore, Maryland, USA, February 18, 2020: The Global Virus Network (GVN), representing 53 Centers of Excellence and 9 Affiliates in 32 countries comprising foremost experts in every class of virus causing disease
- [Global Virus Network (GVN) Convenes Discussions with International Top Experts to Combat Growing Novel Coronavirus Epidemic](https://gvn.org/global-virus-network-gvn-convenes-discussions-with-international-top-experts-to-combat-growing-novel-coronavirus-epidemic/) - The GVN Is Bridging Gaps in the Global Emergency Response and Serving as a “Go-To” Resource for Members Needing Assistance in Obtaining and Disseminating Cutting-Edge Scientific Research Baltimore, Maryland, USA, February 6, 2020: The Global Virus Network (GVN), representing 53 Centers of Excellence and 9 Affiliates in 32 countries comprising foremost experts in every class
- [Global Virus Network (GVN) Experts Combat New Worldwide Coronavirus Outbreak](https://gvn.org/global-virus-network-gvn-experts-combat-new-worldwide-coronavirus-outbreak/) - GVN stands by China and relevant international organizations to support efforts to mitigate the new strain of coronavirus, named 2019-nCoV Baltimore, Maryland, USA, January 30, 2020: As airlines suspend flights, countries evacuate citizens from China and nearly 60 million Chinese experience a lockdown, the Global Virus Network (GVN), representing 53 Centers of Excellence and 9
- [Six Internationally Renowned Virus Research Institutions Join the Global Virus Network to Combat Viral Diseases](https://gvn.org/six-renowned-virus-research-institutions-join-gvn-10242019/) - GVN Adds Four Centers of Excellence and Two Affiliates from India, Peru, Republic of Uzbekistan, South Korea, United States and Zimbabwe Baltimore, Maryland, USA, October 24, 2019: The Global Virus Network (GVN), representing 52 Centers of Excellence and 9 Affiliates in 32 countries comprising foremost experts in every class of virus causing disease in humans
- [GLOBAL VIRUS NETWORK HOSTS SIXTH SHORT COURSE](https://gvn.org/global-virus-network-hosts-sixth-short-course/) - Top GVN Experts Inspire Rising International Virologists Baltimore, Maryland, USA, August 29, 2019: The Global Virus Network (GVN) earlier this month held its 6th Annual Short Course in Basic and Translational Virology on July 28-August 3 for 18 early-career human and animal virologists from Argentina, Bolivia, Germany, Hong Kong, Jamaica, Japan, Kenya, Nigeria, South Korea
- [A Summary of Recent Advances in Ebola Treatment](https://gvn.org/a-summary-of-recent-advances-in-ebola-treatment/) - August 21, 2019 Only two years ago, neither a vaccine cure for the Ebola Virus, nor effective antivirals existed to prevent Ebola Virus Disease. Recovery for those infected was through the strength of their own immune system, and according to the U.S. Centers of Disease Control and Prevention (CDC), doctors treated patients while keeping them
- [Ebola Outbreak in the Democratic Republic of the Congo Shines Light on Global Challenges](https://gvn.org/ebola-outbreak-in-the-democratic-republic-of-the-congo-shines-light-on-global-challenges/) - Last Week the WHO Declared the Epidemic a Public-Health Emergency of International Concern Baltimore, MD, USA, July 24, 2019: Last week, the World Health Organization (WHO) declared the current Ebola outbreak in the Democratic Republic of the Congo (DRC) a public-health emergency of international concern (PHEIC), signaling a risk to multiple countries that requires a
- [WORLD EXPERTS IN VIROLOGY ALERT THAT CLIMATE CHANGE AND GLOBALIZATION ARE AN ADDED PROBLEM IN VIRAL DISEASE TRANSMISSION](https://gvn.org/world-experts-in-virology-alert-that-climate-change-and-globalization-are-an-added-problem-in-viral-disease-transmission/) - WORLD EXPERTS IN VIROLOGY ALERT THAT CLIMATE CHANGE AND GLOBALIZATION ARE AN ADDED PROBLEM IN VIRAL DISEASE TRANSMISSION Dr. William Hall Receives The GVN Robert C. Gallo Award for Scientific Excellence and Leadership Baltimore, MD, USA, July 2, 2019: The Global Virus Network (GVN), representing 48 Centers of Excellence and 7 Affiliates in 29 countries
- [THE GLOBAL VIRUS NETWORK (GVN) LAUNCHES AFRICA GVN TO JOIN FRENCH AND ENGLISH-SPEAKING SCIENTISTS IN THE FIGHT AGAINST INFECTIOUS DISEASES AND ONGOING EPIDEMICS](https://gvn.org/the-global-virus-network-gvn-launches-africa-gvn-to-join-french-and-english-speaking-scientists-in-the-fight-against-infectious-diseases-and-ongoing-epidemics/) - In the Midst of the Second Worst Ebola Outbreak Since Its Discovery, Top African Scientists Identify Ways to Battle Deadly Diseases Together Baltimore, Maryland, USA, June 25, 2019: During a meeting held last month in Entebbe, Uganda, the Global Virus Network (GVN), representing 48 Centers of Excellence and 7 Affiliates in 29 countries comprising foremost
- [The Global Virus Network (GVN) Announces The Addition Of Three New Centers Of Excellence Joining Organization](https://gvn.org/the-global-virus-network-gvn-announces-the-addition-of-three-new-centers-of-excellence-joining-organization/) - University of Wisconsin-Madison Global Health Institute, U.S. Food and Drug Administration’s Office of Vaccine Research and Review and the Smorodintsev Research Institute of Influenza of the Ministry of Health of the Russian Federation Join Renowned Global Virus Network to Combat Viral Diseases Baltimore, Maryland, USA, June 4, 2019: The Global Virus Network (GVN), representing 48
- [“THE HOT ZONE” SCENARIO – WILL IT HAPPEN AGAIN?](https://gvn.org/the-hot-zone-scenario-will-it-happen-again/) - The Global Virus Network (GVN) Confirms That Deadly Hemorrhagic Viruses Are a Real & Imminent Threat Baltimore, MD, May 28, 2019: “The Hot Zone,” which premiered on Monday, May 27, 2019, is a three night limited series on National Geographic, based on Richard Preston’s best-selling book that depicts the true story of deadly, airborne hemorrhagic
- [The Global Virus Network (GVN) Launches Anticipation & Preparedness Taskforce Following 10th International Meeting in Annecy, France](https://gvn.org/the-global-virus-network-gvn-launches-anticipation-preparedness-taskforce-following-10th-international-meeting-in-annecy-france/) - The GVN Undertakes Worldwide Initiative to Support Public Health Authorities Baltimore, Maryland, USA, March 27, 2019: The Global Virus Network (GVN), a worldwide coalition of preeminent virologists engaged in the preparedness, defense and first research response to emerging, exiting and unidentified viruses that pose a clear and present threat to public health, has launched the
- [Global Virus Network Center Of Excellence Researchers Discover That A Bacterial Protein Promotes Cancer](https://gvn.org/global-virus-network-center-of-excellence-researchers-discover-that-a-bacterial-protein-promotes-cancer/) - Institute of Human Virology at the University of Maryland School of Medicine Research Suggests that Bacterial Infections May Contribute Far More to Cancers Than Previously Thought Baltimore, Maryland, USA, December 4, 2018: The Institute of Human Virology (IHV) at the University of Maryland School of Medicine, a Global Virus Network Center of Excellence, announced today the discovery
- [Global Virus Network Adds Singapore Consortium as Newest Center of Excellence](https://gvn.org/global-virus-network-adds-singapore-consortium-as-newest-center-of-excellence/) - Baltimore, Maryland, USA, and Singapore, August 22, 2018: The Global Virus Network (GVN) and the GVN-Singapore Center of Excellence, comprised of 7 virology research intuitions led by Duke-NUS Medical School, announced today the induction of the Singaporean coalition as GVN’s newest Center of Excellence. The GVN represents 42 Centers of Excellence and 7 affiliates in
- [The Time to Cure Hepatitis B is Now](https://gvn.org/the-time-to-cure-hepatitis-b-is-now/) - Nature Reviews Commentary lays groundwork for the momentum behind hepatitis B cure research and the long-term implementation of HBV cure preparedness worldwide. On the eve of World Hepatitis Day, the International Coalition to Eliminate HBV (ICE-HBV), a global group of researchers, patient representatives and health organisations including the Global Virus Network (GVN),
- [Global Virus Network (GVN) Centers of Excellence Contribute Expertise to Nipah Virus Outbreak in Kerala, India](https://gvn.org/gvn-centers-contribute-expertise-to-nipah-virus-outbreak-in-kerala-india/) - In the wake of the outbreak, the Government of Kerala is fast-tracking the launch of the Institute of Advanced Virology, which will house a unit of the GVN Baltimore, Maryland, USA, June 5, 2018: Several of the Global Virus Network’s (GVN) Centers of Excellence have been researching Nipah virus (NiV) and are currently contributing expertise
- [Global Virus Network Responds to Ebola Outbreak in the Democratic Republic of the Congo](https://gvn.org/ebola/) - Global Virus Network Responds to Ebola Outbreak in the Democratic Republic of the Congo Baltimore, Maryland, USA, May 31, 2018: The Global Virus Network (GVN) is mobilizing a coordinated effort to the Ebola outbreak in the Democratic Republic of the Congo (DRC) through its Centers of Excellence. The GVN represents 41 Centers of Excellence and
- [Update on the Nipah Virus Outbreak in Kerala, India](https://gvn.org/update-on-the-nipah-virus-outbreak-in-kerala-india/) - Update on the Nipah Virus Outbreak in Kerala, India May 30, 2018 By Benhur Lee, MD, Professor, Department of Microbiology at the Icahn School of Medicine at Mount Sinai, a Global Virus Network (GVN) Center of Excellence and Linfa Wang, PhD, Professor & Director, Emerging Infectious Diseases Programme, Duke-NUS Medical School, Singapore What is Nipah
- [GVN Bestows Diane Griffin with The GVN Robert C. Gallo Award for Scientific Excellence and Leadership](https://gvn.org/gvn-bestows-diane-griffin-with-the-gvn-robert-c-gallo-award-for-scientific-excellence-and-leadership/) - Dr. Griffin was presented the Award during the 9th International Meeting in Melbourne last September Baltimore, MD, USA, February 1, 2018: The Global Virus Network (GVN), an international coalition of the world’s foremost medical virologists, comprising 40 Centers of Excellence in 25 countries, dedicated to identifying and researching, combatting and preventing, current and emerging pandemic
- [INTERNATIONALLY RENOWNED VIROLOGIST CHRISTIAN BRÉCHOT APPOINTED PRESIDENT OF THE GLOBAL VIRUS NETWORK (GVN)](https://gvn.org/brechot/) - Brings Decades of Scientific & Organizational Leadership To Advance GVN’s Mission Melbourne, Australia, September 25, 2017: The Global Virus Network (GVN), an international coalition of the world’s foremost medical virologists, comprising 40 Centers of Excellence in 24 countries, dedicated to identifying and researching, combatting and preventing, current and emerging pandemic viruses that pose a critical
- [Global Virus Network Adds Internationally Renowned Mérieux Foundation as Newest Center of Excellence](https://gvn.org/global-virus-network-adds-internationally-renowned-merieux-foundation-as-newest-center-of-excellence/) - Global Virus Network Adds Internationally Renowned Mérieux Foundation as Newest Center of Excellence Baltimore, Maryland, USA, and Lyon, France, July 12, 2017: The Global Virus Network (GVN) and the Mérieux Foundation announced today the induction of the foundation as GVN’s newest Center of Excellence. The GVN represents 39 Centers of Excellence and six affiliates in
- [Pioneers in Infectious Agents and Cancer Meeting in Naples March 22-23, 2017](https://gvn.org/pioneers-in-infectious-agents-and-cancer-meeting-in-naples-march-22-23-2017/) - The Institute Naz. – Tumori Fondazione Pascale, in partnership with GVN and the online journal Infectious Agents and Cancer, hosted the “Pioneers in Infectious Agents and Cancer Meeting” in Naples March 22-23, 2017 to honor GVN’s Co-Founder & Scientific Director, Robert Gallo, MD, in celebration of his 80th Birthday. https://sites.google.com/site/infectagentscancer1/iac/pioneers-in-infectious-agents-and-cancer
- [Global Virus Network (GVN) Announces Seven Distinguished  International Appointments to Board of Directors](https://gvn.org/global-virus-network-gvn-announces-seven-distinguished-international-appointments-to-board-of-directors/) - Global Virus Network (GVN) Announces Seven Distinguished International Appointments to Board of Directors World leaders in business & science are committed to supporting the GVN Baltimore, MD (March 22, 2017) – The Global Virus Network (GVN), a coalition of the world’s leading medical virology research centers working together to prevent illness and death from viral
- [Gilead Sciences Awards $148K to the Global Virus Network (GVN) to Combat Hepatitis C Virus (HCV) in Remote Regions of India](https://gvn.org/gilead/) - Gilead Sciences Awards $148K to the Global Virus Network (GVN) to Combat Hepatitis C Virus (HCV) in Remote Regions of India The pilot study will build specific training models to test, link and treat specialized HCV patient populations in high prevalence regions of India Baltimore, Maryland, USA, March 1, 2017: The Global Virus Network (GVN),
- [Global Virus Network Inspires New Collaborations to Combat Viral Threats During Meeting of Top Medical Researchers](https://gvn.org/global-virus-network-inspires-new-collaborations-to-combat-viral-threats-during-meeting-of-top-medical-researchers/) - Dr. Ab Osterhaus Presented with The GVN Robert C. Gallo Award for Scientific Excellence and Leadership Baltimore, MD, November 17, 2016: The Global Virus Network (GVN), a coalition of the world’s leading medical virology research centers working together to prevent illness and death from viral disease, held its 8th meeting in Sapporo, Japan late last
- [Global Virus Network Adds Tulane University School of Medicine as Newest Center of Excellence](https://gvn.org/global-virus-network-adds-tulane-university-school-of-medicine-as-newest-center-of-excellence-global-virus-network-adds-tulane-university-school-of-medicine-as-newest-center-of-excellence-global-virus/) - Baltimore, Maryland, USA, and Atlanta, GA, USA, Oct. 19, 2016: The Global Virus Network (GVN) and Tulane University School of Medicine announced today the induction of Tulane as GVN’s newest Center of Excellence. The GVN represents 38 Centers of Excellence and six affiliates in 25 countries and comprises foremost experts in every class of virus
- [Global Virus Network Announces $100,000 Donation from The Allergan Foundation to Establish International Serum Bank for Zika Task Force](https://gvn.org/donation-allergan-foundation/) - Serum bank provides leading repository of Zika serum samples to support coordinated, global research effort to address Zika crisis Baltimore, Maryland, US – October 17, 2016: The Global Virus Network (GVN), representing 37 Centers of Excellence and six affiliates in 25 countries and comprising foremost experts in every class of virus causing disease in humans,
- [Global Virus Network Adds Emory University  as a Center of Excellence](https://gvn.org/emory/) - Baltimore, Maryland, USA, and Atlanta, GA, USA, Sept. 1, 2016: The Global Virus Network (GVN) and Emory University announced today the induction of Emory as GVN’s newest Center of Excellence. The GVN represents 37 Centers of Excellence and six affiliates in 25 countries and comprises foremost experts in every class of virus causing disease in
- [Global Virus Network Adds International Vaccine Institute (IVI)](https://gvn.org/korea/) - Global Virus Network Adds International Vaccine Institute (IVI) as Newest Center of Excellence Baltimore, Maryland, USA, August 8, 2016: The Global Virus Network (GVN), representing 36 Centers of Excellence and 6 Affiliates in 25 countries and comprising foremost experts in every class of virus causing disease in humans, and the International Vaccine Institute (IVI) announced
- [Institut Pasteur and University of the West Indies, Mona Join Renowned Global Virus Network to Combat Viral Diseases](https://gvn.org/institut-pasteur-and-university-of-the-west-indies-mona-join-renowned-global-virus-network-to-combat-viral-diseases/) - Institut Pasteur and University of the West Indies, Mona Join Renowned Global Virus Network to Combat Viral Diseases Baltimore, Maryland, USA, May 24, 2016: The Global Virus Network (GVN), representing 36 Centers of Excellence and 6 Affiliates in 24 countries comprising foremost experts in every class of virus causing disease in humans, announced today the
- [GVN Launches Zika Task Force](https://gvn.org/zika-task-force/) - Global Virus Network (GVN) Launches Zika Task Force Comprised of Leading Virus Researchers from Around the Globe GVN catalyzes international collaborations in an effort to address the urgent need to share information and research to better combat the global Zika outbreak February 11, 2016, Baltimore, MD: The Global Virus Network (GVN), representing 35 Centers of
- [Renowned Public Health Virologist José Esparza Ushers in New Era for Global Virus Network (GVN) as President](https://gvn.org/renowned-public-health-virologist-jose-esparza-ushers-in-new-era-for-global-virus-network-gvn-as-president/) - Renowned Public Health Virologist José Esparza Ushers in New Era for Global Virus Network (GVN) as President Prominent drug discoverer, virologist, and entrepreneur Raymond Schinazi is also elected to the GVN executive committee and esteemed lawyer Tim Moynahan is reappointed as GVN Chairman of the Board of Directors January 27, Baltimore, MD: The Global Virus
- [Middle East Virus Travels to Far East](https://gvn.org/mersvirus/) - Middle East Virus (MERS) Travels to Far East On June 14, The World Health Organization (WHO) described the Middle East Respiratory Syndrome coronavirus (MERS-CoV) outbreak in South Korea as “large and complex.” The WHO, joined by South Korea’s Ministry of Health and Welfare, called for strengthening of contact tracing, monitoring and quarantine as well as
- [Global Virus Network Meeting Strengthens Ties Among Top Virus Researchers](https://gvn.org/gvn-meeting-beijing-2015/) - GVN’s programs facilitate international collaborations to address growing viral threats May 19, 2015, Beijing, China--The Global Virus Network (GVN), a coalition of the world’s leading medical virology research centers working together to prevent illness and death from viral disease, held its 7th meeting in partnership with Beijing University of Technology, a GVN Center of Excellence,
- [Top Virologists Meet in China to Address Threats](https://gvn.org/top-virologists-meet-in-china-to-address-threats/) - Top Virologists of the Global Virus Network (GVN) Meet in China to Address Threats The Addition of Two GVN Centers of Excellence Strengthen GVN’s Worldwide Reach Baltimore, Maryland, USA, May 11, 2015: The Global Virus Network (GVN), a coalition of the world’s leading medical virology research centers working together to prevent illness and death from
- [GVN Scientist Publishes Ebola - Marburg Virus Connection](https://gvn.org/gvn-scientists-publishes-ebola-marburg-virus-connection/) - Dr. Erica Ollmann Saphire's Lab of The Scripps Research Institute recently published in Cell the discovery of an antibody that binds to both the Marburg and Ebola virus. The ability of an antibody to bind to both of these deadly viruses is a major step forward in the potential treatment of them. Article
- [Confronting Ebola at its Origins:   GVN Member, The South African National Institute for Communicable Diseases, Deploys their Mobile Diagnostic Laboratory to Sierra Leone](https://gvn.org/ebola-origins/) - The 2014/15 outbreak of Ebola virus disease is the largest ever reported of this deadly, highly infectious, hemorrhagic disease since its initial discovery in humans in 1976. The current outbreak was first recognized in March, 2014 in Guinea and has since crossed international boundaries into Sierra Leone and Liberia where case numbers have now surpassed
- [GVN Symposium on the Global Spread of Chikungunya](https://gvn.org/gvn-symposium-on-the-global-spread-of-chikungunya/) - GVN Symposium on the Global Spread of Chikungunya On November 5, GVN and its partner, ASTMH, convened a special symposium on "The Global Spread of Chikungunya: Epidemiology, Evolution, Pathogenesis and Global Needs" at the annual ASTMH meeting in New Orleans. All three of GVN's Task Force Chairs on Chikungunya spoke at the session, which was
- [June 18, 2014 The view from Estonia](https://gvn.org/june-18-2014-the-view-from-estonia/) - June 18, 2014 The view from Estonia by GVN's President. Here in the homeland of Skype, Mobile ID, online voting and X-Road data exchanges, it did not take long for more than a hundred local and foreign virologists to merge seamlessly into the first GVN Scandinavian-Baltic Conference. The June 10-13 conference included scientists and physicians from
- [MEDIA ADVISORY](https://gvn.org/media-advisory/) - Who: The Windward Islands Research and Education Foundation (WINDREF) and St. George’s University (SGU) in partnership with the Global Virus Network (GVN) Dr. Robert Gallo, Director, Institute of Human Virology, University of Maryland School of Medicine and Co-Founder and Scientific Director, GVN Dr. Anders Vahlne, Professor of Clinical Virology at the Department of Laboratory Medicine, Karolinska Institute, and Center Director
- [Prominent Virologist Stanley Plotkin Joins GVN as Senior Advisor](https://gvn.org/prominent-virologist-stanley-plotkin-joins-gvn-as-senior-advisor/) - Baltimore, MD: January 14, 2014 ;The Global Virus Network (GVN) is honored to have Dr. Stanley A. Plotkin, Emeritus Professor of the University of Pennsylvania and consultant to all of the major vaccine manufacturers, serve as a senior advisor. Dr. Plotkin is world renowned for his development of the rubella vaccine- now in standard use throughout the world,
- [A New Pathogen in Paradise](https://gvn.org/a-new-pathogen-in-paradise/) - A New Pathogen in Paradise A new virus with a strange name recently emerged in the popular press and the public consciousness. On 19 December 2013, two confirmed cases of locally acquired chikungunyavirus (CHIK) were reported on the French Caribbean island of Martinique. The World Health Organization announced that this is the first time local transmission of this virus has been detected in the Americas. CHIK is
- [Gallo reflects on 30 years in HIV research](https://gvn.org/gallo-reflects-on-30-years-in-hiv-research/) - Gallo reflects on 30 years in HIV research Dan Rodricks, of the Baltimore Sun in January 4 th interview of Dr. Robert Gallo, and discusses the current advances leading to a "functional cure" .
- [Chikunguya virus (CHIKV) outbreak in St. Martin](https://gvn.org/chikunguya-virus-chikv-outbreak-in-st-martin/) - Chikunguya virus (CHIKV) outbreak in St. Martin December 20, 2013, Baltimore, MD: St. Martin, in the Caribbean, is the first country in the Western Hemisphere to experience a Chikunguya virus (CHIKV) outbreak. Global Virus Network (GVN) member of the Sweden-Estonia GVN Center of Excellence and CHIKV specialist, Andres Merits, PhD says once we know the
- [Gallo Speaks to Dan Rodricks](https://gvn.org/gallo-speaks-to-dan-rodricks/) - Dr. Gallo spoke about the beginning of AIDS, the need for the next generation of trained virologists, the creation of the Global Virus Network, viruses in general, IHV’s HIV preventive vaccine candidate, a PEPFAR for the U.S., among other important issues. At the end, the reporter thanks Gallo and his team for choosing the University
- [Distinguished Attorney Timothy C. Moynahan Named Chairman of the Global Virus Network (Gvn) Board of Directors](https://gvn.org/distinguished-attorney-timothy-c-moynahan-named-chairman-of-the-global-virus-network-gvn-board-of-directors/) - DISTINGUISHED ATTORNEY TIMOTHY C. MOYNAHAN NAMED CHAIRMAN OF THE GLOBAL VIRUS NETWORK (GVN) BOARD OF DIRECTORS Will Forge Partnerships With Multinational Corporations & Private Benefactors To Mitigate The Threat & Financial Impact Of Pandemic Viral Diseases Baltimore, MD (December 17, 2013) – The Global Virus Network (GVN), a coalition of the world’s foremost medical virology
- [Global Virus Network and Institute of Human Virology Awarded $100K from the Windward Islands Research and Education Foundation](https://gvn.org/global-virus-network-and-institute-of-human-virology-awarded-100k-from-the-windward-islands-research-and-education-foundation/) - Global Virus Network and Institute of Human Virology Awarded $100K from the Windward Islands Research and Education Foundation BALTIMORE--(BUSINESS WIRE)-- The Global Virus Network (GVN), representing more than 20 countries and comprising foremost experts in every class of virus causing disease in humans, and the Institute of Human Virology (IHV) at the University of Maryland
- [Global Virus Network Warns U.S. of Growing Measles Threat](https://gvn.org/measles-whats-old-is-new-again/) - Oct. 1, 2013 17:39 UTC Global Virus Network Warns U.S. of Growing Measles Threat BALTIMORE--(BUSINESS WIRE)-- The Global Virus Network (GVN), a coalition of the world’s leading medical virology research centers working to prevent illness and death from viral disease, today warned the U.S. of a startling rise in measles cases particularly in the last couple
- [Moscow Meeting of Top Virus Researchers Catalyzes Global Collaborations](https://gvn.org/moscow-meeting-of-top-virus-researchers-catalyzes-global-collaborations/) - September 26, 2013 11:41 AM Eastern Daylight Time BALTIMORE--(BUSINESS WIRE)--Members of the Global Virus Network (GVN), which includes foremost experts in every class of human virus, and represents more than 20 countries, met in Moscow this month to share information on devastating viral threats. Top scientists shared intelligence on an array of diseases threatening global health,
- [GVN Co-Founder William Hall Receives Prestigious Vietnamese Honor](https://gvn.org/gvn-co-founder-william-hall-receives-prestigious-vietnamese-honor/) - GVN Co-Founder William Hall Receives Prestigious Vietnamese Honor In a ceremony in Hanoi this month, GVN Co-Founder William Hall of University College Dublin, Ireland and Director of the Atlantic Philanthropies (AP), was presented an insignia award by the Vietnam Union of Friendship Organisations (VUFO) for his immense efforts and contributions to the development of the
- [An evening discussion on pandemic disease and economic security](https://gvn.org/an-evening-discussion-on-pandemic-disease-and-economic-security/) - Recently, GVN was hosted in Washington to tell its story to a high-powered group of diplomats, business leaders, media and public policy gurus, all with the view of discussing the importance of the Global Virus Network within the context of national security. We were hosted by one of GVN’s newest Board Members, Franco Nuschese, who
- [Reflections on the GVN Munich meeting](https://gvn.org/reflections-on-the-gvn-munich-meeting/) - June 3, 2013 With the 5th semi-annual meeting of the Global Virus Network just behind us, I take this opportunity to offer some reflections and perspectives. My first reflection is to look back on the beautiful host city of Munich, a bustling modern city that has managed to maintain its particular historic charm and warmth.
- [Join Us!](https://gvn.org/presidents-address/) - Dear GVN Friends and Colleagues, Every day, and on every corner of the globe, people become sick, and millions die, from viral infections. Old, young, rich and poor. We are all susceptible to viral disease. While preventive vaccines and drugs are available to fight some of these viruses, for many diseases, the scientific community has
- [Munich Meeting Discussion](https://gvn.org/munich-meeting-discussion/) - The following are comments from the Munich Meeting.
- [The Global Virus Network Convenes in Munich](https://gvn.org/1573-2/) - Top virologists to discuss emerging viral threats BALTIMORE--(BUSINESS WIRE)-- The Global Virus Network, a coalition of the world’s leading medical virology research centers working to prevent illness and death from viral disease, will hold its spring 2013 meeting in Munich, Germany May 30 to June 1. The closed meeting, hosted by the Institute of Virology

## Pages

- [Home](https://gvn.org/) - GVN Expertise Dashboard This interactive dashboard showcases the GVN's international community of Centers of Excellence and Affiliate institutions. Explore the geographic distribution of GVN expertise, research programs, laboratory capabilities, biosafety infrastructure, and public health partnerships across the network. Designed to support global pandemic preparedness, the dashboard connects institutional expertise with viral surveillance and outbreak information,
- [News](https://gvn.org/about/news/) - News GVN shares the latest updates on scientific breakthroughs, global collaborations, educational initiatives, and emerging viral threats. This section features our press releases, monthly newsletters, media coverage reports, and other key communications that highlight GVN's global impact. Through proactive media engagement and transparent, evidence-based reporting, GVN provides trusted information that strengthens public understanding of virology
- [Webinars](https://gvn.org/activities/nurture/webinars/) - WELCOME TO THE Webinars The GVN, in partnership with the University of South Florida, hosts the Forefront of Virology Webinar Series to share knowledge on pressing viral threats and the latest scientific progress. Each session features leading virologists from GVN Centers of Excellence and Affiliates worldwide. The webinars include a 30-40 minute live presentation followed
- [Training and Education](https://gvn.org/activities/nurture/) - Education & Training Educating and training the next generation of virologists is a foundational cornerstone of the GVN's mission. There is a global shortage of experts in basic, clinical, and translational research, especially in low- and middle-income countries. To help close this gap, GVN senior virologists provide mentorship and intensive training for early-career scientists. Thanks
- [Board](https://gvn.org/about/board/) - Leadership Board of Directors Robert Gallo, MD GVN Co-Founder; International Scientific Director & Chairman of the GVN Scientific Leadership Committee; GVN Board Executive Committee; Director, University of South Florida (USF) Institute of Translational Virology and Innovation; James P. Cullison Professor of Medicine, USF Health Morsani College of Medicine; Director, Microbial Oncology Program, Tampa General Hospital
- [GVN Milestones](https://gvn.org/gvn-milestones/) - GVN Milestones Since its founding in 2011, the Global Virus Network has worked to strengthen the world's capacity to understand, prevent, and respond to viral threats through scientific collaboration, research, education, and public engagement. From building an international network of leading virologists to advancing pandemic preparedness initiatives and shaping responses to emerging outbreaks, GVN's accomplishments
- [Team](https://gvn.org/about/team/) - Team Mathew L. Evins Chief Executive Officer, Global Virus Network Treasurer & Emeritus Executive Chair, GVN Board GVN Board Executive Committee Chairman & CEO, Evins Communications, Ltd. Biography Mathew L. Evins is a founding board member and Emeritus Executive Chair of the Global Virus Network (GVN) and currently serves as the organization's Treasurer and Managing
- [GVN Short Course](https://gvn.org/gvn-short-course/) - 2026 GVN Short Course Section 1 - Contact InformationName(Required) First Last Email(Required) Phone(Required)Address(Required) Street Address Address Line 2 City State / Province / Region ZIP / Postal Code AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCabo VerdeCambodiaCameroonCanadaCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColombiaComorosCongoCongo, Democratic Republic of theCook IslandsCosta
- [COVID-19 Variants and Vaccines](https://gvn.org/covid-19-variants-and-vaccines/) - WELCOME TO THE COVID-19 VARIANTS AND VACCINES VACCINES Can I get COVID-19 after vaccination, and can I still spread the virus? Yes, although this is rare, since the current vaccines are effective against the Delta variant. Yet reinfections (i.e., breakthrough infections) can occur. The US CDC has recently evaluated breakthrough infections that cause hospitalization or
- [Annual International Scientific Meetings](https://gvn.org/annual-international-scientific-meetings/) - Annual International Scientific Meetings GVN's Annual Scientific Meetings convene global experts, researchers, and public health leaders to advance virology research and strengthen international collaboration. Each meeting plays a vital role in enhancing pandemic preparedness, driving scientific innovation, and building global capacity to address viral threats. Upcoming Meetings 2027 GVN Annual International Scientific Meeting Singapore 10
- [2026 Annual International Scientific Meeting ](https://gvn.org/2026-annual-international-scientific-meeting/) - Organizing Committee Robert Gallo, MD GVN; USF Health Institute for Translational Virology & Innovation TGH Cancer Institute Mathew Evins GVN Christian Bréchot, MD, PhD GVN; USF Microbiomes Institute Sten Vermund, MD, PhD GVN; USF Health College of Public Health GVN Featuring Robert Gallo, MD GVN; USF Health Institute for Translational Virology & Innovation; TGH Cancer
- [2026 Presentations Annual Meeting](https://gvn.org/2026-presentations-annual-meeting/) - Day One Brett Giroir Nadia Adjoa Sam Peter Palese Igor Koralnik Sharon Lewin Daniela Weiskopf Salim A. Karim William Moss Day Two Quarraisha A. Karim Brett Giroir Mariano Molina Peter Palese Scott C. Weaver Carla Freitas Michael Teng Ron Desrosiers Michael G. Berg Mihai Netea Day Three Susan R. Weiss​ Robert F. Garry
- [2026 GVN Annual International Scientific Meeting Post-Survey](https://gvn.org/2026-gvn-annual-international-scientific-meeting-post-survey/) - 2026 GVN Annual International Scientific Meeting Post-Survey 1. Please choose your attendance category(Required) In-person Virtual 2. How would you rate the overall scientific content of the 2026 GVN Annual International Scientific Meeting?(Required) Excellent Very Good Good Fair Poor 3. What topics were you especially pleased to see presented?(Required)4. What topics do you feel were missing
- [Register Form International Science Innovation Week 2026](https://gvn.org/register-form-international-science-innovation-week-2026/) - International Science Innovation Week 2026 Name(Required) First Last Email(Required) Phone(Required)Address(Required) Street Address Address Line 2 City State / Province / Region ZIP / Postal Code CountryAfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCabo VerdeCambodiaCameroonCanadaCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColombiaComorosCongoCongo, Democratic Republic of theCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaCôte d'IvoireDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl
- [GVN Academic Centers of Excellence & Affiliates](https://gvn.org/members/gvn-academic-centers-of-excellence-and-affiliates/) - WELCOME TO THE Research Centers of Excellence & Affiliates GVN Research Centers of Excellence & Affiliates conduct vital research in medical virology around the world. Together, they are dedicated to understanding, preventing, and responding to viral threats to human health, with a central focus on pandemic preparedness. Centers of Excellence serve as leading hubs with
- [TGH International Meeting](https://gvn.org/international-science-innovation-week-2026/) - TGH Cancer Institute International Meeting "Microbes, Genes and Cancer" March 2-3, 2026 Register Here Organizing Committee Robert Gallo, MD TGH Cancer Institute; GVN; USF Health Institute for Translational Virology & Innovation Eduardo Sotomayor, MD TGH Cancer Institute Jack Pledger, PhD TGH Cancer Institute GVN Annual International Scientific Meeting "Pandemic Preparedness?" March 4-6, 2026 Registration CLosed
- [TGH Cancer Institute Meeting](https://gvn.org/tgh-cancer-institute-meeting/) - "Microbes, Genes and Cancer" March 2-3, 2026 Register Here Organizing Committee Robert Gallo, MD TGH Cancer Institute; GVN; USF Health Institute for Translational Virology & Innovation Eduardo Sotomayor, MD TGH Cancer Institute Jack Pledger, PhD TGH Cancer Institute TGH Cancer Institute Featuring Rafi Ahmed, PhD Emory University; U.S.A. Matthew Anderson, MD, PhD TGH Cancer Institute;
- [Global Guardian for Pandemic Preparedness](https://gvn.org/global-guardians-youth-for-pandemic-preparedness-application-form/) - WELCOME TO THE Global Guardian for Pandemic Preparedness Application Form Global Guardian for Pandemic Preparedness Section 1 - Parent/Guardian InformationParent/Guardian Name(Required)Parent/Guardian Email Address(Required) Parent/Guardian Phone Number (include country code) (e.g., +1 480-374-000)(Required)Section 2 - Student InformationStudent Applicant Name(Required)Address(Required) Street Address Address Line 2 City State / Province / Region ZIP / Postal Code AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua
- [Awards and Honoraria](https://gvn.org/awards-and-honoraria/) - Awards & Honoraria The GVN Robert C. Gallo Award for Scientific Excellence and Leadership The GVN Robert C. Gallo Award for Scientific Excellence and Leadership recognizes scientists who have made outstanding contributions to virology and to the mission of the Global Virus Network. Honorees are nominated by their peers for publishing important scientific discoveries in
- [Regional Scientific Meetings](https://gvn.org/regional-scientific-meetings/) - Regional Scientific Meetings GVN's Regional Scientific Meetings convene experts, researchers, clinicians, and public health leaders within specific geographic regions to address local viral threats, strengthen scientific collaboration, and build research capacity. These meetings support GVN's global mission by fostering regional networks, advancing surveillance and diagnostics, and promoting coordinated responses to emerging and re-emerging viruses. If
- [Action Committees](https://gvn.org/action-committees/) - WELCOME TO THE Action Committees Action Committees, formerly known as Task Forces and Watch Groups, are a central initiative of the GVN, uniting experts across academic, institutional, and corporate partners to address pressing viral challenges. Each committee focuses on a specific viral category or emerging threat, such as poxviruses, respiratory viruses, hemorrhagic fever viruses, arboviruses,
- [Global Health Strategies & Solutions](https://gvn.org/global-health-strategies-solutions/) - Global Health Strategies & Solutions GVN's global health strategies drive a powerful, unified response to viral threats through coordinated action, evidence-based decisions, and groundbreaking research. By delivering critical briefings, materials, and outreach, GVN informs and empowers policymakers with the latest virology issues, insights, and pandemic preparedness strategies. A critical aspect of this program is the
- [Research](https://gvn.org/research/) - Research GVN's research programs focus on advancing scientific knowledge in virology and global health, as well as promoting the practical application of this knowledge in real-world settings. By fostering collaboration among global experts, GVN is committed to developing innovative solutions to emerging health threats, enhancing disease prevention, and improving pandemic preparedness and response. Our interdisciplinary
- [GVN INTERNATIONAL HEADQUARTERS](https://gvn.org/gvn-international-headquarters/) - GVN International Headquarters In July 2024, the Global Virus Network (GVN) selected the University of South Florida (USF) to host its international headquarters, recognizing the university's leadership and dedication to biomedical research and innovation. The vision and commitment of USF and USF Health leadership were instrumental in bringing GVN to USF, serving as the driving
- [Mission](https://gvn.org/about/mission/) - Mission To ensure and facilitate global pandemic preparedness for viral diseases that pose a threat to public health. The GVN achieves this through three foundational cornerstones: enhancing scientific research, advancing education and training, strengthening preparedness and response, and fostering a coordinated approach to combating viral diseases worldwide by collaborating with national and international scientific institutions
- [Meeting & Events](https://gvn.org/meeting-events/) - WELCOME TO THE Meeting & Events GVN convenes leading scientists, clinicians, policymakers, and public health experts through Annual International Scientific Meetings, Regional Scientific Meetings, and the Forefront of Virology webinar series. These gatherings accelerate knowledge-sharing, foster global collaboration, and highlight innovations shaping the future of pandemic preparedness. Annual International Scientific Meetings Regional Scientific Meetings
- [Partners](https://gvn.org/partners-2/) - WELCOME TO THE Partners GVN works closely with national and international scientific institutions, government agencies, academic centers, and industry collaborators to strengthen global resilience against viral diseases. These partnerships expand research capacity, enhance diagnostics and surveillance, and support unified efforts to prepare for and respond to emerging pathogens. Corporate Partners The business and institutional communities
- [The Network](https://gvn.org/the-network/) - WELCOME TO THE The Network GVN unites the world's leading virologists through a global network of Centers of Excellence and Affiliates dedicated to addressing viral threats. This collaborative infrastructure supports high-quality research, shared expertise, and coordinated responses across 40+ countries, ensuring that scientific insights and solutions can reach communities everywhere. Center of Excellence & Affiliates
- [What We Do](https://gvn.org/activities/) - What We Do GVN advances pandemic preparedness by accelerating scientific discovery, training the next generation of virologists, and delivering actionable global health solutions. Our work spans cutting-edge research, intensive education and mentorship programs, real-time virology briefings, and international collaborations that inform diagnostics, therapies, and outbreak response. Education & Training Research Global Health Strategies & Solutions
- [About](https://gvn.org/about/) - About The GVN is an international coalition of 90+ Centers of Excellence and Affiliates across 40+ countries, working to strengthen global pandemic preparedness for current and future viral threats. Through world-class research, education, and coordinated global health strategies, GVN provides the expertise needed to detect, understand, and combat viral diseases worldwide. Mission Leadership Team GVN
- [GVN Robert C. Gallo Award](https://gvn.org/members/robert-c-gallo-award/) - Who We Are > Robert C. Gallo Award The GVN Robert C. Gallo Award for Scientific Excellence and Leadership The GVN Robert C. Gallo Award for Scientific Excellence and Leadership awardees are nominated by their peers in recognition of their publication of important scientific information in the areas of virology of interest to the GVN,
- [Contact](https://gvn.org/about/contact/) - GVN International Headquarters is located at the USF Research Park GVN International Headquarters
- [Careers](https://gvn.org/careers/) - WELCOME TO THE Careers Current Careers We currently do not have any open positions. Please check back for future opportunities.
- [Thank You (International Science Innovation Week 2026)](https://gvn.org/thank-you-international-science-innovation-week-2026/) - WELCOME TO THE Thank You Thank you for registering for the International Science Innovation Week 2026! Your selection has been recorded, and we are looking forward to your participation. We will reach out to you if any items in your registration need clarification. What's next? Leading up to the event, we will send you updates
- [GVN Corporate and Institutional Partners](https://gvn.org/members/corporate-and-institutional-partners/) - WELCOME TO THE Corporate Partners The business and institutional communities are integral partners in strengthening global preparedness against viral threats. Outbreaks such as SARS-CoV-2 / COVID-19 know no boundaries, spreading rapidly across countries and disrupting societies, economies, and workforces. Multinational corporations, businesses, and institutions with global reach are vital partners in advancing solutions to current
- [Institutional Partners](https://gvn.org/institutional-partners/) - WELCOME TO THE Institutional Partners GVN is a member of: Abbott Pandemic Defense Coalition (APDC) Global Outbreak Alert and Response Network (GOARN) International Pathogen Surveillance Network (IPSN) Preventing ZOonotic Disease Emergence (PREZODE) UN Global Wastewater Initiative (GWWI) Institutional Partners: Coalition for Epidemic Preparedness Innovations (CEPI) European Research Infrastructure on Highly Pathogenic Agents (ERINHA) International Readiness
- [Impact](https://gvn.org/impact/) - WELCOME TO THE Impact Coming Soon
- [SARS-CoV-2/COVID-19](https://gvn.org/sars-cov-2-covid-19/) - WELCOME TO THE SARS-CoV-2/COVID19 Long COVID Responding to Long COVID Responsibly. 2022 GVN Science of Long COVID Conference GVN Convenes First-of-its-kind Conference to Evaluate the Public Health Magnitude of Long Covid Could Viral Persistence Explain Long Covid? Long COVID Action Committee COVID-19 and Innate Immunity Case Study [pdf-embedder url="https://gvn.org/wp-content/uploads/2025/02/COVID-and-Innate-Immunity-Advocacy-Case-Study-1.pdf" title="COVID and Innate Immunity Advocacy Case
- [CHIKUNGUNYA TASK FORCE](https://gvn.org/chikungunya-task-force/) - ABOUT THE CHIKUNGUNYA TASK FORCE ABOUT THE TASK FORCE The GVN Chikungunya Task Force is a group of leading scientists from around the world committed to finding solutions to the growing problem of Chikungunya virus. TASK FORCE MEMBERSWHAT IS CHIKUNGUNYA? Chikungunya is a mosquito-borne viral disease that causes its victims to suffer fever and severe, debilitating and
- [Singapore](https://gvn.org/gvn-centers-of-excellence/asia-australia/singapore/) - WELCOME TO Singapore Center of Excellence Singapore Director, Professor Linfa Wang, PhD, Duke-NUS Medical School The GVN Singapore Center of Excellence is led by Duke-NUS and is a composite of university, city, and country-wide researchers committed to monitoring, containing and treating major infectious diseases. Prof. Linfa Wang, Director of the GVN Singapore Center, continues the
- [Action Committees](https://gvn.org/activities/collaborative-groups/) - What We Do > Action Committees Action Committees Action Committees (formerly Task Forces and Watch Groups) is a key activity of the Global Virus Network. There are two types: Formed in response to a specific virus outbreak, epidemic, or pandemic. Focused on seven highly pathogenic virus categories and emerging pathogens: respiratory, retroviruses, oncogenic, arbovirology, hemorrhagic
- [GVN 2024 Durban Registration](https://gvn.org/gvn-2024-durban-registration/) - GVN Annual Scientific Meeting in Durban, South Africa Cohost: The Centre for the AIDS Programme of Research in South Africa (CAPRISA) Meeting Dates: September 16-18, 2024 Hotel and Venue: Coastlands Umhlanga Hotel and Convention Centre Cost: Depends on registration, see below. Note: registration costs increase after July 31.
- [2025 GVN Regional Meeting: Caribbean and Latin America &  Arbovirus Research and Education Symposium The University of the West Indies, Mona Campus, Kingston, Jamaica](https://gvn.org/2025-gvn-regional-meeting-caribbean-and-latin-america-arbovirus-research-and-education-symposium-the-university-of-the-west-indies-mona-campus-kingston-jamaica/) - 2025 GVN Regional Meeting: Caribbean and Latin America & Arbovirus Research and Education Symposium The University of the West Indies, Mona Campus, Kingston, Jamaica May 1- 2, 2025 (CME Available) In Partnership With SUNY-UWI Global Infectious Diseases (GID) Research Training Program Global Virus Network Name(Required) First Last Email(Required) Phone (include country code)Address(Required) Street Address Address
- [Advocacy](https://gvn.org/programs/advocacy/) - WELCOME TO THE Accomplishments GVN works to raise awareness and mobilize resources on critical needs in medical virology. GVN works with governments, multilateral institutions, private-sector groups, and non-profit organizations to increase funding for medical virology worldwide, and call attention to critical research and training needs related to pandemic preparedness. SARS-CoV-2/COVID19 H5N1 HTLV MPOX EBOLA ZIKA
- [GVN WEBINARS](https://gvn.org/gvn-webinars/) - WELCOME TO THE GVN WEBINARS GVN Forefront of Virology Webinar featuring Dr. Christine Stabell BennWELCOME TO Beyond Prevention: Exploring the Broad Impact of Vaccines and Global Health Collaboration. Dr. Christine Stabell Benn, MD, PhD, DMSc, MAE, is a Professor of Global Health at the University of Southern Denmark and...Read moreby vgn1No CommentsGVN Forefront of Virology
- [Alpha (B.1.1.7)](https://gvn.org/alpha-b-1-1-7/) - Tracking of Variants - GISAID Map Background The variant known as Alpha or B.1.1.7 or 20O/501Y.v1 was first detected in the UK This variant emerged with an unusual large number of mutations. The spread of this variant greatly affected a surge of COVID-19 cases in UK since November, 2021. The variant comprises roughly 95% of
- [Fellowships and Grants](https://gvn.org/activities/nurture/nourish/) - What We Do > Training and Education > Fellowships and Grants Fellowships and Grants Through fellowships and grants, the Global Virus Network identifies and supports promising researchers, engaging them with top virology experts and cutting-edge research initiatives. In addition to the postdoctoral GVN Postdoctoral Fellowship Training Program (GPFTP) offered through the GVN Drs. Yang Liu
- [Measles](https://gvn.org/measles/) - WELCOME TO THE Measles Measles is popping up in the US. Here's how to avoid one of the world's most contagious viruses A Statement from the Global Virus Network (GVN) on the Rise of Measles Cases in the U.S. and Global Implications Health officials closely monitoring several measles cases across the country, including one case
- [Polio](https://gvn.org/polio-virus/) - WELCOME TO THE POLIO GVN Signs Scientific Declaration on Polio Eradication
- [Zika](https://gvn.org/zika/) - WELCOME TO THE ZIKA GVN organizes Zika Patient Serum Bank to Improve Diagnostic Tests
- [Ebola](https://gvn.org/ebola/) - WELCOME TO THE EBOLA Ebola Virus Q&A GVN Center Directors turn competitors into collaborators GVN supports F1000Research's Ebola Collection initiative that enables all Ebola-related knowledge to be made available
- [MPOX](https://gvn.org/mpox/) - WELCOME TO THE MPOX
- [HTLV](https://gvn.org/htlv/) - WELCOME TO THE HTLV HTLV CASE STUDY [pdf-embedder url="https://gvn.org/wp-content/uploads/2025/02/GVN-HTLV-Case-Study-1.pdf" title="GVN HTLV Case Study 1"] Global Virus Network Issues Open Letter to WHO On Potent Human Carcinogen - HTLV-1 GVN calls for better screening for Human T-Cell Leukemia Viruses in transplant organs
- [H5N1](https://gvn.org/h5n1/) - WELCOME TO THE H5N1 H5N1: How worried should we be? GVN Experts Convene to Discuss H5N1 Flu - 3rd ad hoc panel GVN Experts Convene to Discuss H5N1 Flu - 2nd ad hoc panel Global Virus Network Experts Convene to Discuss H5N1 Flu Battling Pandemic Viruses Like Avian Influenza
- [Administrative Manager](https://gvn.org/about/team/administrative-manager/) - WELCOME TO THE Now Hiring: POSITION SPECIFICATION Position: Administrative Manager Company: Global Virus Network (GVN) Location: Tampa, Florida & Hybrid Reporting Relationship: Senior Vice President Website: https://www.gvn.org/ POSITION SUMMARY GVN is seeking an experienced Administrative Manager to oversee and streamline daily administrative operations. This role will coordinate with internal and external stakeholders, including human resources, finance,
- [Scientific Project Manager](https://gvn.org/about/team/scientific-project-manager/) - WELCOME TO THE Now Hiring: POSITION SPECIFICATION Position: Scientific Project Manager Company: Global Virus Network (GVN) Location: Tampa, Florida & Hybrid Reporting Relationship: Program Director Website: https://www.gvn.org/ POSITION SUMMARY GVN is seeking a highly organized and detail-oriented Scientific Project Manager to oversee and coordinate key scientific and research initiatives, ensuring the successful execution of projects that
- [End Of Year Brief 2024](https://gvn.org/end-of-year-brief-2024/) - END OF YEAR BRIEF 2024
- [A Holiday message from GVN's President Dr. Sten Vermund"](https://gvn.org/a-holiday-message-from-gvns-president-dr-sten-vermund/) - A Holiday Message from GVN's President Dr. Sten Vermund Dear GVN Friends and Colleagues, On behalf of all of us at the GVN international headquarters, I wish you a joyful and peaceful holiday season. Here are a few of the year's highlights. This past year marked a new era in GVN's growth as we moved
- [Newsletter](https://gvn.org/newsletter-2/) - WELCOME TO THE Newsletters Monthly Newsletters November 2024
- [Get Involved](https://gvn.org/join/) - Get Involved Types of Memberships Thank you for your interest in joining the Global Virus Network. There are several membership options, whether as an academic virologist, corporate partner, other partner institution, as well as opportunities for individual and student members. Please review the types of memberships below and be in touch if you would like
- [Thank You for Completing this Post-Conference Evaluation](https://gvn.org/thank-you-for-completing-this-post-conference-evaluation/) - WELCOME TO THE Thank You Thank you for completing this post-conference evaluation. We appreciate your time and support with our evaluation and will use the information to make meaningful improvements. For any questions about the just concluded evaluation, please contact avitauk@gvn.org
- [Thank You For Registering](https://gvn.org/thank-you-for-registering/) - WELCOME TO THE Thank You For Registering Thank you for registering. If any of the items in your registration require follow-up communication, please be on the lookout for an email from gvn.org.
- [8th Annual Short Course](https://gvn.org/8th-annual-short-course/) - solving viral challenges facing humanity
- [Footer](https://gvn.org/footer/) - CONTACT US Copyright © 2024 · GVN · All Rights Reserved Site originally developed by Absolute Marketing Solutions
- [Header](https://gvn.org/header/)
- [GVN: Forefront of Virology COVID-19 Webinar Featuring Dr. Emma Thomson](https://gvn.org/gvn-forefront-of-virology-covid-19-webinar-featuring-dr-emma-thomson-2/) - WELCOME TO DR. EMMA THOMSON – APRIL 7, 2022 – “CHARACTERISING THE OMICRON VARIANT OF SARS-COV-2” Dr. Emma Thomson Professor of Clinical Infectious Diseases MRC-University of Glasgow Centre for Virus Research London School of Hygiene and Tropical Medicine GVN Member Bio sketch Emma Thomson is clinical professor of infectious diseases at the MRC-University of Virus
- [ONLINE COURSE ON MICROBIOMES AND THEIR IMPACT ON VIRAL INFECTIONS](https://gvn.org/online-course-on-microbiomes-and-their-impact-on-viral-infections/) - Online Training Microbiomes and Their Impact on Viral Infections The study of the microbiome is one of the most promising scientific and medical revolutions in recent times. It is now clear that changes in the microbiome composition (referred to as dysbiosis) are major drivers to several human diseases and public health threats. In particular, there
- [GVN: Forefront of Virology Webinar Featuring Dr. Hideki Hasegawa](https://gvn.org/gvn-webinar-hasegawa-2023/) - WELCOME TO Dr. Hideki Hasegawa - July 28, 2023 - "Development of mucosal vaccine, impact of s-IgA on acute respiratory infections." Hideki Hasegawa, MD, PhD Director, WHO Collaborating Centre for Reference and Research on Influenza Director, Research Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, Japan Director, GVN Center of Excellence
- [GVN Center and Member Spotlight - Paul Young](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-paul-young/) - Members > Spotlights > Paul Young GVN Center and Member Spotlight Paul Young Head of School School of Chemistry and Molecular Biosciences Affiliated Professor, Institute for Molecular Bioscience University of Queensland (UQ) What are the major problems that we are facing to curb the current pandemic situation? There are a number of problems facing
- [GVN Center and Member Spotlight - Linfa Wang](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-linfa-wang/) - Members > Spotlights > Linfa Wang GVN Center and Member Spotlight Linfa Wang Professor Director of the Program in Emerging Infectious Diseases Duke-NUS Medical School, Singapore Comparing with other countries, Singapore has a relatively low infection rate of COVID-19. What can Singapore teach the U.S. and the rest of the world about responding to COVID-19?
- [GVN Center and Member Spotlight - David Topham](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-david-topham/) - Members > Spotlights > David Topham GVN Center and Member Spotlight David Topham Department of Microbiology and Immunology University of Rochester Medical Center, URMC Rochester, USA What are you and your institution currently working on regarding COVID-19? The Topham Lab launched a coronavirus research study to understand how the immune system responds to acute COVID-19 infection,
- [GVN Center and Member Spotlight - Rohit Talwani](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-rohit-talwani/) - Members > Spotlights > Rohit Talwani GVN Center and Member Spotlight Rohit Talwani Associate Professor of Medicine, Institute of Human Virology at the University of Maryland School of Medicine, GVN Center of Excellence Chief, Section of Infectious Diseases, VA Maryland Healthcare System Service Chief for General Infectious Diseases Consult Team at UMMC, USA What are
- [GVN Center and Member Spotlight - Robert Silverman](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-robert-silverman/) - Members > Spotlights > Robert Silverman GVN Center and Member Spotlight Robert Silverman Center for Innate Immunity Research (CIIR) at Lerner Research Institute at Cleveland Clinic, Ohio, USA What are you and your institution currently working on regarding COVID-19? Cleveland Clinic made a rapid pivot in response to the COVID-19 pandemic with its multidisciplinary team
- [GVN Center and Member Spotlight - Zhengli Shi](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-zhengli-shi/) - Members > Spotlights > Zhengli Shi GVN Center and Member Spotlight Zhengli Shi Director, Center for Emerging Infectious Diseases of the Wuhan Institute of Virology, China Director, GVN Center of Excellence What are you and your institution currently working on regarding COVID-19? Our institute has non-primate and mouse models for testing antiviral drugs or monoclonal
- [GVN Center and Member Spotlight - Raymond Schinazi](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-raymond-schinazi/) - Members > Spotlights > Raymond Schinazi GVN Center and Member Spotlight Dr. Raymond Schinazi Frances Winship Walters Professor of Pediatrics Director of the Laboratory of Biochemical Pharmacology Co-Director of the HIV Cure Scientific Working Group within the NIH-sponsored Emory University Center for AIDS Research (CFAR) in Atlanta, Georgia, USA What are you and your institution
- [GVN Center and Member Spotlight - Richard Scheuermann](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-richard-scheuermann/) - Members > Spotlights > Richard Scheuermann GVN Center and Member Spotlight Richard Scheuermann Director, La Jolla Campus Craig Venter Institute What are you and your institution currently working on regarding SARS-CoV-2? Dr. Scheuermann is leading a team of investigators at JCVI in response to the COVID-19 outbreak. Through his NIH-sponsored Bioinformatics Resource Center project,
- [GVN Center and Member Spotlight - Mohammad Sajadi](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-mohammad-sajadi/) - Members > Spotlights > Mohammad Sajadi GVN Center and Member Spotlight Mohammad Sajadi Associate Professor of Medicine, Division of Clinical Care and Research, Institute of Human Virology, University of Maryland, School of Medicine, USA What are you and your institution currently working on regarding COVID-19? Early in the in pandemic, our lab developed the tools
- [GVN Center and Member Spotlight - Carlos del Rio](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-carlos-del-rio/) - Members > Spotlights > Carlos del Rio GVN Center and Member Spotlight Carlos del Rio Emory University School of Medicine, Professor of Global Health and Epidemiology Rollins School of Public Health of Emory University, USA What are you and your institution currently working on regarding COVID-19? At Emory we have been very active in COVID-19
- [GVN Center and Member Spotlight - Osbourne Quaye](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-osbourne-quaye/) - Members > Spotlights > Osbourne Quaye GVN Center and Member Spotlight Dr. Osbourne Quaye Head of the Virology Laboratory and Lead of Monitoring and Evaluation West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana Associate Professor and Head of Department Department of Biochemistry, Cell and Molecular Biology, University of Ghana What
- [GVN Center and Member Spotlight - Damian Purcell](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-damian-purcell/) - Members > Spotlights > Damian Purcell GVN Center and Member Spotlight Damian Purcell Head of the Molecular Virology Laboratory in the Department of Microbiology and Immunology, University of Melbourne The Doherty Institute for Infection and Immunity, Australia What are you and your institution currently working on regarding COVID-19? Over the past two winter months, Melbourne
- [GVN Center and Member Spotlight - David Ostrov](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-david-ostrov/) - Members > Spotlights > David Ostrov GVN Center and Member Spotlight Dr. David Ostrov Associate Professor University of Florida, Department of Pathology, Immunology and Laboratory Medicine University of Florida College of Medicine Florida, United States What are you and your institution currently working on regarding COVID-19? We are studying genetic risk factors for SARS-CoV-2 infection,
- [GVN Center and Member Spotlight - Ab Osterhaus](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-ab-osterhaus/) - Members > Spotlights > Ab Osterhaus GVN Center and Member Spotlight Ab Osterhaus Scientific Director The Research Center for Emerging Infections and Zoonoses (RIZ) University of Veterinary Medicine in Hanover What are the major problems that we are facing to curb the current pandemic situation? Mitigation and suppression of the virus spreading Testing strategy coupled
- [GVN Center and Member Spotlight - Mihai Netea](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-mihai-netea/) - Members > Spotlights > Mihai Netea GVN Center and Member Spotlight Mihai Netea Head, Division of Experimental Medicine, Department of Internal Medicine at the Radboud University Medical Center. Director, GVN Center of Excellence What are you and your institution currently working on regarding COVID-19? At the Radboud University Medical Center, Nijmegen, the Netherlands, several important
- [GVN Center and Member Spotlight - Gene Morse](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-gene-morse/) - Members > Spotlights > Gene Morse GVN Center and Member Spotlight Gene Morse Professor University at Buffalo HIV and HCV Clinical Pharmacology Laboratory Center for Integrated Global Biomedical Sciences University at Buffalo, State University of New York What are you and your institution currently working on regarding COVID-19? (One paragraph) The GVN Center in Buffalo
- [GVN Center and Member Spotlight - Natàlia Majó](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-natalia-majo/) - Members > Spotlights > Natàlia Majó GVN Center and Member Spotlight Dr. Natàlia Majó Director Research Center on Animal Health (Centre de Recerca enSanitat Animal-CReSA) Institute of Agrifood Research and Technology (Institut de Recerca i Tecnologia Agrolimentaria (IRTA) Barcelona, Spain What are you and your institution currently working on regarding COVID-19? IRTA-CReSA is currently involved
- [GVN Center and Member Spotlight - Sharon Lewin](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-sharon-lewin/) - Members > Spotlights > Sharon Lewin GVN Center and Member Spotlight Sharon Lewin Director The Peter Doherty Institute for Infection and Immunity Melbourne, Australia What do you see as the more promising, efficacious or affordable treatment/therapy for SARS-CoV-2? I am not too optimistic about any of the antivirals currently being evaluated for COVID19. If
- [GVN Center and Member Spotlight - Florian Krammer](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-florian-krammer/) - Members > Spotlights > Florian Krammer GVN Center and Member Spotlight Florian Krammer Mount Sinai Professor in Vaccinology Department of Microbiology at the Icahn School of Medicine at Mount Sinai, New York What are you and your institution currently working on regarding SARS-CoV-2? Mount Sinai has spearheaded serological testing which was used to screen
- [GVN Center and Member Spotlight - Marion Koopmans](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-marion-koopmans/) - Members > Spotlights > Marion Koopmans GVN Center and Member Spotlight Marion Koopmans Head of Erasmus University Medical Center Rotterdam Department of Viroscience, Rotterdam, Netherlands What efforts are you making on COVID-19 serology, and how would you assess the progress of current testing? Serological assays are important as an adjunct to diagnosis of COVID-19, to
- [GVN Center and Member Spotlight - Alexander Khromykh](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-alexander-khromykh/) - Members > Spotlights > Alexander Khromykh GVN Center and Member Spotlight Dr. Alexander Khromykh Associate Professor, Deputy Director (Virology), Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences University of Queensland Brisbane, QLD, Australia What are you and your institution currently working on regarding COVID-19? The Australian Infectious Disease Research Centre
- [GVN Center and Member Spotlight - Pontiano Kaleebu](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-pontiano-kaleebu/) - Members > Spotlights > Pontiano Kaleebu GVN Center and Member Spotlight Pontiano Kaleebu Director of the Uganda Virus Research Institute (UVRI) and Director of MRC/UVRI and LSHTM Uganda Research Unit What are you and your institution currently working on regarding COVID-19? Our institute has been the major diagnostic center for the country. UVRI was
- [GVN Center and Member Spotlight - Donald Ingber](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-donald-ingber/) - Members > Spotlights > Donald Ingber GVN Center and Member Spotlight Dr. Donald Ingber Founding Director, Wyss Institute at Harvard University Professor, Harvard Medical School & Boston Children's Hospital Professor at the Harvard John A. Paulson School of Engineering and Applied Sciences What are you and your institution currently working on regarding COVID-19? The Wyss
- [GVN Center and Member Spotlight - Elodie Ghedin](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-elodie-ghedin/) - Members > Spotlights > Elodie Ghedin GVN Center and Member Spotlight Elodie Ghedin, PhD Chief, Systems Genomics Section, Laboratory of Parasitic Diseases National Institute of Allergy and Infectious Diseases, National Institutes of Health USA What are you and your institution currently working on regarding COVID-19? The NIAID has many projects and programs currently focused on
- [GVN Center and Member Spotlight - Adolfo García-Sastre](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-adolfo-garcia-sastre/) - Members > Spotlights > Adolfo García-Sastre GVN Center and Member Spotlight Adolfo García-Sastre Professor, Department of Microbiology Director of the Global Health and Emerging Pathogens Institute Icahn School of Medicine at Mount Sinai in New York, USA What are you and your institution currently working on regarding COVID-19? My lab, together with the Palese and Krammer
- [GVN Center and Member Spotlight - Matthew Frieman](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-matthew-frieman/) - Members > Spotlights > Matthew Frieman GVN Center and Member Spotlight Matthew Frieman Associate Professor, The Department of Microbiology and Immunology; Associate Member of The Center for Vaccine Development and Global Health University of Maryland School of Medicine, USA What are you and your institution currently working on regarding SARS-CoV-2? (One paragraph) My lab
- [GVN Center and Member Spotlight - Peter Doherty](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-peter-doherty/) - Members > Spotlights > Peter Doherty GVN Center and Member Spotlight Nobel Laureate Dr. Peter Doherty The Doherty Institute for Infection and Immunity Member researcher, GVN Center of Excellence Melbourne, Australia What are you and your institution currently working on regarding COVID-19? The PDI combines the University of Melbourne Department of Microbiology and Immunology
- [GVN Center and Member Spotlight - Roman Chicz](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-roman-chicz/) - Members > Spotlights > Roman Chicz GVN Center and Member Spotlight Roman Chicz Global Project Head Recombinant COVID Vaccine Project Sanofi What are you and your company currently working on regarding COVID-19? Sanofi is putting world-leading scientific expertise to the development of 2 vaccine candidates against COVID-19. The first is an adjuvant recombinant protein vaccine
- [GVN Center and Member Spotlight - Mike Catton](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-mike-catton/) - Members > Spotlights > Mike Catton GVN Center and Member Spotlight Mike Catton Director of the Victorian Infectious Diseases Reference Laboratory The Doherty Institute for Infection and Immunity, Australia What are you and your institution currently working on regarding COVID-19? Our group is currently completing a project to develop and validate saliva-sample based surveillance using
- [GVN Center and Member Spotlight - Arnaldo Caruso](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-arnaldo-caruso/) - Members > Spotlights > Arnaldo Caruso GVN Center and Member Spotlight Arnaldo Caruso Full Professor of Microbiology and Clinical Microbiology at the University of Brescia Medical School (Italy) Head of the Department of Diagnostic Laboratories at the "Spedali Civili" of Brescia (Italy) President of the Italian Society for Virology (SIV-ISV) Director of the Laboratory of
- [GVN Center and Member Spotlight - Christine Carrington](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-christine-carrington/) - Members > Spotlights > Christine Carrington GVN Center and Member Spotlight Christine Carrington Professor, Molecular Genetics and Virology The University of the West Indies St. Augustine Campus, Trinidad and Tobago Director, GVN Center of Excellence What are you and your laboratory currently working on regarding COVID-19? Since the start of the COVID-19 epidemic, members of
- [GVN Center and Member Spotlight - Christine Benn](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-christine-benn/) - Members > Spotlights > Christine Benn GVN Center and Member Spotlight Christine Benn Professor University of Southern Denmark Studiestræde 6, 1455 Copenhagen, Denmark What are you and your institution currently working on regarding COVID-19? We are testing large-scale randomized clinical trials in Denmark, Guinea-Bissau, Mozambique and Cape Verde to determine whether BCG vaccine and
- [GVN Center and Member Spotlight - Akhil Banerjea](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-akhil-banerjea/) - Members > Spotlights > Akhil Banerjea GVN Center and Member Spotlight Akhil Banerjea Emeritus Scientist Institute of Advanced Virology, GVN Affiliate Trivandrum, Kerala, India What are you and your institution currently working on regarding COVID-19 I am the Director at Institute of Advanced Virology, Trivandrum, Kerala, India. This institute focuses on studying viruses causing infectious
- [GVN Center and Member Spotlights](https://gvn.org/members/spotlights/) - Who We Are > Spotlights GVN Center and Member Spotlights GVN Center and Member Spotlights is a series featuring expert virologists from GVN Centers of Excellence and their work on emerging infectious diseases. Each article consists of a selected GVN member's professional summary, research questions highlighting their contributions, and an organizational overview. Janko Nikolich Janko
- [GVN Center and Member Spotlight - Adeola Fowotade](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-adeola-fowotade/) - Members > Spotlights > Adeola Fowotade WELCOME TO THE GVN SPOTLIGHT ON: DR. ADEOLA FOWOTADE - FEBRUARY 17, 2022 Dr. Adeola Fowotade Senior Lecturer/Consultant Virologist Coordinator, Biorepository Clinical Virology Laboratory College of Medicine, University of Ibadan, Nigeria What are you and your institution currently working on regarding COVID-19? In response to the urgent need for
- [GVN Center and Member Spotlight - Anthony Amoroso](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-anthony-amoroso/) - Members > Spotlights > Anthony Amoroso GVN Center and Member Spotlight Anthony Amoroso, MD Associate Director, Division of Clinical Care & Research Associate Chief, Division of Infectious Diseases, Department of Medicine Institute of Human Virology at the University of Maryland School of Medicine Baltimore, USA What are you and your institution currently working on regarding
- [GVN Center and Member Spotlight - Tonya Colpitts](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-tonya-colpitts/) - Members > Spotlights > Tonya Colpitts WELCOME TO THE GVN SPOTLIGHT ON: DR. TONYA COLPITTS - DECEMBER 7, 2022 Tonya Colpitts, PhD Director, Virology Infectious Disease Research, Moderna Faculty, National Emerging Infectious Diseases Laboratories (NEIDL), Boston University Professional Summary Dr. Colpitts is a molecular virologist currently focused on prophylactic and therapeutic infectious disease research &
- [GVN Center and Member Spotlight - Syed Sattar](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-syed-sattar/) - Members > Spotlights > Syed Sattar WELCOME TO THE GVN SPOTLIGHT ON: DR. SYED SATTAR - DECEMBER 2, 2022 Syed Sattar, PhD Faculty of Medicine: Department of Biochemistry, Microbiology and Immunology (BMI) University of Ottawa, Ottawa, Canada Professor Emeritus of Microbiology, Co-Founder and CSO CREM Co Vice-Chair, GVN's Task Force on Public Health and Hygiene
- [GVN Center and Member Spotlight - Piya Paul Mudgal](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-piya-paul-mudgal/) - Members > Spotlights > Piya Paul Mudgal WELCOME TO THE GVN SPOTLIGHT ON: DR. PIYA PAUL MUDGAL - APRIL 21, 2022 Dr. Piya Paul Mudgal Associate Professor, Manipal Institute of Virology Manipal Academy of Higher Education Karnataka, India Professional Summary Dr. Piya Paul Mudgal is an Associate Professor in the Manipal Institute of Virology
- [GVN Center and Member Spotlight - Rubaiyea Farrukee](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-rubaiyea-farrukee/) - Members > Spotlights > Rubaiyea Farrukee WELCOME TO THE GVN SPOTLIGHT ON: DR. RUBAIYEA FARRUKEE - March 31, 2022 Dr. Rubaiyea Farrukee Research Officer, Department of Microbiology and Immunology University of Melbourne, Doherty Institute Are you currently pursuing COVID-19 related research? My research area is focused on innate immune responses to viral infections. I am
- [GVN Center and Member Spotlight - Birendra Gupta](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-birendra-gupta/) - Members > Spotlights > Birendra Gupta WELCOME TO THE GVN SPOTLIGHT ON: DR. BIRENDRA GUPTA - March 28, 2022 Dr. Birendra Gupta Research Scientist Tribhuvan University, Nepal How did you learn and become interested in the GVN? I have always had an inclination towards virology, and have been participating actively in most of the relevant symposiums,
- [GVN Center and Member Spotlight - William M. de Souza](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-william-m-de-souza/) - Members > Spotlights > William M. de Souza WELCOME TO THE GVN SPOTLIGHT ON: DR. WILLIAM M. DE SOUZA - March 24, 2022 Dr. William M. de Souza University Texas Medical Branch-UTMB, Galveston National Laboratory Microbiology and Immunology How did you learn and what do you hope to gain from GVN and Fellowship Program? I learned
- [GVN Center and Member Spotlight - Pardis Sabeti](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-pardis-sabeti/) - Members > Spotlights > Pardis Sabeti GVN Center and Member Spotlight Dr. Pardis Sabeti, MD, DPhil Professor, Harvard University School of Public Health Institute Member, Broad Institute of Harvard and MIT Investigator, Howard Hughes Medical Institute What are you and your institution currently working on regarding COVID-19? As soon as the SARS-CoV-2 genomes were
- [GVN Center and Member Spotlight - Kizzmekia Corbett](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-kizzmekia-corbett/) - Members > Spotlights > Kizzmekia Corbet WELCOME TO THE GVN SPOTLIGHT ON: DR. KIZZMEKIA CORBET - FEBRUARY 4, 2022 Dr. Kizzmekia Corbett Assistant Professor of Immunology and Infectious Diseases Harvard T.H. Chan School of Public Health Immunology and Infectious Diseases Dr. Corbett's research work on the mRNA 1273 vaccine Dr. Corbett's research on coronaviruses was
- [GVN Center and Member Spotlight - Jana Broadhurst](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-jana-broadhurst/) - Members > Spotlights > Jana Broadhurst WELCOME TO THE GVN SPOTLIGHT ON: DR. JANA BROADHURST - JANUARY 20, 2022 Dr. Jana Broadhurst University of Nebraska Medical Center Assistant Professor, Department of Pathology and Microbiology Director, Nebraska Biocontainment Unit Clinical Laboratory Director, Emerging Pathogens Laboratory Professional summary I am an Assistant Professor of Pathology and Microbiology
- [GVN Center and Member Spotlight - A.J. te Velthuis](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-a-j-te-velthuis/) - Members > Spotlights > A.J. te Velthuis WELCOME TO THE GVN SPOTLIGHT ON: DR. A.J. TE VELTHUIS - APRIL 14, 2022 Dr. A.J. te Velthuis Assistant Professor of Molecular Biology Princeton, Department of Molecular Biology Professional Summary Dr te Velthuis uses virology, molecular biology, structural biology, and single-molecule techniques to study the replication and
- [GVN Center and Member Spotlight - David Markovitz](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-david-markovitz/) - Members > Spotlights > David Markovitz WELCOME TO THE GVN SPOTLIGHT ON: DR. DAVID MARKOVITZ - JANUARY 4, 2023 Dr. David Markovitz University of Michigan - Division of Infectious Diseases Professional Summary David Markovitz is a Professor of Internal Medicine in the Division of Infectious Diseases who also has appointments in the programs in
- [GVN Center and Member Spotlight - Janko Nikolich](https://gvn.org/members/spotlights/gvn-center-and-member-spotlight-janko-nikolich/) - Members > Spotlights > Janko Nikolich WELCOME TO THE GVN SPOTLIGHT ON: DR. JANKO NIKOLICH - MARCH 21, 2023 Dr. Janko Nikolich University of Arizona - Aegis Consortium Health Science Innovation Building Tucson, Arizona Professional Summary Dr. Janko Nikolich is an internationally recognized leader in immunology and gerontology. He received his M.D., MSc and Ph.D.
- [Who We Are](https://gvn.org/members/) - WELCOME TO Members Members of the Global Virus Network are Academic Centers of Excellence, Academic Affiliates, Academic Regional Headquarters, Corporate Partners, Institutional Partners, and, in exceptional circumstances, Individual members. We work with governments, multilateral institutions, private-sector groups, and non-profit organizations to improve medical virology worldwide, call attention to critical research and training needs, and provide
- [GVN Regional Headquarters](https://gvn.org/gvn-regional-headquarters-3/) - WELCOME TO GVN REGIONAL HEADQUARTERS GVN REGIONAL HEADQUARTERS OVERVIEW The overall mission of a GVN Regional Headquarters office is to collaborate with the GVN global headquarters located in Baltimore, Maryland, USA. A GVN Regional HQ provides organizational support and leadership to strengthen basic and translational research in virology, as well as preparedness and response to
- [Partners](https://gvn.org/about-2/partners/) - WELCOME TO PARTNERS The Global Health Security Agenda (GHSA) was launched in February 2014 and is a growing partnership of over 50 nations, international organizations, and non-governmental stakeholders to help build countries’ capacity to help create a world safe and secure from infectious disease threats and elevate global health security as a national and global
- [GVN Members](https://gvn.org/gvn-member/) - WELCOME TO Members GVN REGIONAL HEADQUARTERS OVERVIEW The overall mission of a GVN Regional Headquarters office is to collaborate with the GVN global headquarters located in Baltimore, Maryland, USA. A GVN Regional HQ provides organizational support and leadership to strengthen basic and translational research in virology, as well as preparedness and response to viral pandemic
- [THE GVN – ABBOTT PANDEMIC DEFENSE POSTDOCTORAL FELLOWSHIP PROGRAM](https://gvn.org/programs/gvn-abbott-pandemic-defense-postdoctoral-fellowship-program/) - THE GVN ABBOTT PANDEMIC DEFENSE POSTDOCTORAL FELLOWSHIP PROGRAM ABOUT THE PROGRAM An important aspect of GVN’s mission includes training future virologists to meet the current, and future, need of highly qualified, well-trained virologists worldwide. Since late 2019, through the GVN Corporate Partnership program, Abbott and GVN have been working collaboratively to mitigate viral threats and subsequently
- [Perspectives and Positions](https://gvn.org/activities/perspectives-and-positions/) - What We Do > Perspectives and Positions Perspectives and Positions The Global Virus Network represents the interests of a worldwide network of virologists seeking to end viral threats through collaborative science. As part of our mission, we publish science-driven information, including perspectives and position statements. Position Statements Improving Ventilation and Filtration for Public Health The
- [Watch Groups](https://gvn.org/watch-groups/) - ABOUT THE GVN WATCH GROUPS Current Updates: The GVN Virus Task Force and Watch groups are one of the key activities of the GVN. We have two currently active VWGs (Emerging Pathogens and Public Health and Hygiene) and four TFGs (COVID/Sars-CoV-2, Long COVID, Dengue, Mpox). We resumed the activities of two more VWGs, on Respiratory
- [Previous Publications](https://gvn.org/previous-publications/) - Previous Publications 2023 July 2023 A common allele of HLA is associated with asymptomatic SARS-CoV-2 infectionNature, July 19, 2023 Picolinic acid is a broad-spectrum inhibitor of enveloped virus entry that restricts SARS-CoV-2 and influenza A virus in vivoCell Reports Medicine, July 17, 2023 Swift and extensive Omicron outbreak in China after sudden exit from
- [Archived News Articles](https://gvn.org/covid-19/archived-news-articles/) - WELCOME TO THE ARCHIVED NEWS Archived News Articles 2023 June 2023 New COVID jabs are coming - who should get them?Nature, June 29, 2023 3 Years Into Long COVID: Where Do We Go From Here?Medscape Infectious Diseases, June 29, 2023 Covid inquiry: 'No plan' could have helped Scotland cope'The Herald, June 28, 2023 Long COVID:
- [Turkey](https://gvn.org/gvn-centers-of-excellence/europe/turkey/) - WELCOME TO Turkey Center of Excellence Turkey For an overview of GVN Centers of Excellence, click here. Turkish Virology Consortium İzmir Tinaztepe University, Galen Research Center, Aydoğdu mahallesi, 1267/1. Sokak, No:4, 35400 Buca/İzmir Center Director: Prof. Mehmet Öztürk Management: Dr Gülhas Solmaz (Email: gulhas.solmaz@tinaztepe.edu.tr) Member Researchers: Prof Hakan Abacıoğlu, Prof Neşe Atabey, Prof Fatma Sırmatel
- [Australia](https://gvn.org/gvn-centers-of-excellence/asia-australia/australia/) - WELCOME TO Australia Center of Excellence Australia For an overview of GVN Centers of Excellence, click here. The Doherty Institute for Infection and Immunity 792 Elizabeth Street Melbourne VIC 3000 Australia Center Director: Professor Sharon Lewin, FRACP, PhD, FAHMS Co-Directors: Leon Caley and Sarah Londrigan Member Researchers (Virology): Aeron Hurt, Amy Chung, Bruce Thorley, Ian
- [GVN DRS. YANG LIU & PAN ZHENG ACADEMY PROGRAM](https://gvn.org/gvn-drs-yang-liu-pan-zheng-academy-program/) - WELCOME TO GVN DRS. YANG LIU & PAN ZHENG ACADEMY PROGRAM There is a shortage of virologists in basic, clinical and translational researches, in particular in low- and middle-income countries. Training and educating the next generation of virologists is a core pillar of the GVN mission. GVN senior virologists are committed to sharing their invaluable
- [GVN Centers of Excellence](https://gvn.org/gvn-centers-of-excellence/) - GVN Centers of Excellence conduct research in medical virology around the world. Our work is dedicated to understanding, preventing, and eradicating viral disease threats to mankind. We also affirm the need for new programs to coordinate, support and promote research that bridges the gap between virus surveillance and public health implementation. Criteria for a GVN
- [Other SARS-CoV-2 Updates - Diagnostics](https://gvn.org/sars-cov-2-response-efforts/other-sars-cov-2-updates-diagnostics/) - SARS-CoV-2 Updates - Diagnostics Other SARS-CoV-2 updates Robert Koch-Institut Centre for International Health Protection (ZIG), Germany, Dr. Heinz Ellerbrok PCR Primer Diagnostics and Probes & Controls Test regions: Nigeria-CDC, Ivory Coast, Democratic Republic of the Congo, Namibia Rwanda and Namibia-Diagnostics Training and receive WHO coordination Further, we support WHO WPRO in Manila and WHO Headquarters
- [Israel](https://gvn.org/gvn-centers-of-excellence/africa/israel/) - WELCOME TO Israel Center of Excellence Israel For an overview of GVN Centers of Excellence, click here. Tel Aviv University Center for Nanoscience and Nanotechnology Cohen Porter United Kingdom Bldg. Rm. 229 Tel Aviv 69978, Israel Center Director: Dr. Jonathan Gershoni Member Researchers: Drs. Eran Bacharach, Marcelo Ehrlich, Irit Gat-Viks, Tal Pupko The Center of Excellence
- [Brasil](https://gvn.org/gvn-centers-of-excellence/north-south-america/brasil/) - WELCOME TO Brasil Center of Excellence Brasil For an overview of GVN Centers of Excellence, click here. Scientific Platform Pasteur-USP Av. Prof. Lucio Martins Rodrigues, 370, Bloco A, 3° e 4° andares - Butantã, São Paulo - Brasil - CEP: 05508-020 The Scientific Platform Pasteur USP The Scientific Platform Pasteur-USP (SPPU) carries out studies focused
- [Zambia](https://gvn.org/gvn-centers-of-excellence/africa/zambiacoe/) - WELCOME TO Zambia Center of Excellence Zambia For an overview of GVN Centers of Excellence, click here. Zambia and the Africa Center of Excellence for Infectious Diseases of Humans and Animals (ACEIDHA) School of Veterinary Medicine University of Zambia P.O. Box 32379 Lusaka, Zambia Center Director: Dr. Bernard Hang'ombe Member Researchers: William Hall, Hiroshi Kida, Yasuhika Suzuki, Hirofumi
- [Thailand](https://gvn.org/gvn-centers-of-excellence/asia-australia/thailand/) - WELCOME TO Thailand Centers of Excellence Thailand For an overview of GVN Centers of Excellence, click here. Mahidol Virus Network Center Director: Professor Prasert Auewarakul BSL-2 Laboratory at Faculty of Medical Technology BSL-3 Laboratory at Faculty of Veterinary Science Faculty of Medicine Siriraj Hospital Founded in 1888, the Faculty of Medicine Siriraj Hospital is the
- [Contact Us](https://gvn.org/contact-us/) - Contact Us Want to get in touch with the GVN? Please fill out this form with your name, email, and message.
- [Donations - Sponsorship](https://gvn.org/sponsorship/) - SPONSORSHIP A copy of Global Virus Network's latest financial reports and state registrations may be obtained by contacting us at 725 West Lombard Street, Baltimore, MD 21021, 410-706-1966. California: The official registration and financial information can be obtained from the Attorney General’s website at: https://oag.ca.gov/charities. Florida: A COPY OF THE OFFICIAL REGISTRATION AND FINANCIAL INFORMATION MAY
- [GVN Welcomes New Zambia Affiliate](https://gvn.org/press-releases-2/virion-newsletter/gvn-welcomes-new-zambia-affiliate/) - GVN Welcomes New Zambia Affiliate In January, the Africa Center of Excellence for Infectious Diseases of Humans and Animals (ACEIDHA) at the University of Zambia (UNZA) in Lusaka, Zambia became the newest GVN Affiliate member. ACEIDHA will partner with two longtime GVN Centers of Excellence, Hokkaido University (HU) in Sapporo, Japan and University College Dublin
- [Deadly, But Largely Unknown: GVN Spurs Efforts to Combat HTLV-1](https://gvn.org/press-releases-2/virion-newsletter/deadly-but-largely-unknown-gvn-spurs-efforts-to-combat-htlv-1/) - Deadly, But Largely Unknown: GVN Spurs Efforts to Combat HTLV-1 Thirty-eight years ago, Dr. Robert Gallo and his colleagues discovered Human T-cell Leukemia Virus 1 (HTLV-1), the first known human retrovirus and the first virus shown to cause cancer. This breakthrough is perhaps best known because it led another momentous discovery, the identification of HIV.
- [GVN Short Courses Train Next Generation of Virus Researchers](https://gvn.org/press-releases-2/virion-newsletter/gvn-short-courses-train-next-generation-of-virus-researchers/) - GVN Short Courses Train Next Generation of Virus Researchers Worldwide, the number of deadly viral threats are on the rise. Yet the number of people entering the field of virology, including basic and medical research, around the world has been declining. “My colleagues and I have noticed a disturbing, declining trend in those entering the
- [GVN Fights Lassa Fever Epidemic in Nigeria](https://gvn.org/press-releases-2/virion-newsletter/gvn-fights-lassa-fever-epidemic-in-nigeria/) - GVN Fights Lassa Fever Epidemic in Nigeria Outbreaks of Lassa fever used to be limited to northern Nigeria. An acute viral haemorrhagic virus transmitted by rodents, Lassa can cause severe damage to the liver, spleen, kidneys and other organs. For the last few years, though, the virus has spread to other parts of the country
- [Virion Newsletter](https://gvn.org/press-releases-2/virion-newsletter/) - Virion Newsletter A Newsletter of the Global Virus Network May 2018 Virion | Printable PDF
- [Donations - Payment](https://gvn.org/payment/) - PAYMENT - SHORT COURSE
- [COVID-19 Vaccine Development & Clinical Trials](https://gvn.org/covid-19/covid-19-vaccine-development-clinical-trials/) - Front-Runner COVID-19 Vaccines mRNA based vaccine by Expressing stabilized spike protein Required 2 doses (3 weeks apart) and freezer storage at –70°C Protective efficacy is 94%. A similar level of vaccine efficacy (94%) was observed for people older than 65. The vaccine remains effective in a mass vaccination campaign in Israel. Vaccination has resulted in
- [test](https://gvn.org/test-2/)
- [SARS-COV-2 TASK FORCE](https://gvn.org/sars-cov-2-task-force/) - ABOUT THE SARS-CoV-2 Task Force With representatives from 32 GVN CoEs in 13 countries, the GVN SARS-CoV-2 Task Force meets virtually bimonthly to monthly to share latest research findings and to discuss diagnostics, serological tests and vaccine development. TASK FORCE MEMBERS View Task Force Members Larry Blatt (GVN, USA) Christian Brechot (GVN, USA) Franco Buonaguro (Instituto Tumori,
- [A GVN Summer Internship Testimonial](https://gvn.org/a-gvn-summer-internship-testimonial/) - A GVN SUMMER INTERNSHIP TESTIMONIAL Sofia Krause, a Senior at Greenwich Academy in Connecticut September 22, 2022 The past 2 months, I had the unique opportunity to serve as a research intern for the Global Virus Network (GVN). Entering this internship, I had many expectations and envisioned many opportunities for learning and developing. My assignments
- [News](https://gvn.org/news/) - WELCOME TO NEWS The Global Virus Network (GVN) was co-founded in 2011 by Robert Gallo, MD of the Institute of Human Virology at the University of Maryland School of Medicine, William Hall, MD, PhD of University College Dublin and the late Reinhard Kurth, MD, PhD, of the Robert Koch Institute. The GVN is an essential
- [Communication](https://gvn.org/communication/) - WELCOME TO THE COMMUNICATION The Global Virus Network (GVN) was co-founded in 2011 by Robert Gallo, MD of the Institute of Human Virology at the University of Maryland School of Medicine, William Hall, MD, PhD of University College Dublin and the late Reinhard Kurth, MD, PhD, of the Robert Koch Institute. The GVN is an
- [Nigeria](https://gvn.org/gvn-centers-of-excellence/africa/nigeria-2/) - WELCOME TO Nigeria Center of Excellence Nigeria For an overview of GVN Centers of Excellence, click here. Institute for Human Virology - Nigeria Pent House, Maina Court Plot 252, Herbert Macaulay Way Central Business District P.O. Box 9396 Garki, Abuja Center Director: Dr. Alash’le Abimiku Co-Director: Dr. Patrick Dakum Member Researchers: Alashle Abimiku, Clement Adebamowo
- [Vaccine Saftey](https://gvn.org/vaccine-saftey/) - COVID-19 Vaccine Safety Risk The health agencies approved COVID-19 vaccines under emergency use authorization by reviewing the data (safety and protective efficacy) from clinical trials. However, we have encountered unexpected adverse events with certain vaccines since the vaccine rollout. The GVN is updating current status of using these vaccines. Oxford-AstraZeneca Expand A rare blood clot
- [Vaccine Development & Clinical Trials](https://gvn.org/vaccine-development-and-clinical-trials/) - Front-Runner COVID-19 Vaccines Pfizer-BioNTech Expand mRNA based vaccine by Expressing stabilized spike protein Required 2 doses (3 weeks apart) and freezer storage at –70°C Protective efficacy is 94%. A similar level of vaccine efficacy (94%) was observed for people older than 65. The vaccine remains effective in a mass vaccination campaign in Israel. Vaccination
- [Vaccine Overview](https://gvn.org/vaccine-overview/) - Vaccine Overview Vaccination can be the most efficient and effective measures in controlling the pandemics and save millions of lives. There are currently more than 60 COVID-19 vaccine candidates in clinical development and over 170 in pre-clinical development. The GVN is providing valuable information and resources for COVID-19 vaccines. Spike Protein of SARS-CoV-2 for Vaccine
- [Variants of Interest](https://gvn.org/variants-of-interest/) - Tracking of Variants - GISAID Map Eta (B.1.525) This variant was first detected in Nigeria and UK in December 2020. It has been seen in other countries, including U.S., Canada, Denmark, Britain, France, Belgium, Spain, Finland, Nigeria, Ghana, Jordan, Australia and Singapore. As of Feb. 17, 46 and 12 cases of the variant had been
- [Omicron (B.1.1.529)](https://gvn.org/omicron-b-1-1-529/) - Tracking of Variants - GISAID Map GVN Perspective: Global Spread of Omicron, New Variant of Concern Background SUBVARIANT BA.1 The first known confirmed B.1.1.529 infection was from a specimen collected on 9 November 2021. This variant has been detected at faster rates than previous surges in infection, suggesting that this variant may have a growth
- [Delta (B.1.617.2)](https://gvn.org/delta-1-617-2/) - Tracking of Variants - GISAID Map Background This variant has been named as the Delta variant by the WHO. The Delta variant was first detected in India in December 2020 and became the most commonly reported variant in the country from mid-April 2021. The variant could be more than twice as transmissible as the original
- [Gamma (P.1)](https://gvn.org/gamma-p-1/) - Tracking of Variants - GISAID Map Background The variant known as Gamma or P.1 was first detected in Brazil It has caused widespread infection in the city of Manaus. As shown with other UK and South African variants, the Brazilian variant has shown to enhanced transmissibility and is spreading globally. Notable mutations: N501Y, K417N, and
- [Beta (B.1.351)](https://gvn.org/beta-b-1-351/) - Tracking of Variants - GISAID Map Background The variant known as Beta, or B.1.351, was first detected in South Africa. This variant emerged with an unusually large number of mutations in South Africa. As the variant spreads faster than other earlier variants of the virus, the variant may be driving the second wave of the
- [HTLV-1 TASK FORCE](https://gvn.org/htlv-1-task-force/) - ABOUT THE HTLV-1 TASK FORCE HTLV WORLD DAY – NOVEMBER 10TH – CLICK HERE TO LEARN MORE ABOUT THE TASK FORCE The Global Virus Network (GVN) formed an international Task Force on Human T-Leukemia Virus (HTLV-1), the world’s first known human retrovirus and the only known leukemia-causing virus. Experts from 11 countries, led by Dr. Robert Gallo, GVN co-founder
- [Test](https://gvn.org/test/)
- [Omicron (B.1.1529)](https://gvn.org/covid-19/omicron-b-1-1529/) - WELCOME TO THE Omicron (B.1.1.529) GVN Perspective: Global Spread of Omicron, New Variant of Concern Tracking of Variants - GISAID MAP Background SUBVARIANT BA.1 The first known confirmed B.1.1.529 infection was from a specimen collected on 9 November 2021. This variant has been detected at faster rates than previous surges in infection, suggesting that this
- [Nigeria](https://gvn.org/gvn-centers-of-excellence/africa/nigeria/) - WELCOME TO Nigeria Center of Excellence Nigeria For an overview of GVN Centers of Excellence, click here. Institute for Human Virology -Nigeria Pent House, Maina Court Plot 252, Herbert Macaulay Way Central Business District P.O. Box 9396 Garki, Abuja The Institute of Human Virology, Nigeria (IHVN) was established in 2004 as an affiliate of the
- [GVN SCIENCE OF LONG COVID CONFERENCE](https://gvn.org/events/science-of-long-covid/) - WELCOME TO THE GVN SCIENCE OF LONG COVID CONFERENCE MEETING OVERVIEW Over the past two years, the GVN SARS-CoV-2 Task Force has played an active role in facilitating GVN scientists sharing cutting-edge research findings and discussing developments in diagnostics, treatment, and vaccines. We firmly believe that science-driven and independent expertise are the driving forces for
- [Search](https://gvn.org/search/) - SEARCH FOR INFORMATION Search
- [Ghana](https://gvn.org/gvn-centers-of-excellence/africa/ghana/) - WELCOME TO Ghana Center of Excellence Ghana For an overview of GVN Centers of Excellence, click here. West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), University of Ghana College of Basic and Applied Sciences Volta Road, University of Ghana P.O. Box LG 54, Legon Accra, Ghana Unit Director: Dr. Gordon Awandare Center Director: Dr. Osbourne Quaye
- [Senegal](https://gvn.org/gvn-centers-of-excellence/africa/senegal/) - WELCOME TO Senegal Center of Excellence Senegal For an overview of GVN Centers of Excellence, click here. Institut de Recherche en Santé, de Surveillance Epidémiologique et de Formation , or IRESSEF Arrondissement 4, Rue 2D1, Pole Urbain de Diamniadio, BP 7325, Dakar 20000, Senegal Center Director: Dr. Souleymane Mboup Member Researchers: Professor Coumbe Toure Kane,
- [South Africa](https://gvn.org/gvn-centers-of-excellence/africa/south-africa/) - WELCOME TO South Africa Center of Excellence South Africa For an overview of GVN Centers of Excellence, click here Centre for the AIDS Programme of Research in South Africa (CAPRISA) 719 Umbilo Rd. Nelson R. Mandela School of Medicine University of KwaZulu-Natal Durban, South Africa Center Director: Dr. Salim Abdool Karim CAPRISA was created in
- [Uganda](https://gvn.org/gvn-centers-of-excellence/africa/ugandacoe/) - WELCOME TO Uganda Center of Excellence Uganda For an overview of GVN Centers of Excellence, click here. Uganda Virus Research Institute Plot No: 51 -59 Nakiwogo Road P.O.Box 49 Entebbe Uganda Center Director: Dr. Pontiano Kaleebu UVRI vision is to become a world-class center of excellence in health research, conducting scientific investigations on viral and
- [India](https://gvn.org/gvn-centers-of-excellence/asia-australia/india/) - WELCOME TO India Center of Excellence India For an overview of GVN Centers of Excellence, click here. Amrita Institute of Medical Sciences and Research Center Ponekkara, Kochi, Kerala 682 041 Center Directors: Dr. Prem Nair and Dr.K.N.Panicker Member Researchers: Drs. Veena Menon, K.P. Gireeshkumar, Rajesh G, Vidya P. Menon and R. Anupama This center mainly runs
- [Japan](https://gvn.org/gvn-centers-of-excellence/asia-australia/japan/) - WELCOME TO Japan Center of Excellence Japan For an overview of GVN Centers of Excellence, click here. National Institute of Infectious Diseases, Tokyo Toyama 1-23-1, Shinjuku Tokyo 162-8640 Center Director: Dr. Hideki Hasegawa Member Researchers: Tetsuro Matano Originally founded in 1892, the National Institute of Infectious Diseases aims at carrying out extensive and original research
- [South Korea](https://gvn.org/gvn-centers-of-excellence/asia-australia/south-korea/) - WELCOME TO South Korea Center of Excellence South Korea For an overview of GVN Centers of Excellence, click here. International Vaccine Institute SNU Research Park Gwanak-ro, Gwanak-gu Seoul, 08826 Korea Center Director: Dr. Jerome Kim The International Vaccine Institute (IVI) is the world’s only international organization devoted exclusively to developing and introducing new and improved
- [Belgium](https://gvn.org/gvn-centers-of-excellence/europe/belgium/) - WELCOME TO Belgium Center of Excellence BELGIUM For an overview of GVN Centers of Excellence, click here. Northern Europe Consortium at Gembloux Agro-Bio Tech Passage de Déportés, 2 5030 Gembloux Center Director: Dr. Arsène Burny and Luc Willems Member Researchers: University Hospital in Liège – Prof. Michel Moutschen, Dr. Anne Vandenbroeke Institute of Molecular Biology and Medicine
- [Denmark](https://gvn.org/gvn-centers-of-excellence/europe/denmark/) - WELCOME TO Denmark Center of Excellence Denmark For an overview of GVN Centers of Excellence, click here. University of Southern Denmark Campusvej 55, 5230 Odense, Denmark Center Director: Dr. Christine Benn Member Researchers: Peter Aaby, Ane Fisker, Frederik Schaltz-Buchholzer Amabelia Rodrigues, Cesario Martins “The University of Southern Denmark’s Global Health Center is committed to a
- [France](https://gvn.org/gvn-centers-of-excellence/europe/france/) - WELCOME TO France Center of Excellence France For an overview of GVN Centers of Excellence, click here. Institut Pasteur Paris, France Center Directors: Dr. Marc Lecuit and Dr. Antoine Gessain The Institut Pasteur, a private foundation with officially recognized charitable status set up by Louis Pasteur in 1887, is today an internationally renowned center for
- [Germany](https://gvn.org/gvn-centers-of-excellence/europe/germany/) - WELCOME TO Germany Center of Excellence Germany For an overview of GVN Centers of Excellence, click here. Robert Koch Institute, Berlin Nordufer 20 D-13353 Berlin-Wedding Center Director: Dr. Lothar H. Wieler Member Researchers: Dr. Heinz Ellerbrok The Robert Koch Institute is one of the central institutions for health protection in Germany. It serves the Federal
- [Ireland](https://gvn.org/gvn-centers-of-excellence/europe/ireland/) - WELCOME TO Ireland Center of Excellence IRELAND Centre for Research in Infectious Diseases University College Dublin Belfield Dublin 4 The CoE is based in the Centre for Research in Infectious Diseases (CRID) at University College Dublin (UCD) and is also associated with the National Virus Reference Laboratory. Research activities are focused on pathogenesis of HTLV-1
- [Italy](https://gvn.org/gvn-centers-of-excellence/europe/italy/) - WELCOME TO Italy Center of Excellence Italy For an overview of GVN Centers of Excellence, click here. Center Director: Dr. Franco Maria Buonaguro, National Cancer Institute – IRCCS “Fondazione Pascale”, Napoli University of Padova Department of Surgery, Oncology & Gastroenterology via Gattamelata 64 35128 Padua The Department of Oncology and Surgical Services is nestled under
- [Netherlands](https://gvn.org/gvn-centers-of-excellence/europe/netherlands/) - WELCOME TO Netherlands Center of Excellence Netherlands For an overview of GVN Centers of Excellence, click here. Erasmus University Medical Center Rotterdam Dr. Molewaterplein 40 3015 GD, Rotterdam Center Director: Dr. Marion Koopmans Member Researchers: Arno Andeweg, Charles Boucher, Rik de Swart, Ron Fouchier, Pieter Fraaij, Rob Gruters, Bart Haagmans, Thijs Kuiken, Byron Martina, David
- [Russia](https://gvn.org/gvn-centers-of-excellence/europe/russia/) - WELCOME TO Russia Center of Excellence Russia For an overview of GVN Centers of Excellence, click here. Institute of Biomedical Systems and Biotechnologies at the Peter the Great St. Petersburg Polytechnic University 195251, Russia, St. Petersburg, Polytechnicheskaya, 29 Center Director: Dr. Andrey Vasin Member Researchers: Dr. Dmitry Moshkoff, Marcus Gallo, Victor Trukhin, Dr. German Shipulin, Dr. Ilya Bezprozvanny, Dr. Alexander Kanapin, Dr. Anastasia Samsonova, Dr. Ilia Tikhonov, Dr. Andrey Konevega,
- [Spain](https://gvn.org/gvn-centers-of-excellence/europe/spain/) - WELCOME TO Spain Center of Excellence Spain For an overview of GVN Centers of Excellence, click here. Severo Ochoa Center for Molecular Biology (CBMSO), Madrid C/Nicolas Cabrera 1 Cantoblanco (Campus UAM) 28049 – Madrid Center Director: Dr. José Felix de Celis Member Researchers: Esteban Domingo, Luis Menendez Aris, Antonio Alcamí, José María Almendral, Encarnación Martínez-Salas, Mauricio G. Mateu, Francisco Sobrino
- [Sweden](https://gvn.org/gvn-centers-of-excellence/europe/sweden/) - WELCOME TO Sweden Center of Excellence Sweden For an overview of GVN Centers of Excellence, click here. Karolinska Institute-Karolinska University Hospital Department of Laboratory Medicine Alfred Nobels Allé 8 SE-17177 Flemingsberg Center Director: Dr. Anders Vahlne Member Researchers: Anders Sonnerborg, Gunnel Biberfeld, Britta Wahren, Jan Albert, Tomas Bergstrom, Ingemar Ernberg, Maria Masucci, Matti Sallberg,
- [United Kingdom](https://gvn.org/gvn-centers-of-excellence/europe/united-kingdom/) - WELCOME TO United Kingdom Center of Excellence United Kingdom For an overview of GVN Centers of Excellence, click here. The Pirbright Institute Pirbright Laboratory Ash Road Pirbright, Surrey, England GU24 0NF UK Center Director: Dr. Bryan Charleston The Pirbright Institute is a world leading centre of excellence in research and surveillance of virus diseases of
- [Argentina](https://gvn.org/gvn-centers-of-excellence/north-south-america/argentina/) - WELCOME TO Argentina Center of Excellence Argentina For an overview of GVN Centers of Excellence, click here. Institute of Biotechnology & Molecular Biology (IBBM) Universidad Nacional de La Plata Calle 49 y 115 1900 La Plata Argentina Center Director: Victor Romanowski Member Researchers: Ricardo Gomez, Agustin E. Ure, Laura Perez-Vidakovics, Florencia Ferrer The Institute of Biotechnology and Molecular
- [Colombia](https://gvn.org/gvn-centers-of-excellence/north-south-america/colombia/) - WELCOME TO Colombia Center of Excellence COLOMBIA For an overview of GVN Centers of Excellence, click here. Colombia/Wisconsin One-Health Consortium, (CWOHC) Carrera 87 N° 30 65 Medellin Colombia Center Director: Dr. Jorge Osorio Member Researchers: Dr. Bruce Christensen, Dr. David Schwartz The CWOHC provides a unique opportunity for UW, Colombian, and international institutions to demonstrate leadership and
- [Peru](https://gvn.org/gvn-centers-of-excellence/north-south-america/peru/) - WELCOME TO Peru Center of Excellence Peru For an overview of GVN Centers of Excellence, click here. Instituto de Medicina Tropical “Alexander von Humboldt” IMTAvH of the Universidad Peruana Cayetano Heredia (UPCH) Universidad Peruana Cayetano Heredia Av. Honorio Delgado 430 San Martín de Porres, Peru Center Director: Dr. Eduardo Gotuzzo Co-Director: Dr. Theresa Ochoa W.
- [Programs](https://gvn.org/programs-2/)
- [Saliva Testing for Frequent and Rapid Diagnostic of COVID-19](https://gvn.org/programs/saliva-testing-for-frequent-and-rapid-diagnostic-of-covid-19/) - ABOUT SALIVA TESTING FOR COVID-19 Saliva-Based Testing Delayed detection of SARS-CoV-2 has been a major hindrance in curbing the current COVID-19 pandemic. Widespread testing is the most practical way out of the current crisis. The current gold standard for COVID-19 diagnosis is real-time reverse transcription polymerase chain reaction (RT-PCR) detection of SARS-CoV-2 from nasopharyngeal swabs.
- [GVN Center Activities and Industry Contributions](https://gvn.org/gvn-center-activities-and-industry-contributions/) - WELCOME TO THE GVN Center Activities and Industry Contributions Read what GVN Members from our Centers of Excellence and Affiliates are doing to combat the virus, as well as updates from industry efforts and the latest SARS-CoV-2 News. VACCINES EPIDEMIOLOGY THERAPEUTICS CLINICAL FEATURES DIAGNOSTICS CLEANING/SANITIZATION
- [Zika Task Force](https://gvn.org/zika-task-force/) - ABOUT THE ZIKA TASK FORCE CHAIR: SCOTT WEAVER, MS, PHD Galveston National Laboratory University of Texas Medical Branch, Galveston, TX, USA Zika FAQ Task Force Biographies TERMS OF REFERENCE (TOR) – GLOBAL VIRUS NETWORK ZIKA TASK FORCE The Zika Task Force is composed of members of any of the GVN Centers of Excellence, its affiliates and
- [Ireland](https://gvn.org/gvn-centers-of-excellence/europe/ireland-3/) - Ireland For an overview of GVN Centers of Excellence, click here. Centre for Research in Infectious Diseases University College Dublin Belfield Dublin 4 The CoE is based in the Centre for Research in Infectious Diseases (CRID) at University College Dublin (UCD) and is also associated with the National Virus Reference Laboratory. Research activities are focused
- [Press Releases](https://gvn.org/press-releases-2/press-releases/) - Press Releases 2017 August 17, 2017 GVN Adds Premier Rega Institue for Medical Research as Newest Center of Excellence. June 1, 2017 Global Virus Network (GVN) Center of Excellence TSRI Investigation Reveals First-Ever Image of Elusive Viral Protein. March 22, 2017 GVN Announces Seven Distinguished International Appointments to Board of Directors. March 24, 2017 Pioneers
- [GVN's First Journalist Virology Workshop in Grenada](https://gvn.org/events-2/journalist_conference/) - Journalist Workshop In conjunction with St. George’s University and the Windward Islands Research & Education Foundation. In conjunction with St. George’s University and the Windward Islands Research & Education Foundation. About The Virology Workshop for Journalists will provide reporters from varying U.S. and Caribbean media outlets an opportunity to learn firsthand about the nature of
- [Chikungunya Task Force](https://gvn.org/programs/chikungunya-task-force/) - Chikungunya Task Force About The Task Force The GVN Chikungunya Task Force is a group of leading scientists from around the world committed to finding solutions to the growing problem of Chikungunya virus. What is Chikungunya? Chikungunya is a mosquito-borne viral disease that causes its victims to suffer fever and severe, debilitating and often chronic
- [Asia & Australia](https://gvn.org/gvn-centers-of-excellence/asia-australia/) - Asia and Australia We represent centers of excellence for research in medical virology from across the globe. Our work is dedicated to understanding, preventing and eradicating viral disease threats to mankind. Today, we affirm the need for new programs to coordinate, support and promote research that bridges the gap between virus surveillance and public health
- [Africa & Middle East](https://gvn.org/gvn-centers-of-excellence/africa/) - We represent centers of excellence for research in medical virology from across the globe. Our work is dedicated to understanding, preventing and eradicating viral disease threats to mankind. Today, we affirm the need for new programs to coordinate, support and promote research that bridges the gap between virus surveillance and public health implementation. The criteria
- [GVN Meetings](https://gvn.org/events-2/gvn-meetings/) - GVN Meetings The Global Virus Network (GVN) regularly convenes general meetings of the network, including the first meeting launch in Washington, DC at the Embassy of Italy in March 2011. Initiating and executing consistent international meetings including GVN’s diverse, dispersed international group of top medical virologists is integral to the success of GVN. These meetings,
- [Zika Virus Task Force](https://gvn.org/programs/zika-virus-task-force/) - Zika Task Force Chair: Scott Weaver, MS, PhD Galveston National Laboratory University of Texas Medical Branch, Galveston, TX, USA Zika FAQ Task Force Biographies Terms of Reference (TOR) – Global Virus Network Zika Task Force The Zika Task Force is composed of members of any of the GVN Centers of Excellence, its affiliates and top global experts who
- [Frequently Asked Questions About Zika](https://gvn.org/programs/zika-virus-task-force/faq-zika/) - FREQUENTLY ASKED QUESTIONS RELATED TO ZIKA VIRUS Q: What is the Zika virus? A: Zika virus is a mosquito-borne virus that is a member of the flavivirus group. This group includes several other viruses that cause serious, sometimes life-threatening diseases such as yellow fever, dengue fever, West Nile and Japanese encephalitis. Zika virus has been known
- [6th Annual Short Course in Basic and Translational Virology](https://gvn.org/programs/6th-short-course/) - 6th Annual Short Course in Basic and Translational Virology of the GVN A Course For Emerging Leaders in Virology July 28 – August 3, 2019 Location: Institute of Human Virology at the University of Maryland School of Medicine, A GVN Center of Excellence What A one-week intensive course on basic, translational, and clinical aspects of viruses
- [Robert C. Gallo Award for Scientific Excellence](https://gvn.org/events-2/robert-c-gallo-award-for-scientific-excellence/) - The GVN Robert C. Gallo Award for Scientific Excellence and Leadership 2020 Honoree 2019 Honoree 2018 Honoree Sharon Lewin, FRACP, PhD, FAHMS Director The Peter Doherty Institute for Infection and Immunity Melbourne, Australia William Hall, BSc, PhD, MD, DTMH Michael Oldstone, MD Professor, department of Immunology and Microbiology, California Campus. Faculty member, Scripps
- [Press Releases](https://gvn.org/press-releases-2/) - GVN Press Releases
- [Essays](https://gvn.org/press-releases-2/essays/) - Essays Dengue in Mexico HIV in South Africa Latent HIV Infection Marburg virus Zoonotic Viruses The Forgotten Viruses MERS Nipah Virus Outbreak
- [HTLV-1 Task Force](https://gvn.org/programs/htlv-1-task-force/) - HTLV-1 Task Force HTLV world day - November 10th - click here to learn more About The Task Force The Global Virus Network (GVN) formed an international Task Force on Human T-Leukemia Virus (HTLV-1), the world’s first known human retrovirus and the only known leukemia-causing virus. Experts from 11 countries, led by Dr. Robert Gallo,
- [Zika Virus Meeting](https://gvn.org/events-2/zika-virus-meeting/) - Zika Virus Meeting Bridging the Sciences: Zika Virus Meeting Overview On behalf of Raymond Schinazi, PhD, DSc; José Esparza, MD, PhD; and Mauro Teixeira, MD, PhD, course directors and co-chairs, we are pleased to invite you to Bridging the Sciences: Zika Virus, to be held in Atlanta, Georgia, on May 1 – 3, 2016. This
- [Hepatitis In India](https://gvn.org/programs/hep-in-india/) - Hepatitis In India
- [Support](https://gvn.org/support/) - Support the GVN The Global Virus Network (GVN) needs your support for our pandemic preparedness programs and to push science forward to understand viral killers, their treatments, and prevention strategies. Join us! There are many ways you can support the GVN’s efforts to: Develop new ways to detect and prevent new and re-emerging viral diseases
- [GVN Mailing List](https://gvn.org/mailing-list/) - Join Our Mailing List
- [Short Course Alumni Database](https://gvn.org/programs/short-course-alumni-database/) - Short Course Alumni Database Training the next generation of medical virologists is the core of the GVN Mission. The GVN Short Course (SC) has been offered each summer since 2013. The latest course is scheduled for August 13-19, 2017. The SC is held in Baltimore for participants holding PhD, MD, DVM degrees, and for PhD candidates and MSc
- [Map of COE](https://gvn.org/map-of-coe/)
- [Time to eradicate HTLV-1: an open letter to WHO](https://gvn.org/who/) - Time to eradicate HTLV-1: an open letter to WHO 10, May 2018 **Summary version of this letter published Lancet here. On behalf of Human T Cell Leukemia Virus-1 (HTLV-1) positive patients, expert clinicians and scientists working in the field of HTLV-1 clinical and laboratory research. Dear Dr. Tedros Ghebreyesus, We are writing to you today
- [May Virion](https://gvn.org/may-virion/)
- [The GVN 11th International Meeting in Barcelona](https://gvn.org/press-releases-2/virion-newsletter/the-gvn-11th-international-meeting-in-barcelona/) - Join Us For the GVN 11th International Meeting June 9-12, 2019 in Barcelona Researchers and virologists from around the globe will gather for the 11th International Meeting of the Global Virus Network (GVN) on June 9-12, 2019 in Barcelona, Spain. Organized jointly with the Spanish Society of Virology (Sociedad Espanola de Virologia or SEV), the
- [GVN Short Course Helps Virologists Broaden Expertise in 2019](https://gvn.org/gvn-short-course-helps-virologists-broaden-expertise-in-2019/) - GVN Short Course Helps Virologists Broaden Expertise Education and training are central to the Global Virus Network’s (GVN) mission. “We want to support and train the next generation of virologists,” says Christian Bréchot, MD, PhD, the president of GVN, “and make sure we have enough highly-skilled experts in the field around the world.” As part
- [Virion Newsletter](https://gvn.org/virion-newsletter/)
- [Other SARS-CoV-2 Updates - Epidemiology](https://gvn.org/sars-cov-2-response-efforts/other-sars-cov-2-updates-epidemiology/) - SARS-CoV-2 Updates - Epidemiology Other SARS-CoV-2 updates Track current COVID-19 cases: Johns Hopkins Coronavirus Resource Center - Live Case Map CDC: Cases in the United States Stability of SARS-CoV-2 on Produce following a Low-Dose Aerosol Exposure The American Journal of Tropical Medicine and Hygiene, September 14, 2020 Contact Tracing during Coronavirus Disease Outbreak, South Korea,
- [Other SARS-CoV-2 Updates - Vaccines](https://gvn.org/sars-cov-2-response-efforts/other-sars-cov-2-updates-vaccines/) - SARS-CoV-2 Updates - Vaccines Other SARS-CoV-2 updates An mRNA Vaccine against SARS-CoV-2 — Preliminary Report NEJM, July 14, 2020 Developing Vaccines for SARS-CoV-2 and Future Epidemics and Pandemics: Applying Lessons from Past Outbreaks Health Security, June 17, 2020 University Queensland, Australia, Paul Young Vaccine Animal Models CEPI Funded to accelerate the Clamp Trimer vaccine-modify S-protein.
- [Other SARS-CoV-2 Updates - Clinical Pattern/presentation/features](https://gvn.org/sars-cov-2-response-efforts/other-sars-cov-2-updates-clinical-pattern-presentation-features/) - SARS-CoV-2 Updates - Clinical Pattern/presentation/features Other SARS-CoV-2 updates Role of vitamin D in preventing of COVID-19 infection, progression and severity Journal of Infection and Public Health, October 2020 Enanthem in Patients With COVID-19 and Skin Rash JAMA Network, July 15, 2020 Phenotype and Kinetics of SARS-CoV-2-specific T Cells in COVID-19 Patients with Acute Respiratory Distress
- [GVN in the News](https://gvn.org/sars-cov-2-response-efforts/gvn-in-the-news/) - GVN in the News A compilation of GVN SARS-CoV-2 news 2021 November 2021 ‘If you wanted to break the chain of virus transmission, it was necessary to close the airports’ Realnoe Vremya, November 10, 2021 Exavir Therapeutics announces preclinical data demonstrating complete elimination of HIV from human cells with LNP-delivered Tat-targeted CRISPR-Cas9 The Bakersfield Californian,
- [Other SARS-CoV-2 Updates - Cleaning/Sanitization](https://gvn.org/sars-cov-2-response-efforts/other-sars-cov-2-updates-cleaning-sanitization/) - SARS-CoV-2 Updates - Cleaning/Sanitization Other SARS-CoV-2 updates Two GVN Centers of Excellence Independently Verify an Antimicrobial Technology That Kills Sars-Cov-2 on Surfaces For More Than Six Weeks GVN, June 4, 2020 How Long Does the Coronavirus Live on Surfaces? WebMD BIOPROTECTUs(TM) System Used To Disinfect & Protect New Rochelle City Schools & Facilities Olean Times
- [Media Inquiries](https://gvn.org/press-releases-2/media-inquiries/) - Media Contact: Nora Samaranayake Public Relations Senior Advisor Global Virus Network (GVN) 725 West Lombard St. Baltimore, MD 21201 443-823-0613 nsamaranayake@gvn.org (email is preferable)
- [Highlights from Global Virus Network Media Coverage Regarding the Oral Polio Vaccine for SARS-CoV-2/COVID-19](https://gvn.org/sars-cov-2-response-efforts/highlights-from-global-virus-network-media-coverage-regarding-the-oral-polio-vaccine-for-sars-cov-2-covid-19/) - Highlights from Global Virus Network Media Coverage Regarding the Oral Polio Vaccine for SARS-CoV-2/COVID-19 COVID-19 outbreaks are multiplying and immunity may be short-lived. Could existing “live” vaccines, which stimulate innate immunity, outshine vaccines targeting the “spike” protein? 13D Global Strategy & Research, July 2, 2020 An Old Vaccine May Help Against Coronavirus Wall Street Journal,
- [Doherty Institute Report on ViaClean Products and SARS-CoV-2](https://gvn.org/doherty-institute-report-on-viaclean-products-and-sars-cov-2/) - Doherty Institute Report on TEST A: SARS-CoV-2 Viricidal Effectiveness Testing with ViaClean Products Doherty Institute Report on TEST B: SARS-CoV-2 Viricidal Effectiveness Testing with ViaClean Products
- [GVN Corporate Partnership Program Overview](https://gvn.org/gvn-corporate-partnership-program-overview/) - GVN Corporate Partnership Program Overview About GVN Corporate Partnership Program The business community is an integral partner in stemming the spread of viral diseases worldwide. Viral outbreaks, such as SARS-CoV-2 / COVID19, know no boundaries and spread rapidly beyond national borders, accompanied by panic, uncertainty, and losses to workforces, productivity and revenue streams. Multinational corporations
- [GVN Centers of Excellence and Affiliates Overview](https://gvn.org/gvn-centers-of-excellence-and-affiliates-overview/) - GVN Centers of Excellence and Affiliates Overview About GVN Centers of Excellence We represent Centers of Excellence for research in medical virology from across the globe. Our work is dedicated to understanding, preventing and eradicating viral disease threats to mankind. Today, we affirm the need for new programs to coordinate, support and promote research that
- [GVN Center and Member Spotlight - Alash'le Abimiku](https://gvn.org/sars-cov-2-response-efforts/gvn-center-and-member-spotlight-alashle-abimiku/) - GVN Center and Member Spotlight Alash’le Abimiku, M.SC; PhD, Executive Director, International Research Center of Excellence at the Institute of Human Virology-Nigeria (IRCE-IHVN) Professor of Medicine, University of Maryland School of Medicine, Institute of Human Virology, Baltimore What are you and your institution currently working on regarding COVID-19? The Institute of Human Virology Nigeria
- [GVN Academic Centers of Excellence & Affiliates](https://gvn.org/gvn-academic-centers-of-excellence-affiliates/) - GVN Academic Centers of Excellence and Affiliates About GVN Centers of Excellence We represent Centers of Excellence for research in medical virology from across the globe. Our work is dedicated to understanding, preventing and eradicating viral disease threats to mankind. Today, we affirm the need for new programs to coordinate, support and promote research that
- [GVN Special Annual Meeting 2020](https://gvn.org/events-2/gvn-special-annual-meeting-2020/) - GVN 2020 Special Annual Meeting Executive Summary GVN 2020 Meeting Press Release GVN International Press Conference September 24, 2020
- [Online Course on Microbiomes and their Impact on Viral Infections](https://gvn.org/programs/online-course-on-microbiomes-and-their-impact-on-viral-infections/) - Online Course on Microbiomes and their Impact on Viral Infections The study of the microbiome is one of the most promising scientific and medical revolutions in recent times. It is now clear that changes in the microbiome composition (referred to as dysbiosis) are major drivers to several human diseases and public health threats. In particular,
- [GVN Center and Member Spotlight - Konstantin Chumakov](https://gvn.org/sars-cov-2-response-efforts/gvn-center-and-member-spotlight-konstantin-chumakov/) - GVN Center and Member Spotlight Konstantin Chumakov U.S. Food and Drug Administration (FDA)/Office of Vaccines Research and Review (OVRR), Maryland, USA What are you and your institution currently working on regarding COVID-19? The U.S. FDA Center for Biologics Evaluation and Research (CBER) investigators have established hamster models of SARS-CoV-2 infection and are currently working on
- [SARS-CoV-2 Task Force](https://gvn.org/programs/sars-cov-2-task-force/) - SARS-CoV-2 Task Force About The Task Force With representatives from 32 GVN CoEs in 13 countries, the GVN SARS-CoV-2 Task Force meets virtually bimonthly to monthly to share latest research findings and to discuss diagnostics, serological tests and vaccine development. Task Force Members Larry Blatt (GVN, USA) Christian Brechot (GVN, USA) Franco Buonaguro (Instituto Tumori,
- [Translational Medicine and Clinical Research](https://gvn.org/programs/translational-medicine-and-clinical-research/) - Translational Medicine and Clinical Research GVN Translational Medicine and Clinical Research Infectious diseases are emerging or reemerging almost every year. The majority of emerged diseases have been associated with viral diseases, such as acquired immunodeficiency syndrome, severe acute respiratory syndrome (SARS), West Nile, avian influenza, H1N1 flu (2009 swine flu), Middle East respiratory syndrome (MERS),
- [GVN Variants and Vaccine Resource Portal](https://gvn.org/covid-19/) - Alpha (B.1.1.7) Beta (B.1.351) Gamma (P.1) Delta (B.1.617.2) GVN Experts Address What You Need to Know About Variants and Vaccines Vaccines Yes, although this is rare, since the current vaccines are effective against the Delta variant. Yet reinfections (i.e., breakthrough infections) can occur. The US CDC has recently evaluated breakthrough infections that cause hospitalization or
- [Vaccine Overview](https://gvn.org/covid-19/vaccine-overview/) - Vaccine Overview Vaccination can be the most efficient and effective measures in controlling the pandemics and save millions of lives. There are currently more than 60 COVID-19 vaccine candidates in clinical development and over 170 in pre-clinical development. The GVN is providing valuable information and resources for COVID-19 vaccines. Spike Protein of SARS-CoV-2 for Vaccine
- [Beta (B.1.351)](https://gvn.org/covid-19/beta-b-1-351/) - Background The variant known as Beta, or B.1.351, was first detected in South Africa This variant emerged with an unusually large number of mutations in South Africa. As the variant spreads faster than other earlier variants of the virus, the variant may be driving the second wave of the pandemic in the country. This variant is
- [Gamma (P.1)](https://gvn.org/covid-19/gamma-p-1/) - Background The variant known as Gamma or P.1 was first detected in Brazil It has caused widespread infection in the city of Manaus. As shown with other UK and South African variants, the Brazilian variant has shown to enhanced transmissibility and is spreading globally. Notable mutations: N501Y, K417N, and E484K in the receptor binding domain
- [Epsilon (B.1.427/B.1.429)](https://gvn.org/covid-19/epsilon-b-1-427-b-1-429/) - Background The variant known as Epsilon was first detected in California, USA It has two distinct lineages, B.1.427 and B.1.429, in clade 20C The most recent common ancestor emerged on May 20, 2020 (95% highest posterior. The branches giving rise to the B.1.427 and B.1.429 lineages were predicted to have diverged In July and June,
- [Alpha (B.1.1.7)](https://gvn.org/covid-19/alpha-b-1-1-7/) - Background The variant known as Alpha or B.1.1.7 or 20I/501Y.V1 was first detected in the UK This variant emerged with an unusual large number of mutations. The spread of this variant greatly affected a surge of COVID-19 cases in UK since November, 2021. The variant comprises roughly 95% of new SARS-CoV-2 infections in England. The
- [Variants of Interest](https://gvn.org/covid-19/variants-of-interest/) - Eta (B.1.525) This variant was first detected in Nigeria and UK in December 2020. It has been seen in other countries, including U.S., Canada, Denmark, Britain, France, Belgium, Spain, Finland, Nigeria, Ghana, Jordan, Australia and Singapore. As of Feb. 17, 46 and 12 cases of the variant had been confirmed by gene sequencing in the
- [GVN Drs. Yang Liu & Pan Zheng Academy Program](https://gvn.org/programs/gvn-drs-yang-liu-pan-zheng-academy-program/) - GVN Drs. Yang Liu & Pan Zheng Academy Program There is a shortage of virologists in basic, clinical and translational researches, in particular in low- and middle-income countries. Training and educating the next generation of virologists is a core pillar of the GVN mission. GVN senior virologists are committed to sharing their invaluable expertise with
- [GVN Healthcare & Pharma Centers of Excellence Coalition](https://gvn.org/gvn-healthcare-pharma-centers-of-excellence-coalition/) - GVN Healthcare & Pharma Centers of Excellence Coalition GVN Healthcare & Pharma Centers of Excellence The business community is an integral partner in stemming the spread of viral diseases worldwide. Viral outbreaks, such as SARS-CoV-2 / COVID19, know no boundaries and spread rapidly beyond national borders, accompanied by panic, uncertainty, and losses to workforces, productivity
- [Vaccine Safety](https://gvn.org/covid-19/vaccine-safety/) - COVID-19 Vaccine Safety Risk The health agencies approved COVID-19 vaccines under emergency use authorization by reviewing the data (safety and protective efficacy) from clinical trials. However, we have encountered unexpected adverse events with certain vaccines since the vaccine rollout. The GVN is updating current status of using these vaccines. A rare blood clot with low
- [GVN Regional Headquarters](https://gvn.org/gvn-regional-headquarters/) - GVN Regional Headquarters Overview The overall mission of a GVN Regional Headquarters office is to collaborate with the GVN global headquarters located in Baltimore, Maryland, USA. A GVN Regional HQ provides organizational support and leadership to strengthen basic and translational research in virology, as well as preparedness and response to viral pandemic threats. Responsibilities Acting
- [GVN Center and Member Spotlight - Chiranjay Mukhopadhyay](https://gvn.org/sars-cov-2-response-efforts/gvn-center-and-member-spotlight-chiranjay-mukhopadhyay/) - GVN Center and Member Spotlight Dr. Chiranjay Mukhopadhyay MBBS, MD, PDCC (Infectious Diseases), PhD Professor of Microbiology and Associate Dean, Kasturba Medical College, Manipal Director, Manipal Institute of Virology Manipal Academy of Higher Education, Manipal, Karnataka, India GVN Center Director What are you and your institution currently working on regarding COVID-19? Manipal Institute of Virology
- [Delta (B.1.617.2)](https://gvn.org/covid-19/delta-b-1-617-2/) - Background This variant has been named as the Delta variant by the WHO. The Delta variant was first detected in India in December 2020 and became the most commonly reported variant in the country from mid-April 2021. The variant could be more than twice as transmissible as the original strain of SARS-CoV-2. The variant was
- [GVN Center and Member Spotlight - Juan Pablo Hernández-Ortiz](https://gvn.org/sars-cov-2-response-efforts/gvn-center-and-member-spotlight-juan-pablo-hernandez-ortiz/) - GVN Center and Member Spotlight Juan Pablo Hernández-Ortiz, Ph.D. Professor of Materials and Nanotechnology, Universidad Nacional de Colombia, Medellín Director, Colombia/Wisconsin One-Health Consortium Honorary Associate at the Pritzker School of Molecular Engineering at the University of Chicago, and The Biotechnology Center at the University of Wisconsin-Madison GVN Member What are you and your institution currently
- [GVN Center and Member Spotlight - Aydar Ishmukhametov](https://gvn.org/sars-cov-2-response-efforts/gvn-center-and-member-spotlight-aydar-ishmukhametov/) - GVN Center and Member Spotlight Aydar Ishmukhametov CEO Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences Moscow, Russia GVN Center Director What are you and your institution currently working on regarding COVID-19 At the Chumakov FSC R&D IBP RAS, we developed CoviVac, an inactivated vaccine against SARS-CoV-2,
- [HTLV-1 Letter](https://gvn.org/htlv-1-letter/) - ABOUT HTLV-1 LETTER Time to eradicate HTLV-1: an open letter to WHO 10, May 2018 **Summary version of this letter published Lancet here. On behalf of Human T Cell Leukemia Virus-1 (HTLV-1) positive patients, expert clinicians and scientists working in the field of HTLV-1 clinical and laboratory research. Dear Dr. Tedros Ghebreyesus, We are writing
- [Initiatives](https://gvn.org/initiatives-2/) - WELCOME TO INITITATIVES The Global Virus Network (GVN) was co-founded in 2011 by Robert Gallo, MD of the Institute of Human Virology at the University of Maryland School of Medicine, William Hall, MD, PhD of University College Dublin and the late Reinhard Kurth, MD, PhD, of the Robert Koch Institute. The GVN is an essential
- [ZIKA VIRUS MEETING](https://gvn.org/zika-virus-meeting/) - WELCOME TO THE ZIKA VIRUS MEETING BRIDGING THE SCIENCES: ZIKA VIRUS MEETING OVERVIEW On behalf of Raymond Schinazi, PhD, DSc; José Esparza, MD, PhD; and Mauro Teixeira, MD, PhD, course directors and co-chairs, we are pleased to invite you to Bridging the Sciences: Zika Virus, to be held in Atlanta, Georgia, on May 1 –
- [The Other Side of Virology: Beyond the COVID-19 Pandemic](https://gvn.org/the-other-side-of-virology-beyond-the-covid-19-pandemic/) - WELCOME TO THE THE OTHER SIDE OF VIROLOGY: BEYOND OF THE COVID-19 PANDEMIC
- [HEPATITIS IN INDIA](https://gvn.org/hepatitis-in-india/) - ABOUT Hepatitis in India Hepatitis B Hepatitis C
- [SHORT COURSE ALUMNI DATABASE](https://gvn.org/short-course-alumni-database/) - WELCOME TO SHORT COURSE ALUMNI DATABASE TRAINING THE NEXT GENERATION OF MEDICAL VIROLOGISTS IS THE CORE OF THE GVN MISSION. The GVN Short Course (SC) has been offered each summer since 2013. The latest course is scheduled for August 13-19, 2017. The SC is held in Baltimore for participants holding PhD, MD, DVM degrees, and for PhD candidates
- [Partners](https://gvn.org/partners/) - WELCOME TO PARTNERS OUR PARTNERS Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam Global Health Security Agenda (GHSA) The Global Health Security Agenda (GHSA) was launched in February 2014 and is a growing partnership of over 50 nations, international organizations, and non-governmental stakeholders to help build countries’ capacity to help create a world safe and
- [GVN and SARS-COV-2](https://gvn.org/gvn-and-sars-cov-2/) - ABOUT GVN AND SARS-COV-2 The Global Virus Network (GVN) was co-founded in 2011 by Robert Gallo, MD of the Institute of Human Virology at the University of Maryland School of Medicine, William Hall, MD, PhD of University College Dublin and the late Reinhard Kurth, MD, PhD, of the Robert Koch Institute. The GVN is an
- [Member Login](https://gvn.org/member-login/)
- [COVID-19 and Vaccines](https://gvn.org/covid-19-and-vaccines/)
- [Postdoc hiring](https://gvn.org/postdoc-hiring/)
- [WORLD EXPERTS IN VIROLOGY ALERT THAT CLIMATE CHANGE AND GLOBALIZATION ARE AN ADDED PROBLEM IN VIRAL DISEASE TRANSMISSION](https://gvn.org/world-experts-in-virology-alert-that-climate-change-and-globalization-are-an-added-problem-in-viral-disease-transmission/) - WORLD EXPERTS IN VIROLOGY ALERT THAT CLIMATE CHANGE AND GLOBALIZATION ARE AN ADDED PROBLEM IN VIRAL DISEASE TRANSMISSION Dr. William Hall Receives The GVN Robert C. Gallo Award for Scientific Excellence and Leadership Baltimore, MD, USA, July 2, 2019: The Global Virus Network (GVN), representing 48 Centers of Excellence and 7 Affiliates in 29 countries
- [GVN Celebrates Launch of Jamaica Affiliate](https://gvn.org/press-releases-2/virion-newsletter/gvn-celebrates-launch-of-jamaica-affiliate/) - GVN Celebrates Launch of Jamaica Affiliate In February The Global Virus Network (GVN) celebrated the launch of its new Affiliate Center of Excellence at the University of West Indies (UWI) Mona Campus in Kingston, Jamaica. Robert Gallo, MD, Co-founder and International Scientific Advisor of the GVN, the Homer & Martha Gudelsky Distinguished Professor in Medicine
- [Dr. Gallo Letter for Newsletter 2019](https://gvn.org/press-releases-2/virion-newsletter/a-letter-from-the-gvn-scientific-director-and-chair-scientific-leadership-board-2019/) - Letter from Dr. Robert C. Gallo As a coalition of expert virologists around the world, the Global Virus Network leverages the strengths and knowledge of our members to accomplish our mission of a world better prepared to control and prevent viral epidemics. Across the globe, we are collaborating on research, sharing information, training the next
- [Letter from the GVN President 2019](https://gvn.org/letter-from-the-gvn-president-2019/) - LETTER FROM DR. CHRISTIAN BRECHOT Over the past year and a half it has been my great privilege to serve as president of the Global Virus Network (GVN). I want to thank to all of my colleagues and partners who have worked so hard to transform GVN into what it is today. I also want
- [GVN Launches Anticipation & Preparedness Task Force](https://gvn.org/press-releases-2/virion-newsletter/gvn-launches-anticipation-preparedness-task-force/) - GVN Launches Anticipation & Preparedness Task Force New and potentially deadly viruses are constantly emerging. But just as likely to cause a viral pandemic may be viruses that are already known – or ones that are re-emerging, taking new forms and spreading beyond their traditional spheres due to climate change, urban expansion, deforestation, international travel,
- [Letter From the GVN President](https://gvn.org/press-releases-2/virion-newsletter/letter-from-the-gvn-president/) - Letter From the GVN President Since its founding the Global Virus Network has sought to help create a coordinated global response to the world’s most dangerous viruses. GVN has accomplished a great deal. As the new president, I am privileged and honored to be able to help continue this urgent effort. So much has been
- [A Letter from the GVN International Scientific Advisor and Chair, Scientific Leadership Board](https://gvn.org/press-releases-2/virion-newsletter/a-letter-from-the-gvn-international-scientific-advisor-and-chair-scientific-leadership-board/) - A Letter from the GVN International Scientific Advisor and Chair, Scientific Leadership Board When the Global Virus Network (GVN) was founded in 2011, our mandate was to safeguard mankind from a potential catastrophic and devastating pandemic virus. To accomplish this, we assembled a network of experts from across the globe to share information, collaborate on
- [Letter from the President](https://gvn.org/president-letter/) - Letter from the President Of all the challenges that threaten the world’s population, biosecurity - including highly infectious viruses being used as biological agents to harm mankind - poses one of the greatest, global risks. Viruses cause millions of deaths each year. Old, young, rich and poor – all are susceptible to these silent killers.
- [Prof. Christian Bréchot](https://gvn.org/prof-christian-brechot/) - Prof. Christian Bréchot, MD, PhD, President of Global Virus Network, Biography Christian Bréchot holds MD and PhD degrees. Beginning in 1981 he studied molecular biology, virology, and cellular biology at the laboratory of Pierre Tiollais at the Pasteur Institute, and at the Necker school of medecine (Paris Descartes University); he obtained his PhD in biochemistry from the University
- [North & South America](https://gvn.org/gvn-centers-of-excellence/north-south-america/)
- [Programs](https://gvn.org/programs/)
- [Europe](https://gvn.org/gvn-centers-of-excellence/europe/) - We represent centers of excellence for research in medical virology from across the globe. Our work is dedicated to understanding, preventing and eradicating viral disease threats to mankind. Today, we affirm the need for new programs to coordinate, support and promote research that bridges the gap between virus surveillance and public health implementation. The criteria
- [Lebanon](https://gvn.org/gvn-centers-of-excellence/africa/lebanon/) - Lebanon: PRASE – Lebanese University in Beirut Address: Place de Musée Beirut, Hadath 6573-14

## Meetings

- [GVN 2026 Tampa](https://gvn.org/meeting/gvn-2026-tampa/) - Coming Soon Registration Registration for the 2025 Regional Meeting in Kingston, Jamaica, is open. Please register here. The registration deadline is April 25, 2025. Meeting Agenda DAY ONE - May 1, 2025 The morning session will commence with introductory remarks and welcome statements, succeeded by reports from the Global Virus Network Centers that will emphasize
- [GVN 2025 Jamaica](https://gvn.org/meeting/gvn-2025-jamaica/) - This gathering unites leading virology experts across Latin America and the Caribbean to advance regional research and collaborative efforts. The sessions will explore cutting-edge developments in Arbo-virology, pressing challenges in viral surveillance, and the intricacies of vector biology. Integrated networking opportunities and hands-on workshops will offer invaluable mentorship and training, fostering the next generation of
- [GVN 2024 Durban](https://gvn.org/meeting/gvn-2024-durban/) - It is with deep appreciation that we also thank our anonymous donors for their sponsorship. --> Media Contact Meeting Media Contact: Linman Lilinmanli@gvn.org Where To Stay For attendees who do not wish to stay at the conference venue, here is a list of nearby hotels.Note: non-speakers are responsible for their lodging and transportation to the
- [GVN 2023 Monaco](https://gvn.org/meeting/gvn-2023-monaco/) - Click/tap each Welcome Message for a PDF version Conference Venue Novotel Monte-Carlo 3*** Backstage & Talk show Rooms (Floor -1 Meeting Rooms area) Address: 16 Bd Princesse Charlotte, 98000 Monaco GPS: 43.739239, 7.421961 https://all.accor.com/hotel/5275/index.en.shtml In the heart of the Principality of Monaco, very close to the train station, Place du Casino and the main Monaco

## Webinars

- [GVN Forefront of Virology Webinar featuring Dr. Christine Carrington](https://gvn.org/webinar/gvn-forefront-of-virology-webinar-featuring-dr-christine-carrington/) - WELCOME TO FROM RESPONSE TO READINESS: BUILDING ONE HEALTH MOLECULAR DIAGNOSTIC AND GENOMIC SURVEILLANCE CAPACITY IN THE CARIBBEAN Thursday, August 27, 2026 / 9:00 AM Eastern Time (US and Canada) Dr. Christine Carrington is Professor of Molecular Genetics and Virology at The University of the West Indies (UWI) in Trinidad and Tobago, with over thirty
- [GVN Forefront of Virology Webinar featuring Dr. Aditya N. Bade](https://gvn.org/webinar/gvn-forefront-of-virology-webinar-featuring-dr-aditya-n-bade/) - WELCOME TO Developmental Deficits in Offspring of HIV-1-Mothers: Bridging the Known and the Unknown Aditya N. Bade, PhD, is an Associate Professor in the Department of Pharmacology and Experimental Neuroscience at University of Nebraska Medical Center (UNMC), Omaha, NE. Dr. Bade's research primarily focuses on neurodevelopmental pharmacology and toxicology. His current work is focused on
- [GVN Forefront of Virology Webinar featuring Dr. Rajesh Kumar](https://gvn.org/webinar/gvn-forefront-of-virology-webinar-featuring-rajesh-kumar/) - WELCOME TO ANTIBODY BASED THERAPEUTIC INTERVENTIONS FOR VIRAL INFECTIONS Dr. Kumar's lab develops immunotherapies targeting viral antigens. They have developed in-house naive universal phage display scFv and nanobody libraries that can be potentially used to isolate antibodies against diverse target antigens. Additionally, the library's ability to select binders with nanomolar affinity from a variety of
- [GVN Forefront of Virology Webinar featuring Esimebia Adjovi Amegashie](https://gvn.org/webinar/gvn-forefront-of-virology-webinar-featuring-esimebia-adjovi-amegashie/) - WELCOME TO Immunological Response to Human Coronaviruses among People Living with HIV in Ghana Esimebia Adjovi Amegashie is a PhD student, medical scientist, and research associate in Dr. Osbourne Quaye's lab at the Department of Biochemistry and Cell Biology, University of Ghana. She has expertise in clinical microbiology, clinical chemistry, virology, immunology, and molecular biology.
- [GVN Forefront of Virology Webinar featuring Dr. Fernando Spilki](https://gvn.org/webinar/gvn-forefront-of-virology-webinar-featuring-dr-fernando-spilki/) - WELCOME TO Virus Genomic Surveillance and One Health, diving into the Brazilian virosphere Fernando Rosado Spilki, DVM, MSc, PhD, Full Professor at Feevale University, Brazil. Fellow of the Brazilian National Research Council. Member of the Virus Network expert team of the Brazilian Ministry of Science, Technology and Innovation. Coordinator of the Brazilian National Institute of
- [GVN Forefront of Virology Webinar featuring Dr. Helena Solo-Gabriele](https://gvn.org/webinar/gvn-forefront-of-virology-webinar-featuring-dr-helena-solo-gabriele/) - WELCOME TO Using Wastewater to Track Disease Prevalence Dr. Helena Solo-Gabriele Dr. Helena Solo-Gabriele is a Professor in the Department of Chemical, Environmental, and Materials Engineering at the University of Miami, Coral Gables, FL. As a faculty member she teaches courses in environmental measurements, water and wastewater treatment plant design, and in environmental engineering microbiology.
- [GVN-USF Forefront of Virology Webinar featuring Dr. Benjamin Jacob](https://gvn.org/webinar/gvn-usf-forefront-of-virology-webinar-featuring-dr-benjamin-jacob/) - WELCOME TO Real-Time Geo-AI Mosquito Control: A Case Study from Angola Dr. Benjamin Jacob is a Research Associate Professor of Biostatistics and Data Science at the USF College of Public Health. He holds a Ph.D. in Epidemiology and specializes in AI-infused geospatial public health intelligence. His patented work uses machine learning and drone imagery to
- [GVN - USF Forefront of Virology Webinar featuring Dr. Sten Vermund](https://gvn.org/webinar/gvn-usf-forefront-of-virology-webinar-featuring-dr-sten-vermund/) - WELCOME TO Discovery To Practice Translation: Public Health Implementation of Viral Discovery Sten Vermund, MD, PhD Senior Associate Vice President, USF Health; Dean, USF Health College of Public Health; Director of the Cancer Control Prevention and Epidemiology Program, Tampa General Hospital; Chief Medical Offi cer, Global Virus Network
- [GVN Forefront of Virology Webinar featuring Dr. Gisa Gerold](https://gvn.org/webinar/gvn-forefront-of-virology-webinar-featuring-dr-gisa-gerold/) - WELCOME TO GVN Forefront of Virology Webinar featuring Dr. Gisa Gerold Gisa Gerold is a researcher at the Institute of Virology, Medical University of Innsbruck in Austria. Dr. Gerold's research integrates mass spectrometry-based proteomics and CRISPR-based gene editing to identify and characterize host factors, such as human CD81, that are essential for the replication of
- [GVN - USF Forefront of Virology Webinar featuring Dr. Luigi Buonaguro](https://gvn.org/webinar/gvn-usf-forefront-of-virology-webinar-featuring-dr-luigi-buonaguro/) - WELCOME TO Molecular mimicry as strategy for anti-cancer immunity Dr. Luigi Buonaguro is a leading Italian scientist specializing in virology and cancer research. He is the Director of the "Innovative Immunological Models" Lab at the Istituto Nazionale Tumori "Fondazione G. Pascale" in Naples, a position he has held since April 2020. His work is focused
- [GVN Forefront of Virology Webinar featuring Dr. Hongshuo Song](https://gvn.org/webinar/gvn-forefront-of-virology-webinar-featuring-dr-hongshuo-song/) - WELCOME TO Escape by Shifting: Viral entry pathway alteration as an evolutionary mechanism of immune evasion Dr. Hongshuo Song is an Associate Professor at the University of South Florida. The research in her lab focuses on the fundamental aspects of HIV molecular virology, transmissibility, and immunopathogenesis. She holds a medical degree and a Ph.D. from
- [GVN Forefront of Virology Webinar featuring Dr. Nadia Sam-Agudu](https://gvn.org/webinar/gvn-forefront-of-virology-webinar-featuring-dr-nadia-sam-agudu/) - WELCOME TO Viruses without Borders: Global Health Research in Pandemic Responses Dr. Nadia A. Sam-Agudu is a distinguished physician, researcher, and a leading voice in global pediatrics, infectious diseases, and implementation science. She's a Professor of Pediatrics at the University of Minnesota Medical School and a Senior Technical Advisor for pediatric and adolescent HIV at
- [GVN-USF Forefront of Virology Webinar Featuring Dr. Ali Mirazimi](https://gvn.org/webinar/gvn-usf-forefront-of-virology-webinar-featuring-dr-ali-mirazimi/) - WELCOME TO Uncovering How Crimean-Congo Hemorrhagic Fever Virus Hijacks Cells: The Key Role of the LDL Receptor in Its Replication. Ali Mirazimi, PhD, is a Professor at Karolinska Institutet and a senior expert at both the Public Health Agency of Sweden and Head of Section at the National Veterinary Institute. He is also a member
- [Genetics As A Compass For Life-Threatening Viral Encephalitis](https://gvn.org/webinar/genetics-as-a-compass-for-life-threatening-viral-encephalitis/) - WELCOME TO Genetics As A Compass For Life-Threatening Viral Encephalitis Dr Yi-Hao Chan Dr Yi-Hao Chan completed his PhD with the A*STAR Graduate Scholarship on immune pathogenesis of alphaviruses. He was then awarded the A*STAR International Fellowship to pursue his postdoctoral training in Rockefeller University in New York, USA, under the tutelage of Dr Jean-Laurent
- [GVN Forefront of Virology Webinar featuring Dr. Boghuma K. Titanji](https://gvn.org/webinar/gvn-forefront-of-virology-webinar-featuring-dr-boghuma-k-titanji/) - WELCOME TO The Global Outbreak of Mpox - Implications for Pandemic Preparedness in the Wake of COVID-19 Boghuma Kabisen Titanji, MD, PhD, MSc, DTM&H, is a physician-scientist and Assistant Professor of Medicine at Emory University. Originally from Cameroon, she earned her medical degree from the University of Yaoundé I and later completed a master's in
- [GVN: Forefront Of Virology COVID-19 Webinar Series featuring Dr. Linfa Wang](https://gvn.org/webinar/gvn-forefront-of-virology-covid-19-webinar-series-featuring-dr-linfa-wang/) - WELCOME TO FEATURING DR. LINFA WANG – JUNE 5, 2020 – “ROLE OF SEROLOGY IN THE NEXT PHASE OF COVID-19 INVESTIGATION AND RESPONSE” Linfa Wang Director, GVN Center of Excellence GVN SARS-CoV-2 Task Force Member Director of the Program in Emerging Infectious Diseases Professor, Duke-NUS Medical School, Singapore Bio sketch Professor Linfa Wang, PhD is the
- [GVN: Forefront Of Virology COVID-19 Webinar Series featuring Dr. Johan Neyts](https://gvn.org/webinar/gvn-forefront-of-virology-covid-19-webinar-series-featuring-dr-johan-neyts/) - WELCOME TO FEATURING DR. JOHAN NEYTS – JUNE 19, 2020 – “THE BATTLE OF LEUVEN AGAINST SARS-COV-2: ANTIVIRAL STRATEGIES, VACCINE DEVELOPMENT, AND THE HAMSTER MODEL” Johan Neyts Director, GVN Center of Excellence GVN SARS-CoV-2 Task Force Member Professor, Rega Institute for Medical Research, University of Leuven, Belgium Bio sketch Johan Neyts is full professor of
- [GVN: Forefront Of Virology COVID-19 Webinar Series featuring Dr. Erica Ollmann Saphire](https://gvn.org/webinar/gvn-forefront-of-virology-covid-19-webinar-series-featuring-dr-erica-ollmann-saphire/) - WELCOME TO FEATURING DR. ERICA OLLMANN SAPHIRE – JULY 9, 2020 – “A GLOBAL COLLABORATION FOR ANTIBODY THERAPEUTICS” Erica Ollmann Saphire Director, GVN Center of Excellence GVN SARS-CoV-2 Task Force Member Professor, La Jolla Institute for Immunology, Scripps Research Institute, USA Bio sketch Erica Ollmann Saphire, Ph.D., is a Professor of the La Jolla Institute
- [GVN: Forefront Of Virology COVID-19 Webinar Series featuring Dr. Kanta Subbarao](https://gvn.org/webinar/gvn-forefront-of-virology-covid-19-webinar-series-featuring-dr-kanta-subbarao/) - WELCOME TO FEATURING DR. KANTA SUBBARAO – JULY 23, 2020 – “COVID-19 THROUGH A SARS-1 LENS” Kanta Subbarao Director of the WHO Collaborating Centre for Reference and Research on Influenza Peter Doherty Institute for Infection and Immunity, Australia Bio sketch Professor Kanta Subbarao was appointed Director of the WHO Collaborating Centre for Reference and Research
- [GVN: Forefront Of Virology COVID-19 Webinar Series featuring Dr. Jonathan Sexton](https://gvn.org/webinar/gvn-forefront-of-virology-covid-19-webinar-series-featuring-dr-jonathan-sexton/) - WELCOME TO FEATURING DR. JONATHAN SEXTON – AUGUST 13, 2020 – “MORPHOLOGIC CELL PROFILING OF SARS-COV-2 INFECTED CELLS ENABLES DRUG REPURPOSING SCREENING” Jonathan Sexton Assistant Professor of Internal Medicine, Medical School Assistant Professor of Medicinal Chemistry, College of Pharmacy University of Michigan, USA Member, Global Virus Network Bio sketch Jonny Sexton is an assistant professor
- [GVN: Forefront Of Virology COVID-19 Webinar Series featuring Dr. Richard Scheuermann](https://gvn.org/webinar/gvn-forefront-of-virology-covid-19-webinar-series-featuring-dr-richard-scheuermann/) - WELCOME TO FEATURING DR. RICHARD SCHEUERMANN – SEPTEMBER 18, 2020 – “COMPUTATIONAL AND BIOINFORMATICS RESOURCES TO SUPPORT SARS-COV-2 RESEARCH IN THE VIRUS PATHOGEN RESOURCE (VIPR)” Richard Scheuermann Director, La Jolla Campus at the J. Craig Venter Institute (JCVI) Professor, University of California, San Diego Director, GVN Center of Excellence GVN SARS-CoV Task Force Member Bio
- [GVN: Forefront Of Virology COVID-19 Webinar Series featuring Dr. Damian Purcell](https://gvn.org/webinar/gvn-forefront-of-virology-covid-19-webinar-series-featuring-dr-damian-purcell/) - WELCOME TO FEATURING DR. DAMIAN PURCELL – OCTOBER 8, 2020 – “UTILISING DIAGNOSTIC SARS-COV-2 GENOMICS FOR VIROLOGY AND VACCINE RESEARCH” Damian Purcell Head of the Molecular Virology Laboratory in the Department of Microbiology and Immunology University of Melbourne The Doherty Institute for Infection and Immunity, Australia Bio sketch Professor Damian Purcell is head of the
- [GVN: Forefront Of Virology COVID-19 Webinar Series featuring Dr. Yiming Shao](https://gvn.org/webinar/gvn-forefront-of-virology-covid-19-webinar-series-featuring-dr-yiming-shao/) - WELCOME TO DR. YIMING SHAO – DECEMBER 3, 2020 – “CHINA’S COVID-19 CONTROL RESPONSE AND EFFORTS” Dr. Yiming Shao Chief Expert on AIDS, Chinese Center for Disease Control and Prevention Director of the Division of Research on Virology and Immunology, National Center for AIDS/STD Control and Prevention, China Member of the GVN SARS-CoV-2 Task Force
- [GVN: Forefront Of Virology COVID-19 Webinar Series featuring Dr. Ralph Baric](https://gvn.org/webinar/gvn-forefront-of-virology-covid-19-webinar-series-featuring-dr-ralph-baric/) - WELCOME TO FEATURING DR. RALPH BARIC – FEBRUARY 25, 2021 – “NEW INSIGHTS INTO COVID-19 REPLICATION AND PATHOGENESIS” Dr. Ralph Baric Professor, Department of Epidemiology Professor, Department of Microbiology and Immunology Member, Lineberger Comprehensive Cancer Center The University of North Carolina, United States Bio sketch Dr. Baric is a Distinguished Professor in the Department of
- [GVN: Forefront Of Virology COVID-19 Webinar Series featuring Dr. Scott Weaver](https://gvn.org/webinar/gvn-forefront-of-virology-covid-19-webinar-series-featuring-dr-scott-weaver/) - WELCOME TO FEATURING DR. SCOTT WEAVER – MARCH 25, 2021 – “VARIANTS OF SARS-COV-2: STUDIES OF TRANSMISSION EFFICIENCY AND SUSCEPTIBILITY TO VACCINE-INDUCED IMMUNITY” Dr. Scott Weaver Chair, Department of Microbiology & Immunology Director, Institute for Human Infections & Immunity Scientific Director, Galveston National Laboratory Professor, Microbiology & Immunology and Pathology GVN Center Director, UTMB Bio sketch
- [GVN: Forefront Of Virology COVID-19 Webinar Series featuring Dr. Penny Moore](https://gvn.org/webinar/gvn-forefront-of-virology-covid-19-webinar-series-featuring-dr-penny-moore/) - WELCOME TO FEATURING DR. PENNY MOORE – APRIL 19, 2021 – “IMMUNITY TO SARS-COV-2 502Y.V2 – IMPLICATIONS FOR VACCINES” Dr. Penny Moore NRF/DST South African Research Chair of Virus-Host Dynamics Reader/Associate Professor, University of the Witwatersrand / National Institute for Communicable Diseases (NICD), South Africa GVN Center Director Bio sketch Prof. Penny Moore is the South African Research
- [GVN: Forefront Of Virology COVID-19 Webinar Series featuring Dr. Gavin Cloherty](https://gvn.org/webinar/gvn-forefront-of-virology-covid-19-webinar-series-featuring-dr-gavin-cloherty/) - WELCOME TO FEATURING DR. GAVIN CLOHERTY – MAY 12, 2021 – “ABBOTT PANDEMIC DEFENSE COALITION – LEGACY AND FUTURE OF ABBOTT INFECTIOUS DISEASE RESEARCH.” Dr. Gavin Cloherty Head of Infectious Disease Research at Abbott, USA Research Fellow in Abbott’s Volwiler Society GVN Corporate Center Director Bio sketch Gavin Cloherty received his bachelors and doctoral degrees
- [GVN: Forefront Of Virology COVID-19 Webinar Series featuring Dr. Marion Koopmans](https://gvn.org/webinar/gvn-forefront-of-virology-covid-19-webinar-series-featuring-dr-marion-koopmans/) - WELCOME TO FEATURING DR. MARION KOOPMANS – JUNE 14, 2021 – “ORIGINS OF SARS-COV-2: THE CHINA MISSION” Marion Koopmans Head of Erasmus University Medical Center Rotterdam Department of Viroscience, Rotterdam, Netherlands GVN Center Director Bio sketch Professor Marion Koopmans, DVM, PhD, focuses on global population level impact of rapidly spreading zoonotic virus infections, with special emphasis
- [GVN: Forefront Of Virology COVID-19 Webinar Series featuring Dr. Donald Ingber](https://gvn.org/webinar/gvn-forefront-of-virology-covid-19-webinar-series-featuring-dr-donald-ingber/) - WELCOME TO FEATURING DR. DONALD INGBER – JULY 27, 2021 – “HUMAN ORGAN CHIP-ENABLED DISCOVERY OF ANTIVIRAL THERAPEUTICS FOR INFLUENZA, COVID-19, AND BEYOND” Donald Ingber, MD, PhD Founding Director Wyss Institute for Biologically Inspired Engineering at Harvard University, USA GVN Center Director Bio sketch Donald E. Ingber, MD, PhD is the Founding Director of the
- [GVN: Forefront Of Virology COVID-19 Webinar Series featuring Dr. Youngmee Jee](https://gvn.org/webinar/gvn-forefront-of-virology-covid-19-webinar-series-featuring-dr-youngmee-jee/) - WELCOME TO FEATURING DR. YOUNGMEE JEE – AUGUST 30, 2021 – “COVID-19 RESEARCH IN INSTITUT PASTEUR KOREA” Youngmee Jee, MD, PhD CEO Institut Pasteur Korea, South Korea GVN Center Director Bio sketch Dr. Youngmee Jee (M.D., Ph.D) is Chief Executive Officer of the Institut Pasteur Korea and also serves as Special Representative for Health Diplomacy,
- [GVN: Forefront Of Virology COVID-19 Webinar Series featuring Dr. Matthew Frieman](https://gvn.org/webinar/gvn-forefront-of-virology-covid-19-webinar-series-featuring-dr-matthew-frieman/) - WELCOME TO FEATURING DR. MATTHEW FRIEMAN – OCTOBER 20, 2021 – “PATHOGENESIS AND THERAPEUTIC DEVELOPMENT FOR SARS-COV-2” Matthew Frieman, PhD Associate Professor Microbiology and Immunology University of Maryland School of Medicine Associate Member, Institute of Human Virology GVN Member Bio sketch Dr. Matthew Frieman, PhD, is an Associate Professor at the University of Maryland School
- [GVN: Forefront Of Virology COVID-19 Webinar Series featuring Dr. Robert F. Garry](https://gvn.org/webinar/gvn-forefront-of-virology-covid-19-webinar-series-featuring-dr-robert-f-garry/) - WELCOME TO DR. ROBERT F. GARRY – NOVEMBER 17, 2021 – “SARS-COV-2 – ORIGINS, EVOLUTION, AND FUTURE” Robert F. Garry, PhD Professor of Microbiology and Immunology Assistant Dean for Biomedical Sciences Tulane University School of Medicine GVN Center Director Bio sketch Dr. Robert F. Garry, PhD is a Professor in the Department of Microbiology and Immunology at
- [DR. EMMA THOMSON – APRIL 7, 2022 – “CHARACTERISING THE OMICRON VARIANT OF SARS-COV-2”](https://gvn.org/webinar/gvn-forefront-of-virology-covid-19-webinar-featuring-dr-emma-thomson/) - WELCOME TO DR. EMMA THOMSON – APRIL 7, 2022 – “CHARACTERISING THE OMICRON VARIANT OF SARS-COV-2” Dr. Emma Thomson Professor of Clinical Infectious Diseases MRC-University of Glasgow Centre for Virus Research London School of Hygiene and Tropical Medicine GVN Member Bio sketch Emma Thomson is clinical professor of infectious diseases at the MRC-University of Virus
- [DR. MAURICIO L. NOGUEIRA – MARCH 10, 2022 – “REVISITING THE DENGUE-ZIKA INTERACTIONS: EVIDENCE OF COMPLEX IMMUNE INTERPLAY”](https://gvn.org/webinar/gvn-forefront-of-virology-webinar-featuring-dr-mauricio-l-nogueira/) - WELCOME TO DR. MAURICIO L. NOGUEIRA – MARCH 10, 2022 – “REVISITING THE DENGUE-ZIKA INTERACTIONS: EVIDENCE OF COMPLEX IMMUNE INTERPLAY” Dr. Mauricio L. Nogueira Professor of Microbiology and Infectious Diseases Faculdade de Medicina de SJ Rio Preto (FAMERP) Brazil Bio Sketch Mauricio L. Nogueira is a Professor of Microbiology and Infectious Diseases at Faculdade de
- [DR. RUBESHAN PERUMAL – FEBRUARY 17, 2022 – “LONG COVID – THE TSUNAMI AFTER THE WAVES”](https://gvn.org/webinar/gvn-forefront-of-virology-covid-19-webinar-featuring-dr-rubeshan-perumal/) - WELCOME TO DR. RUBESHAN PERUMAL – FEBRUARY 17, 2022 – “LONG COVID – THE TSUNAMI AFTER THE WAVES” Dr. Rubeshan Perumal Senior Scientist Centre for the AIDS Programme of Research in South Africa (CAPRISA) Specialist Physician and Pulmonologist University of KwaZulu-Natal, South Africa GVN Member Bio sketch Dr. Rubeshan Perumal (MBChB, MPH, MMed, MPhil, FCP(SA),
- [DR. DAVID OSTROV – FEBRUARY 3, 2022 – “HIGHLY SPECIFIC SIGMA RECEPTOR LIGANDS EXHIBIT ANTI-VIRAL PROPERTIES IN SARS-COV-2 INFECTED CELLS”](https://gvn.org/webinar/gvn-forefront-of-virology-covid-19-webinar-series-featuring-dr-david-ostrov/) - WELCOME TO DR. DAVID OSTROV – FEBRUARY 3, 2022 – “HIGHLY SPECIFIC SIGMA RECEPTOR LIGANDS EXHIBIT ANTI-VIRAL PROPERTIES IN SARS-COV-2 INFECTED CELLS” Dr. David Ostrov Associate Professor Department of Pathology, Immunology and Laboratory Medicine University of Florida College of Medicine GVN Member Bio sketch David Ostrov received his PhD from the University of Washington School of
- [GVN: Forefront of Virology COVID-19 Webinar Featuring Dr. Diane Griffin](https://gvn.org/webinar/gvn-forefront-of-virology-webinar-featuring-dr-diane-griffin/) - WELCOME TO Dr. Diane Griffin - September 23, 2022 - "RNA persistence after acute RNA virus infections: Lessons for COVID" Dr. Diane Griffin University Distinguished Service Professor W. Harry Feinstone Department of Molecular Microbiology and Immunology Johns Hopkins Bloomberg School of Public Health GVN Center Director Bio sketch Diane E. Griffin, MD PhD is Johns
- [GVN: Forefront of Virology COVID-19 Webinar featuring Drs. Nicolas Hoertel and Céline Cougoule](https://gvn.org/webinar/gvn-webinar-hoertel-cougoule-2022/) - WELCOME TO Drs. Nicolas Hoertel and Céline Cougoule - June 17, 2022 - "Fluoxetine and fluvoxamine for COVID-19: From bed to bench… to bed" Dr. Céline Cougoule, PhD HDR – CNRS & University of Toulouse Dr. Nicolas Hoertel, MD, MPH, PhD Paris Cité University, INSERM & Corentin-Celton Hospital Biosketches: Céline Cougoule is a CNRS research
- [GVN: Forefront of Virology COVID-19 Webinar Featuring Dr. Avindra Nath](https://gvn.org/webinar/gvn-webinar-nath-2022/) - WELCOME TO Dr. Avindra Nath - June 27, 2022 - "Neurological complications of SARS-CoV-2" Dr. Avindra Nath Chief, Section of Infections of the Nervous System at the National Institute of Neurological Disorders and Stroke NIH Biosketch: Dr. Avindra Nath is a physician–scientist who specializes in neuro-immunology and neurovirology. His research is focused on the clinical
- [GVN: Forefront of Virology COVID-19 Webinar Featuring Dr. Rachel Roper](https://gvn.org/webinar/gvn-forefront-of-virology-webinar-featuring-dr-rachel-roper/) - WELCOME TO Dr. Rachel Roper - November 14, 2022 - "Monkeypox virus, vaccines and virulence" Rachel Roper, MS, PhD Professor, Microbiology & Immunology Brody School of Medicine Co-Chair, Global Virus Network Monkeypox Task Force Adjunct Professor, Biology Adjunct Professor, School of Dental Medicine East Carolina University Bio sketch Dr. Roper is a Professor of Microbiology
- [GVN: Forefront of Virology COVID-19 Webinar Featuring Dr. Stephan Becker](https://gvn.org/webinar/gvn-forefront-of-virology-webinar-featuring-dr-stephan-becker/) - WELCOME TO Dr. Stephan Becker - January 23, 2023 - "Posttranslational modifications affecting Ebola virus transcription and budding" Stephan Becker, PhD Professor of VirologyDirector, Institute of VirologyPhilipps University Marburg, GermanyGVN Center Director Bio sketch Stephan Becker, PhD, is Professor of Virology and Director of the Institute of Virology at Philipps University Marburg. His research focuses on
- [GVN: Forefront of Virology COVID-19 Webinar Featuring Dr. Ulrike Protzer](https://gvn.org/webinar/gvn-webinar-protzer-2023/) - WELCOME TO Dr. Ulrike Protzer - April 17, 2023 - "HBV Cure: Fact or Fiction" Dr. Ulrike Protzer Chair for Virology Technical University of Munich and Helmholtz Munich, Germany GVN Center of Excellence Director Biosketch: Ulrike Protzer is an expert virologist with many years of research in molecular virology, virus-host interaction and immunology. Ulrike studied
- [GVN: Forefront of Virology COVID-19 Webinar Featuring Dr. Hervé Perron](https://gvn.org/webinar/gvn-webinar-perron-2023/) - WELCOME TO Dr. Hervé Perron - May 15, 2023 - "Post-COVID Syndrome as a Post-Viral Disease" Dr. Hervé Perron, PhD University of Lyon, France Chief Scientific Officer of GeNeuro, Switzerland Dr. Perron Personal Statement: During my PhD, I isolated and characterized a novel retroviral element from Multiple Sclerosis (initially named MSRV), itself defining a novel
- [GVN: Forefront of Virology COVID-19 Webinar Featuring Dr. Alessandro Sette](https://gvn.org/webinar/gvn-webinar-sette-2023/) - WELCOME TO Dr. Alessandro Sette - June 1, 2023 - "Adaptive T cell responses to SARS-CoV-2 and its variants in infection and vaccination" Dr. Alessandro Sette Professor and GVN Member La Jolla Institute for Immunology Center for Infectious Disease and Vaccine Research Center for Autoimmunity and Inflammation University of California, School of Medicine Biosketch: Dr.
- [GVN: Forefront of Virology Webinar Featuring Dr. Michaela Gack](https://gvn.org/webinar/gvn-webinar-gack-2023/) - WELCOME TO Dr. Michaela Gack - August 24, 2023 - "Innate and intrinsic host enzymes shaping RNA virus infection" Dr. Michaela Gack, PhD Cleveland Clinic Florida Research & Innovation Center Scientific Director Arthur and Marylin Levitt Endowed Chair GVN Center Director Dr. Gack did her Ph.D. studies in virology at Harvard Medical School as part
- [GVN: Forefront of Virology Webinar Featuring Dr. Prasert Auewarakul](https://gvn.org/webinar/gvn-webinar-auewarakul-2023/) - WELCOME TO Dr. Prasert Auewarakul - November 16, 2023 - "Broad-spectrum antiviral development for emerging and endemic viruses" Dr. Prasert Auewarakul Professor of Virology Faculty of Medicine Siriraj Hospital Mahidol University, Thailand GVN Center Director Dr. Prasert Auewarakul is a professor of virology at the Faculty of Medicine Siriraj Hospital, Mahidol University. He graduated with
- [GVN: Forefront of Virology Webinar Featuring Dr. Maggie L. Bartlett](https://gvn.org/webinar/gvn-webinar-bartlett-2024/) - WELCOME TO Dr. Maggie L. Bartlett - January 31, 2024 - "Multimodal single cell sequencing for biomarker discovery, mechanisms of persistence, and viral kinetics" Maggie L. Bartlett, PhD Program Director, Global Virus Network Faculty, Johns Hopkins Bloomberg School of Public Health Dr. Maggie L. Bartlett is Faculty at Johns Hopkins Bloomberg School of Public
- [GVN: Forefront of Virology Webinar Featuring Drs. Marianna Cortese & Kjetil Bjornevik](https://gvn.org/webinar/gvn-webinar-cortese-bjornevik-2024/) - WELCOME TO Drs. Marianna Cortese & Kjetil Bjornevik - March 27, 2024 - "The role of the Epstein-Barr Virus in Multiple Sclerosis" Marianna Cortese, MD, PhD Senior Research Scientist Department of Nutrition, Harvard T.H. Chan School of Public Health Dr. Cortese is a Senior Research Scientist at the Harvard T.H. Chan School of Public
- [Forefront of Virology Webinar Featuring Dr. Wern Hann Ng](https://gvn.org/webinar/gvn-webinar-wern-hann-ng-2024/) - WELCOME TO Dr. Wern Hann Ng - April 30, 2024 - "The role of FHL1 in alphavirus replication and pathogenesis with implications for alphavirus vaccine design" Wern Hann Ng, PhD Emerging Viruses, Inflammation and Therapeutics Group, Global Virus Network Centre of Excellence in Arboviruses, Menzies Health Institute Queensland, Griffith University Dr. Wern Hann Ng
- [Forefront of Virology Webinar Featuring Dr. Xiang Liu](https://gvn.org/webinar/gvn-webinar-xiang-liu-2024/) - WELCOME TO Dr. Xiang Liu - May 28, 2024 - "Type I IFN Modulation by Alphavirus: Innate Immunity, Ross River Virus, and Disease Pathogenesis" Wern Hann Ng, PhD Institute for Glycomics Global Virus Network Centre of Excellence in Arboviruses Menzies Health Institute Queensland Griffith University Dr. Xiang Liu is a mid-career researcher specializing in arthropod-borne
- [Forefront of Virology Webinar Featuring Dr. Eduardo Gotuzzo](https://gvn.org/webinar/gvn-webinar-eduardo-gotuzzo-2024/) - WELCOME TO Dr. Eduardo Gotuzzo - June 25, 2024 - "HTLV-1 Is also a Sexually Transmitted Infection: New Insights on an Endemic, Oncogenic Virus" Eduardo Gotuzzo, MD FACP FIDSA FESCMID Emeritus Professor Universidad Peruana Cayetano Heredia Instituto de Medicina Tropical "Alexander von Humboldt" Dr. Gotuzzo is Emeritus Professor, Former Director of the Instituto de Medicina
- [Forefront of Virology Webinar Featuring Dr. Abelardo Araujo](https://gvn.org/webinar/gvn-webinar-abelardo-araujo-2024/) - WELCOME TO Dr. Abelardo Araujo - July 30, 2024 - "Neurological Complications of Dengue Fever" Abelardo Araujo, MD, MSc, PhD, FAAN Associate Professor of Neurology, The Federal University of Rio de Janeiro Senior Researcher, The National Institute of Infectious Diseases, FIOCRUZ, Brazilian Ministry of Health Dr. Abelardo Araujo is an Associate Professor of Clinical Neurology
- [Forefront of Virology Webinar Featuring Dr. David Markovitz](https://gvn.org/webinar/gvn-webinar-david-markovitz-2024/) - WELCOME TO Dr. David Markovitz - August 27, 2024 - "A Molecularly Engineered Lectin for the Prevention and Treatment of Coronavirus and Influenza Infection: a Sweet Deal" David Markovitz, MD Professor of Internal Medicine in the Division of Infectious Diseases, University of Michigan David Markovitz, MD, is a Professor of Internal Medicine in the Division
- [Forefront of Virology Webinar featuring Dr. Esteban Domingo](https://gvn.org/webinar/quasispecies-and-error-catastrophe-the-be-or-not-to-be-of-sars-cov-2-genomes/) - WELCOME TO GVN Forefront of Virology Webinar featuring Dr. Esteban Domingo - Quasispecies and Error Catastrophe: The "Be Or Not To Be" of SARS-COV-2 Genomes Esteban Domingo Solans, PhD Emeritus Professor of Research at the Spanish Research Council (CSIC) GVN Center Directo Esteban Domingo Solans, PhD, is "ad honorem" (emeritus) Professor of Research at the
- [GVN Forefront of Virology Webinar featuring Dr. Mark Mimee](https://gvn.org/webinar/lessons-learned-from-using-bacteriophage-cocktails-to-combat-antibiotic-resistant-pathogens-in-the-gut/) - WELCOME TO Lessons Learned from Using Bacteriophage Cocktails to Combat Antibiotic-Resistant Pathogens in the Gut Dr. Mark Mimee Dr. Mimee is an Assistant Professor at the University of Chicago, specializing in synthetic biology and microbiology. After earning a BSc in Microbiology and Immunology at McGill University, they completed a PhD at MIT as an HHMI
- [GVN Forefront of Virology Webinar featuring Prof. Patrick Dakum](https://gvn.org/webinar/hiv-tb-implementation-science-strategies-from-ihv-nigerias-journey/) - WELCOME TO HIV & TB Implementation Science: Strategies from IHV Nigeria's Journey. Prof. Patrick Dakum, MBBS, MPH Prof. Patrick Dakum, MBBS, MPH is a distinguished Nigerian public health physician, implementation scientist, and the Chief Executive Officer of the Institute of Human Virology Nigeria (IHVN). With over 42 years of experience, Dr. Dakum has led IHVN's
- [GVN Forefront of Virology Webinar featuring Dr. Christine Stabell Benn](https://gvn.org/webinar/beyond-prevention-exploring-the-broad-impact-of-vaccines-and-global-health-collaboration/) - WELCOME TO Beyond Prevention: Exploring the Broad Impact of Vaccines and Global Health Collaboration. Dr. Christine Stabell Benn, MD, PhD, DMSc, MAE, is a Professor of Global Health at the University of Southern Denmark and a Chair at the Danish Institute for Advanced Study. She has worked with the Bandim Health Project in Guinea-Bissau since

## Categories

- [Uncategorized](https://gvn.org/category/uncategorized/)
- [Press Release](https://gvn.org/category/press-release/)
- [Board Members](https://gvn.org/category/board-members/)
- [Flu Epidemic](https://gvn.org/category/flu-epidemic/)
- [News](https://gvn.org/category/news/)
- [Centers of Excellence](https://gvn.org/category/centers-of-excellence/)
- [Vaccines](https://gvn.org/category/vaccines/)
- [Awards](https://gvn.org/category/awards/)
- [Zika Task Force Members](https://gvn.org/category/zika-task-force-members/)
- [GVN SARS-CoV-2 Perspectives](https://gvn.org/category/gvn-sars-cov-2-perspectives/)
- [SARS-CoV-2](https://gvn.org/category/sars-cov-2/)
- [Organization Structure](https://gvn.org/category/organization-structure/)
- [HIV](https://gvn.org/category/hiv/)
- [Camel Fever](https://gvn.org/category/camel-fever/)
- [Chikunguna](https://gvn.org/category/chikunguna/)
- [Measles](https://gvn.org/category/measles/)
- [Viral Diseases](https://gvn.org/category/viral-diseases/)
- [Ebola](https://gvn.org/category/ebola/)
- [meeting](https://gvn.org/category/meeting/)
- [Research](https://gvn.org/category/research/)
- [Researcher](https://gvn.org/category/researcher/)
- [Experts](https://gvn.org/category/experts/)
- [Blog](https://gvn.org/category/blog/)
- [The Other Side of Virology: Beyond the COVID-19 Pandemic](https://gvn.org/category/the-other-side-of-virology-beyond-the-covid-19-pandemic/)
- [Hepatitis](https://gvn.org/category/hepatitis/)
- [Alumni Scientific Updates](https://gvn.org/category/alumni-scientific-updates/)
- [Positions](https://gvn.org/category/positions/)
- [MPOX](https://gvn.org/category/mpox/)
- [Scientific Meeting](https://gvn.org/category/scientific-meeting/)
- [Regional](https://gvn.org/category/regional/)
- [Annual](https://gvn.org/category/annual/)
- [Statements](https://gvn.org/category/news/statements/)
- [Global Guardians](https://gvn.org/category/global-guardians/)

## Tags

- [Advisory Committee Members](https://gvn.org/tag/advisory-committee-members/)
- [Board Members](https://gvn.org/tag/board-members/)
- [Global Virus Network](https://gvn.org/tag/global-virus-network/)
- [Measles](https://gvn.org/tag/measles/)
- [HIV](https://gvn.org/tag/hiv/)
- [MERS](https://gvn.org/tag/mers/)
- [SARS-Co-2](https://gvn.org/tag/sars-co-2/)
- [Cicada](https://gvn.org/tag/cicada/)
- [mmr](https://gvn.org/tag/mmr/)
- [vaccination](https://gvn.org/tag/vaccination/)
- [MeaslesOutbreak](https://gvn.org/tag/measlesoutbreak/)
- [Immunization](https://gvn.org/tag/immunization/)
- [hantavirus](https://gvn.org/tag/hantavirus/)
- [outbreak](https://gvn.org/tag/outbreak/)
- [ebola](https://gvn.org/tag/ebola/)
- [ebolaoutbreak](https://gvn.org/tag/ebolaoutbreak/)
- [global guardians](https://gvn.org/tag/global-guardians/)
- [education](https://gvn.org/tag/education/)